ICD-10 code | ICD-10 name | n_patients | n_controls | Relative Risk | Fisher's uncorrected p-value | FDR | Median age at first diagnosis (SD) | Syndrome | In suppl. table | Analysis |
---|---|---|---|---|---|---|---|---|---|---|
A04 | Other bacterial intestinal infections | 26 | 147 | 3.181 | 0.00000247 | 0.00000818 | 27.43 (24.21) | Down syndrome | Table_S1 | Direct comorbidity |
A04 | Other bacterial intestinal infections | 20 | 98 | 3.617 | 0.00000728 | 0.0000239 | 25.33 (22.87) | Down syndrome | Table_S3 | Male DS direct comorbidity |
A04 | Other bacterial intestinal infections | 10 | 46 | 4.082 | 0.000758 | 0.00211 | 4.17 (21.97) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
A08 | Viral and other specified intestinal infections | 98 | 568 | 3.034 | 3.7e-19 | 1.23e-18 | 4.61 (16.08) | Down syndrome | Table_S1 | Direct comorbidity |
A08 | Viral and other specified intestinal infections | 17 | 81 | 3.556 | 0.0000433 | 0.000262 | 21.55 (23.4) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
A08 | Viral and other specified intestinal infections | 7 | 12 | 10.949 | 0.0000197 | 0.0000482 | 1.43 (2.03) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
A08 | Viral and other specified intestinal infections | 6 | 12 | 8.969 | 0.000242 | 0.000774 | 4.08 (4.32) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
A08 | Viral and other specified intestinal infections | 9 | 33 | 5.280 | 0.000183 | 0.000511 | 1.63 (0.96) | Angelman syndrome | Table_S1 | Direct comorbidity |
A08 | Viral and other specified intestinal infections | 43 | 280 | 2.786 | 0.0000000311 | 0.00000011 | 2.98 (14.67) | Down syndrome | Table_S3 | Female DS direct comorbidity |
A08 | Viral and other specified intestinal infections | 55 | 309 | 3.080 | 0.0000000000137 | 0.0000000000448 | 7.03 (16.83) | Down syndrome | Table_S3 | Male DS direct comorbidity |
A08 | Viral and other specified intestinal infections | 54 | 223 | 4.282 | 1.33e-16 | 3.69e-16 | 2.65 (6.13) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
A09 | Diarrhoea and gastroenteritis of presumed infectious origin | 267 | 1995 | 2.341 | 3.25e-33 | 1.07e-32 | 6.61 (19.75) | Down syndrome | Table_S1 | Direct comorbidity |
A09 | Diarrhoea and gastroenteritis of presumed infectious origin | 44 | 508 | 1.524 | 0.0079 | 0.0364 | 7.2 (21.25) | Turner syndrome | Table_S1 | Direct comorbidity |
A09 | Diarrhoea and gastroenteritis of presumed infectious origin | 16 | 41 | 7.202 | 0.00000000267 | 0.00000000653 | 4.17 (3.89) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
A09 | Diarrhoea and gastroenteritis of presumed infectious origin | 12 | 41 | 5.156 | 0.0000122 | 0.0000391 | 1.26 (8.71) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
A09 | Diarrhoea and gastroenteritis of presumed infectious origin | 11 | 68 | 3.122 | 0.00178 | 0.00495 | 5.53 (6.6) | Angelman syndrome | Table_S1 | Direct comorbidity |
A09 | Diarrhoea and gastroenteritis of presumed infectious origin | 19 | 151 | 2.270 | 0.00185 | 0.0178 | 1.7 (14.24) | Fragile X syndrome | Table_S1 | Direct comorbidity |
A09 | Diarrhoea and gastroenteritis of presumed infectious origin | 90 | 967 | 1.673 | 0.00000746 | 0.0000264 | 9.08 (21.47) | Down syndrome | Table_S3 | Female DS direct comorbidity |
A09 | Diarrhoea and gastroenteritis of presumed infectious origin | 177 | 1084 | 2.798 | 1.18e-30 | 3.85e-30 | 6.03 (18.72) | Down syndrome | Table_S3 | Male DS direct comorbidity |
A09 | Diarrhoea and gastroenteritis of presumed infectious origin | 7 | 26 | 5.185 | 0.00111 | 0.0179 | 4.64 (18.6) | Fragile X syndrome | Table_S5 | Female FXS direct comorbidity |
A09 | Diarrhoea and gastroenteritis of presumed infectious origin | 131 | 768 | 2.994 | 6.27e-26 | 1.74e-25 | 4.19 (11.36) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
A38 | Scarlet fever | 13 | 25 | 9.390 | 0.0000000513 | 0.00000017 | 4.07 (12.46) | Down syndrome | Table_S1 | Direct comorbidity |
A38 | Scarlet fever | 7 | 12 | 10.949 | 0.0000339 | 0.00012 | 4.4 (14.42) | Down syndrome | Table_S3 | Female DS direct comorbidity |
A38 | Scarlet fever | 6 | 21 | 5.426 | 0.00309 | 0.0101 | 3.02 (9.17) | Down syndrome | Table_S3 | Male DS direct comorbidity |
A38 | Scarlet fever | 11 | 10 | 19.027 | 0.00000000237 | 0.0000000066 | 3.58 (2.27) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
A39 | Meningococcal infection | 11 | 39 | 5.232 | 0.0000611 | 0.000202 | 4.23 (21.34) | Down syndrome | Table_S1 | Direct comorbidity |
A39 | Meningococcal infection | 6 | 15 | 7.784 | 0.000607 | 0.00215 | 9.29 (21.61) | Down syndrome | Table_S3 | Female DS direct comorbidity |
A39 | Meningococcal infection | 5 | 17 | 5.684 | 0.00617 | 0.0202 | 2.94 (20.77) | Down syndrome | Table_S3 | Male DS direct comorbidity |
A39 | Meningococcal infection | 5 | 21 | 4.757 | 0.0117 | 0.0325 | 2.94 (5.1) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
A40 | Streptococcal septicaemia | 16 | 85 | 3.447 | 0.000106 | 0.000352 | 9.81 (27.6) | Down syndrome | Table_S1 | Direct comorbidity |
A40 | Streptococcal septicaemia | 10 | 31 | 6.116 | 0.0000431 | 0.000153 | 5.12 (29.73) | Down syndrome | Table_S3 | Female DS direct comorbidity |
A40 | Streptococcal septicaemia | 6 | 28 | 4.116 | 0.0101 | 0.0331 | 26.51 (23.62) | Down syndrome | Table_S3 | Male DS direct comorbidity |
A40 | Streptococcal septicaemia | 5 | 21 | 4.757 | 0.0117 | 0.0325 | 1.34 (31.42) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
A41 | Other septicaemia | 5 | 19 | 5.425 | 0.00673 | 0.0325 | 5.69 (27.61) | Edwards syndrome | Table_S1 | Direct comorbidity |
A41 | Other septicaemia | 174 | 770 | 3.958 | 0 | 1.4013e-45 | 47.7 (24.6) | Down syndrome | Table_S1 | Direct comorbidity |
A41 | Other septicaemia | 16 | 136 | 2.139 | 0.0091 | 0.0419 | 58.96 (25.16) | Turner syndrome | Table_S1 | Direct comorbidity |
A41 | Other septicaemia | 74 | 275 | 4.835 | 7e-25 | 2.48e-24 | 44.98 (24.32) | Down syndrome | Table_S3 | Female DS direct comorbidity |
A41 | Other septicaemia | 100 | 458 | 3.752 | 1.28e-25 | 4.18e-25 | 49.43 (24.74) | Down syndrome | Table_S3 | Male DS direct comorbidity |
A41 | Other septicaemia | 50 | 149 | 5.930 | 2.22e-20 | 6.17e-20 | 9.23 (22.69) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
A46 | Erysipelas | 111 | 632 | 3.086 | 4.9e-22 | 1.62e-21 | 46.44 (18.99) | Down syndrome | Table_S1 | Direct comorbidity |
A46 | Erysipelas | 38 | 158 | 3.974 | 0.0000000000346 | 0.000000000209 | 50.77 (14.25) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
A46 | Erysipelas | 17 | 81 | 3.784 | 0.000021 | 0.0000969 | 48.01 (21.89) | Turner syndrome | Table_S1 | Direct comorbidity |
A46 | Erysipelas | 41 | 225 | 3.307 | 0.000000000878 | 0.00000000312 | 45.1 (18.68) | Down syndrome | Table_S3 | Female DS direct comorbidity |
A46 | Erysipelas | 70 | 452 | 2.673 | 0.00000000000762 | 0.000000000025 | 48.37 (19.15) | Down syndrome | Table_S3 | Male DS direct comorbidity |
A46 | Erysipelas | 31 | 95 | 5.814 | 0.000000000000695 | 0.00000000000193 | 19.96 (20.18) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
A46 | Erysipelas | 6 | 22 | 5.136 | 0.00369 | 0.0263 | 29.59 (24.66) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
A49 | Bacterial infection of unspecified site | 81 | 445 | 3.206 | 3.01e-17 | 9.97e-17 | 44.72 (22.93) | Down syndrome | Table_S1 | Direct comorbidity |
A49 | Bacterial infection of unspecified site | 35 | 180 | 3.539 | 0.00000000343 | 0.0000000122 | 44.72 (22.41) | Down syndrome | Table_S3 | Female DS direct comorbidity |
A49 | Bacterial infection of unspecified site | 46 | 264 | 3.024 | 0.00000000114 | 0.00000000374 | 41.02 (23.27) | Down syndrome | Table_S3 | Male DS direct comorbidity |
A49 | Bacterial infection of unspecified site | 25 | 98 | 4.580 | 0.00000000832 | 0.0000000231 | 9.81 (18.25) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
B01 | Varicella [chickenpox] | 32 | 107 | 5.329 | 0.00000000000265 | 0.00000000000878 | 3.24 (11.05) | Down syndrome | Table_S1 | Direct comorbidity |
B01 | Varicella [chickenpox] | 13 | 59 | 4.151 | 0.0000968 | 0.000343 | 3.18 (15.73) | Down syndrome | Table_S3 | Female DS direct comorbidity |
B01 | Varicella [chickenpox] | 19 | 73 | 4.609 | 0.000000566 | 0.00000185 | 3.6 (5.71) | Down syndrome | Table_S3 | Male DS direct comorbidity |
B01 | Varicella [chickenpox] | 22 | 51 | 7.714 | 0.0000000000201 | 0.0000000000558 | 4.18 (4.7) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
B08 | Other viral infections characterized by skin and mucous membrane lesions. not elsewhere classified | 10 | 53 | 3.553 | 0.00193 | 0.00537 | 5.63 (5.3) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
B34 | Viral infection of unspecified site | 260 | 1797 | 2.531 | 3.02e-37 | 1e-36 | 1.95 (8.81) | Down syndrome | Table_S1 | Direct comorbidity |
B34 | Viral infection of unspecified site | 31 | 283 | 1.825 | 0.00264 | 0.0159 | 4.02 (19.15) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
B34 | Viral infection of unspecified site | 20 | 54 | 6.793 | 0.0000000000287 | 0.0000000000703 | 2.48 (6.33) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
B34 | Viral infection of unspecified site | 12 | 52 | 4.085 | 0.0000931 | 0.000298 | 1.98 (4.12) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
B34 | Viral infection of unspecified site | 15 | 84 | 3.379 | 0.0000874 | 0.000243 | 1.38 (1.93) | Angelman syndrome | Table_S1 | Direct comorbidity |
B34 | Viral infection of unspecified site | 110 | 787 | 2.506 | 2.29e-16 | 8.11e-16 | 1.77 (9.07) | Down syndrome | Table_S3 | Female DS direct comorbidity |
B34 | Viral infection of unspecified site | 150 | 992 | 2.593 | 4.15e-23 | 1.36e-22 | 1.98 (8.62) | Down syndrome | Table_S3 | Male DS direct comorbidity |
B34 | Viral infection of unspecified site | 159 | 753 | 3.701 | 3.34994e-41 | 9.3e-41 | 1.96 (6.24) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
B35 | Dermatophytosis | 21 | 76 | 4.983 | 0.000000045 | 0.000000149 | 17.71 (17.44) | Down syndrome | Table_S1 | Direct comorbidity |
B35 | Dermatophytosis | 16 | 31 | 9.059 | 0.00000000212 | 0.00000000697 | 17.62 (17.77) | Down syndrome | Table_S3 | Male DS direct comorbidity |
B35 | Dermatophytosis | 13 | 24 | 9.767 | 0.0000000336 | 0.0000000935 | 17.53 (11.78) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
B37 | Candidiasis | 52 | 278 | 3.313 | 0.00000000000539 | 0.0000000000178 | 31.81 (25.38) | Down syndrome | Table_S1 | Direct comorbidity |
B37 | Candidiasis | 25 | 144 | 3.190 | 0.00000347 | 0.0000123 | 31.62 (27.22) | Down syndrome | Table_S3 | Female DS direct comorbidity |
B37 | Candidiasis | 27 | 127 | 3.730 | 0.0000000972 | 0.000000319 | 35.01 (23.49) | Down syndrome | Table_S3 | Male DS direct comorbidity |
B37 | Candidiasis | 19 | 70 | 4.913 | 0.000000225 | 0.000000625 | 3.26 (21.48) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
B95 | Streptococcus and staphylococcus as the cause of diseases classified to other chapters | 5 | 13 | 7.475 | 0.00218 | 0.00607 | 7.05 (19.83) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
B96 | Other bacterial agents as the cause of diseases classified to other chapters | 10 | 43 | 4.360 | 0.000494 | 0.00163 | 47.87 (22.79) | Down syndrome | Table_S1 | Direct comorbidity |
B96 | Other bacterial agents as the cause of diseases classified to other chapters | 6 | 16 | 7.022 | 0.000986 | 0.00323 | 47.29 (22.5) | Down syndrome | Table_S3 | Male DS direct comorbidity |
B97 | Viral agents as the cause of diseases classified to other chapters | 8 | 28 | 5.412 | 0.00057 | 0.00189 | 0.9 (11.56) | Down syndrome | Table_S1 | Direct comorbidity |
B97 | Viral agents as the cause of diseases classified to other chapters | 5 | 18 | 5.619 | 0.00636 | 0.0225 | 0.27 (1.71) | Down syndrome | Table_S3 | Female DS direct comorbidity |
B97 | Viral agents as the cause of diseases classified to other chapters | 5 | 15 | 6.540 | 0.00361 | 0.01 | 0.42 (3.06) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
C34 | Malignant neoplasm of bronchus and lung | 6 | 483 | 0.252 | 0.00000272 | 0.00000633 | 64.81 (7.87) | Down syndrome | Table_S2 | Inverse comorbidity |
C44 | Other malignant neoplasms of skin | 6 | 481 | 0.253 | 0.00000264 | 0.00000615 | 51.5 (11.95) | Down syndrome | Table_S2 | Inverse comorbidity |
C50 | Malignant neoplasm of breast | 9 | 676 | 0.258 | 0.0000000353 | 0.0000000823 | 55.07 (14.04) | Down syndrome | Table_S2 | Inverse comorbidity |
C50 | Malignant neoplasm of breast | 5 | 280 | 0.368 | 0.00236 | 0.0101 | 48.04 (13.66) | Turner syndrome | Table_S2 | Inverse comorbidity |
C50 | Malignant neoplasm of breast | 9 | 719 | 0.247 | 0.00000000775 | 0.0000000204 | 55.07 (14.04) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
C62 | Malignant neoplasm of testis | 13 | 87 | 2.774 | 0.00294 | 0.00972 | 35.45 (10.24) | Down syndrome | Table_S1 | Direct comorbidity |
C62 | Malignant neoplasm of testis | 13 | 90 | 2.623 | 0.0045 | 0.0147 | 35.45 (10.24) | Down syndrome | Table_S3 | Male DS direct comorbidity |
C91 | Lymphoid leukaemia | 22 | 89 | 4.457 | 0.000000116 | 0.000000383 | 8.32 (15.76) | Down syndrome | Table_S1 | Direct comorbidity |
C91 | Lymphoid leukaemia | 15 | 30 | 9.183 | 0.00000000544 | 0.0000000193 | 6.66 (11.11) | Down syndrome | Table_S3 | Female DS direct comorbidity |
C91 | Lymphoid leukaemia | 12 | 25 | 8.721 | 0.000000313 | 0.000000869 | 6.39 (5.27) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
C92 | Myeloid leukaemia | 20 | 47 | 7.629 | 0.000000000223 | 0.000000000739 | 2.86 (13.82) | Down syndrome | Table_S1 | Direct comorbidity |
C92 | Myeloid leukaemia | 13 | 24 | 9.964 | 0.0000000277 | 0.0000000981 | 2.7 (13.84) | Down syndrome | Table_S3 | Female DS direct comorbidity |
C92 | Myeloid leukaemia | 7 | 27 | 4.872 | 0.00226 | 0.00741 | 3.11 (13.33) | Down syndrome | Table_S3 | Male DS direct comorbidity |
C92 | Myeloid leukaemia | 12 | 5 | 37.789 | 0.00000000000287 | 0.00000000000797 | 3.2 (10.99) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
C94 | Other leukaemias of specified cell type | 6 | 4 | 24.414 | 0.00000439 | 0.0000145 | 1.13 (3.28) | Down syndrome | Table_S1 | Direct comorbidity |
C94 | Other leukaemias of specified cell type | 5 | 2 | 34.105 | 0.00000987 | 0.0000324 | 0.13 (2.22) | Down syndrome | Table_S3 | Male DS direct comorbidity |
C94 | Other leukaemias of specified cell type | 5 | 1 | 52.323 | 0.00000264 | 0.00000734 | 2.12 (3.33) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
C95 | Leukaemia of unspecified cell type | 8 | 12 | 12.073 | 0.00000517 | 0.0000171 | 1.74 (14.2) | Down syndrome | Table_S1 | Direct comorbidity |
C95 | Leukaemia of unspecified cell type | 5 | 5 | 17.792 | 0.0000849 | 0.000301 | 2.13 (16.79) | Down syndrome | Table_S3 | Female DS direct comorbidity |
C95 | Leukaemia of unspecified cell type | 6 | 7 | 15.261 | 0.0000306 | 0.0000852 | 1.74 (3.26) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
D10 | Benign neoplasm of mouth and pharynx | 22 | 191 | 2.089 | 0.00296 | 0.00981 | 39.35 (19.3) | Down syndrome | Table_S1 | Direct comorbidity |
D10 | Benign neoplasm of mouth and pharynx | 12 | 93 | 2.461 | 0.0099 | 0.0351 | 35.95 (21.05) | Down syndrome | Table_S3 | Female DS direct comorbidity |
D12 | Benign neoplasm of colon. rectum. anus and anal canal | 9 | 1108 | 0.157 | 5.69e-17 | 1.33e-16 | 56.67 (12.91) | Down syndrome | Table_S2 | Inverse comorbidity |
D12 | Benign neoplasm of colon. rectum. anus and anal canal | 5 | 459 | 0.232 | 0.00000187 | 0.0000049 | 67.65 (11.29) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
D22 | Melanocytic naevi | 24 | 173 | 2.477 | 0.000198 | 0.000913 | 21.58 (11.52) | Turner syndrome | Table_S1 | Direct comorbidity |
D22 | Melanocytic naevi | 12 | 456 | 0.496 | 0.00392 | 0.00913 | 18.32 (12.49) | Down syndrome | Table_S2 | Inverse comorbidity |
D22 | Melanocytic naevi | 11 | 45 | 4.403 | 0.000198 | 0.00141 | 18.14 (9.89) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
D23 | Other benign neoplasms of skin | 18 | 164 | 2.008 | 0.00999 | 0.0278 | 31.3 (18.98) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
D27 | Benign neoplasm of ovary | 9 | 460 | 0.378 | 0.000206 | 0.000481 | 47.14 (12.48) | Down syndrome | Table_S2 | Inverse comorbidity |
D27 | Benign neoplasm of ovary | 9 | 420 | 0.423 | 0.0015 | 0.00394 | 47.14 (12.48) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
D50 | Iron deficiency anaemia | 17 | 127 | 2.424 | 0.00227 | 0.0104 | 38 (17.2) | Turner syndrome | Table_S1 | Direct comorbidity |
D59 | Acquired haemolytic anaemia | 10 | 29 | 6.394 | 0.0000322 | 0.000107 | 4.53 (17.92) | Down syndrome | Table_S1 | Direct comorbidity |
D59 | Acquired haemolytic anaemia | 5 | 18 | 5.619 | 0.00636 | 0.0225 | 10.22 (21.67) | Down syndrome | Table_S3 | Female DS direct comorbidity |
D59 | Acquired haemolytic anaemia | 5 | 15 | 6.395 | 0.00398 | 0.0131 | 3.67 (7.68) | Down syndrome | Table_S3 | Male DS direct comorbidity |
D59 | Acquired haemolytic anaemia | 6 | 13 | 8.721 | 0.000366 | 0.00102 | 6.46 (15.81) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
D61 | Other aplastic anaemias | 8 | 50 | 3.077 | 0.0126 | 0.0418 | 35.32 (23.9) | Down syndrome | Table_S1 | Direct comorbidity |
D61 | Other aplastic anaemias | 6 | 11 | 10.379 | 0.000166 | 0.00059 | 14.37 (24.3) | Down syndrome | Table_S3 | Female DS direct comorbidity |
D62 | Acute posthaemorrhagic anaemia | 5 | 18 | 5.508 | 0.00685 | 0.019 | 24.77 (20.08) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
D64 | Other anaemias | 20 | 171 | 2.105 | 0.00407 | 0.0187 | 54.32 (14.82) | Turner syndrome | Table_S1 | Direct comorbidity |
D64 | Other anaemias | 17 | 131 | 2.378 | 0.00274 | 0.00761 | 34.37 (22.24) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
D68 | Other coagulation defects | 9 | 38 | 4.154 | 0.00132 | 0.00797 | 42.97 (9.44) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
D69 | Purpura and other haemorrhagic conditions | 35 | 342 | 1.830 | 0.0015 | 0.00497 | 11.86 (21.85) | Down syndrome | Table_S1 | Direct comorbidity |
D69 | Purpura and other haemorrhagic conditions | 19 | 164 | 2.157 | 0.00415 | 0.0147 | 11.86 (21.1) | Down syndrome | Table_S3 | Female DS direct comorbidity |
D69 | Purpura and other haemorrhagic conditions | 15 | 106 | 2.608 | 0.00227 | 0.0063 | 11.65 (17.51) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
D72 | Other disorders of white blood cells | 12 | 64 | 3.488 | 0.00077 | 0.00255 | 7.38 (23.47) | Down syndrome | Table_S1 | Direct comorbidity |
D72 | Other disorders of white blood cells | 8 | 27 | 5.719 | 0.000406 | 0.00144 | 37.22 (24.54) | Down syndrome | Table_S3 | Female DS direct comorbidity |
D72 | Other disorders of white blood cells | 7 | 10 | 12.684 | 0.0000161 | 0.0000447 | 11.16 (18.52) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
D75 | Other diseases of blood and blood-forming organs | 36 | 79 | 8.065 | 2.86e-18 | 9.48e-18 | 36.51 (11.34) | Down syndrome | Table_S1 | Direct comorbidity |
D75 | Other diseases of blood and blood-forming organs | 6 | 5 | 18.901 | 0.0000134 | 0.000081 | 36.4 (14.25) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
D75 | Other diseases of blood and blood-forming organs | 22 | 29 | 13.641 | 0.0000000000000028 | 0.00000000000000994 | 40.57 (10.52) | Down syndrome | Table_S3 | Female DS direct comorbidity |
D75 | Other diseases of blood and blood-forming organs | 14 | 38 | 6.559 | 0.000000583 | 0.00000191 | 35.13 (11.28) | Down syndrome | Table_S3 | Male DS direct comorbidity |
D75 | Other diseases of blood and blood-forming organs | 5 | 14 | 6.976 | 0.00283 | 0.00787 | 38.78 (16.57) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
E03 | Other hypothyroidism | 303 | 590 | 8.970 | 0 | 0 | 27.34 (20.33) | Down syndrome | Table_S1 | Direct comorbidity |
E03 | Other hypothyroidism | 79 | 234 | 5.868 | 1.39e-31 | 6.42e-31 | 35.13 (17.25) | Turner syndrome | Table_S1 | Direct comorbidity |
E03 | Other hypothyroidism | 169 | 483 | 6.249 | 0 | 0 | 34.4 (20.19) | Down syndrome | Table_S3 | Female DS direct comorbidity |
E03 | Other hypothyroidism | 134 | 92 | 24.753 | 0 | 0 | 22.16 (20.05) | Down syndrome | Table_S3 | Male DS direct comorbidity |
E03 | Other hypothyroidism | 97 | 122 | 13.896 | 0 | 0 | 14.79 (16) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
E03 | Other hypothyroidism | 6 | 10 | 10.747 | 0.000105 | 0.000749 | 14.71 (5.38) | Down syndrome | Table_S6 | Mosaic DS direct comorbidity |
E03 | Other hypothyroidism | 26 | 63 | 7.120 | 0.000000000000557 | 0.00000000000397 | 36.52 (13.79) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
E04 | Other nontoxic goitre | 14 | 726 | 0.360 | 0.00000178 | 0.00000415 | 33.41 (17.32) | Down syndrome | Table_S2 | Inverse comorbidity |
E04 | Other nontoxic goitre | 10 | 651 | 0.300 | 0.000000644 | 0.00000169 | 26.35 (18.15) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
E05 | Thyrotoxicosis [hyperthyroidism] | 69 | 598 | 2.038 | 0.000000274 | 0.000000909 | 36.42 (16.34) | Down syndrome | Table_S1 | Direct comorbidity |
E05 | Thyrotoxicosis [hyperthyroidism] | 30 | 133 | 3.945 | 0.00000000603 | 0.0000000198 | 36.54 (15.1) | Down syndrome | Table_S3 | Male DS direct comorbidity |
E05 | Thyrotoxicosis [hyperthyroidism] | 20 | 129 | 2.817 | 0.000159 | 0.000442 | 18.33 (11.55) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
E06 | Thyroiditis | 34 | 141 | 4.298 | 0.0000000000834 | 0.000000000276 | 15.61 (13.24) | Down syndrome | Table_S1 | Direct comorbidity |
E06 | Thyroiditis | 20 | 62 | 5.746 | 0.0000000115 | 0.0000000529 | 28.9 (11.97) | Turner syndrome | Table_S1 | Direct comorbidity |
E06 | Thyroiditis | 16 | 120 | 2.500 | 0.00239 | 0.00847 | 15.2 (11.62) | Down syndrome | Table_S3 | Female DS direct comorbidity |
E06 | Thyroiditis | 18 | 26 | 12.000 | 0.00000000000566 | 0.0000000000186 | 15.95 (14.12) | Down syndrome | Table_S3 | Male DS direct comorbidity |
E06 | Thyroiditis | 14 | 21 | 11.892 | 0.00000000136 | 0.00000000377 | 15.16 (9.8) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
E06 | Thyroiditis | 10 | 25 | 7.140 | 0.0000124 | 0.0000883 | 31.72 (9.09) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
E10 | Insulin-dependent diabetes mellitus | 91 | 902 | 1.777 | 0.000000927 | 0.00000307 | 42.33 (17.27) | Down syndrome | Table_S1 | Direct comorbidity |
E10 | Insulin-dependent diabetes mellitus | 32 | 205 | 2.595 | 0.00000681 | 0.0000412 | 48.31 (15.24) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
E10 | Insulin-dependent diabetes mellitus | 41 | 166 | 4.335 | 0.000000000000469 | 0.00000000000216 | 47.35 (16.4) | Turner syndrome | Table_S1 | Direct comorbidity |
E10 | Insulin-dependent diabetes mellitus | 35 | 328 | 1.947 | 0.000529 | 0.00188 | 44.76 (17.62) | Down syndrome | Table_S3 | Female DS direct comorbidity |
E10 | Insulin-dependent diabetes mellitus | 56 | 551 | 1.761 | 0.000139 | 0.000457 | 41.33 (16.74) | Down syndrome | Table_S3 | Male DS direct comorbidity |
E10 | Insulin-dependent diabetes mellitus | 30 | 159 | 3.379 | 0.000000109 | 0.000000304 | 33.52 (18.85) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
E10 | Insulin-dependent diabetes mellitus | 10 | 27 | 6.630 | 0.0000213 | 0.000152 | 34.96 (15.25) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
E11 | Non-insulin-dependent diabetes mellitus | 71 | 354 | 3.286 | 3.1e-16 | 0.00000000000000187 | 50.46 (13.97) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
E11 | Non-insulin-dependent diabetes mellitus | 60 | 283 | 3.702 | 7.29e-16 | 0.00000000000000336 | 54.13 (14.71) | Turner syndrome | Table_S1 | Direct comorbidity |
E11 | Non-insulin-dependent diabetes mellitus | 9 | 43 | 3.836 | 0.00195 | 0.0139 | 52.69 (5.45) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
E14 | Unspecified diabetes mellitus | 27 | 90 | 4.985 | 0.000000000437 | 0.00000000264 | 53.58 (16.7) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
E14 | Unspecified diabetes mellitus | 15 | 80 | 3.405 | 0.00019 | 0.000877 | 45.27 (18.84) | Turner syndrome | Table_S1 | Direct comorbidity |
E14 | Unspecified diabetes mellitus | 13 | 71 | 3.391 | 0.000556 | 0.00154 | 34.24 (16.9) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
E15 | Nondiabetic hypoglycaemic coma | 13 | 36 | 6.598 | 0.00000142 | 0.0000047 | 47.48 (11.96) | Down syndrome | Table_S1 | Direct comorbidity |
E15 | Nondiabetic hypoglycaemic coma | 10 | 22 | 8.155 | 0.00000552 | 0.0000181 | 43.4 (10.93) | Down syndrome | Table_S3 | Male DS direct comorbidity |
E16 | Other disorders of pancreatic internal secretion | 53 | 241 | 3.891 | 0.0000000000000135 | 0.0000000000000448 | 46.08 (18.88) | Down syndrome | Table_S1 | Direct comorbidity |
E16 | Other disorders of pancreatic internal secretion | 16 | 46 | 6.235 | 0.000000143 | 0.00000066 | 43.01 (20.55) | Turner syndrome | Table_S1 | Direct comorbidity |
E16 | Other disorders of pancreatic internal secretion | 21 | 105 | 3.693 | 0.00000304 | 0.0000108 | 43.58 (20.42) | Down syndrome | Table_S3 | Female DS direct comorbidity |
E16 | Other disorders of pancreatic internal secretion | 32 | 151 | 3.702 | 0.00000000704 | 0.0000000231 | 46.75 (17.69) | Down syndrome | Table_S3 | Male DS direct comorbidity |
E16 | Other disorders of pancreatic internal secretion | 20 | 44 | 8.139 | 0.0000000000788 | 0.000000000219 | 40.69 (23.36) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
E16 | Other disorders of pancreatic internal secretion | 5 | 12 | 7.789 | 0.00181 | 0.0129 | 24.67 (18.39) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
E21 | Hyperparathyroidism and other disorders of parathyroid gland | 10 | 32 | 5.746 | 0.0000678 | 0.000312 | 53.55 (10.49) | Turner syndrome | Table_S1 | Direct comorbidity |
E23 | Hypofunction and other disorders of pituitary gland | 11 | 24 | 7.777 | 0.00000269 | 0.0000162 | 44.67 (14.33) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
E23 | Hypofunction and other disorders of pituitary gland | 20 | 22 | 15.738 | 0.00000000000000765 | 0.0000000000000353 | 11.03 (14.74) | Turner syndrome | Table_S1 | Direct comorbidity |
E23 | Hypofunction and other disorders of pituitary gland | 7 | 3 | 33.753 | 0.000000156 | 0.00000111 | 6.53 (9.98) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
E28 | Ovarian dysfunction | 36 | 147 | 4.309 | 0.0000000000155 | 0.0000000000715 | 19.76 (11.09) | Turner syndrome | Table_S1 | Direct comorbidity |
E28 | Ovarian dysfunction | 16 | 34 | 8.197 | 0.00000000451 | 0.0000000321 | 16.63 (4.39) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
E29 | Testicular dysfunction | 111 | 21 | 82.478 | 0 | 0 | 36.45 (12.95) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
E30 | Disorders of puberty. not elsewhere classified | 10 | 61 | 3.058 | 0.00508 | 0.0234 | 11.62 (2.93) | Turner syndrome | Table_S1 | Direct comorbidity |
E34 | Other endocrine disorders | 11 | 51 | 3.739 | 0.000781 | 0.00472 | 18.85 (18.94) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
E34 | Other endocrine disorders | 10 | 9 | 18.210 | 0.0000000103 | 0.0000000963 | 15.02 (4.75) | XYY syndrome | Table_S1 | Direct comorbidity |
E34 | Other endocrine disorders | 69 | 70 | 16.995 | 0 | 0 | 10.7 (5.82) | Turner syndrome | Table_S1 | Direct comorbidity |
E34 | Other endocrine disorders | 21 | 17 | 20.627 | 2.28e-17 | 1.62e-16 | 8.59 (8.67) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
E34 | Other endocrine disorders | 11 | 8 | 23.333 | 0.000000000173 | 0.0000000192 | 12.03 (3.95) | Turner syndrome | Table_S7 | Mosaic TS direct comorbidity |
E64 | Sequelae of malnutrition and other nutritional deficiencies | 28 | 135 | 3.719 | 0.0000000606 | 0.000000201 | 13.87 (20.72) | Down syndrome | Table_S1 | Direct comorbidity |
E64 | Sequelae of malnutrition and other nutritional deficiencies | 11 | 68 | 3.094 | 0.003 | 0.0106 | 15.46 (19.16) | Down syndrome | Table_S3 | Female DS direct comorbidity |
E64 | Sequelae of malnutrition and other nutritional deficiencies | 17 | 54 | 5.581 | 0.000000237 | 0.000000777 | 12.59 (21.59) | Down syndrome | Table_S3 | Male DS direct comorbidity |
E64 | Sequelae of malnutrition and other nutritional deficiencies | 13 | 27 | 8.721 | 0.0000000976 | 0.000000271 | 15.15 (15.33) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
E66 | Obesity | 70 | 255 | 4.493 | 2.42e-22 | 1.46e-21 | 43.6 (17.06) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
E66 | Obesity | 12 | 83 | 2.670 | 0.00481 | 0.0464 | 24.08 (19.45) | Fragile X syndrome | Table_S1 | Direct comorbidity |
E78 | Disorders of lipoprotein metabolism and other lipidaemias | 38 | 373 | 1.689 | 0.00299 | 0.018 | 53.74 (12.25) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
E78 | Disorders of lipoprotein metabolism and other lipidaemias | 31 | 1947 | 0.286 | 6.07e-19 | 1.41e-18 | 55.69 (14.11) | Down syndrome | Table_S2 | Inverse comorbidity |
E78 | Disorders of lipoprotein metabolism and other lipidaemias | 14 | 750 | 0.355 | 0.00000114 | 0.000003 | 56.79 (12.34) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
E78 | Disorders of lipoprotein metabolism and other lipidaemias | 17 | 1243 | 0.247 | 0.0000000000000115 | 0.0000000000000292 | 51.74 (15.11) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
E78 | Disorders of lipoprotein metabolism and other lipidaemias | 6 | 261 | 0.463 | 0.0196 | 0.05 | 42.42 (17.97) | Down syndrome | Table_S6 | Non-mosaic DS inverse comorbidity |
E86 | Volume depletion | 213 | 908 | 4.106 | 0 | 0 | 49.1 (26.02) | Down syndrome | Table_S1 | Direct comorbidity |
E86 | Volume depletion | 32 | 227 | 2.495 | 0.0000138 | 0.0000638 | 31.66 (31.4) | Turner syndrome | Table_S1 | Direct comorbidity |
E86 | Volume depletion | 12 | 20 | 11.014 | 0.00000000951 | 0.0000000233 | 4.15 (10.14) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
E86 | Volume depletion | 7 | 16 | 7.838 | 0.000133 | 0.000428 | 5.13 (10.84) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
E86 | Volume depletion | 6 | 30 | 4.054 | 0.00879 | 0.0245 | 3.62 (5.72) | Angelman syndrome | Table_S1 | Direct comorbidity |
E86 | Volume depletion | 107 | 476 | 4.028 | 8.78e-30 | 3.12e-29 | 50.46 (26.22) | Down syndrome | Table_S3 | Female DS direct comorbidity |
E86 | Volume depletion | 106 | 532 | 3.423 | 2.33e-24 | 7.63e-24 | 47.95 (25.7) | Down syndrome | Table_S3 | Male DS direct comorbidity |
E86 | Volume depletion | 69 | 276 | 4.407 | 1.55e-21 | 4.3e-21 | 7.82 (24.34) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
E87 | Other disorders of fluid. electrolyte and acid-base balance | 49 | 550 | 1.582 | 0.00303 | 0.01 | 47.86 (24.14) | Down syndrome | Table_S1 | Direct comorbidity |
E87 | Other disorders of fluid. electrolyte and acid-base balance | 21 | 112 | 3.356 | 0.0000108 | 0.0000496 | 61.54 (17.02) | Turner syndrome | Table_S1 | Direct comorbidity |
E87 | Other disorders of fluid. electrolyte and acid-base balance | 17 | 109 | 2.854 | 0.000452 | 0.00126 | 17.4 (22.1) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
F00 | Dementia in Alzheimer's disease | 116 | 73 | 27.572 | 0 | 0 | 56 (5.52) | Down syndrome | Table_S1 | Direct comorbidity |
F00 | Dementia in Alzheimer's disease | 57 | 31 | 32.248 | 0 | 0 | 55.66 (5.54) | Down syndrome | Table_S3 | Female DS direct comorbidity |
F00 | Dementia in Alzheimer's disease | 59 | 21 | 46.506 | 0 | 0 | 56.5 (5.47) | Down syndrome | Table_S3 | Male DS direct comorbidity |
F00 | Dementia in Alzheimer's disease | 14 | 19 | 13.081 | 0.00000000053 | 0.00000000147 | 58.3 (6.02) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
F02 | Dementia in other diseases classified elsewhere | 14 | 26 | 9.688 | 0.0000000112 | 0.0000000371 | 56.38 (11.44) | Down syndrome | Table_S1 | Direct comorbidity |
F02 | Dementia in other diseases classified elsewhere | 11 | 13 | 14.616 | 0.0000000185 | 0.0000000607 | 55.64 (12.67) | Down syndrome | Table_S3 | Male DS direct comorbidity |
F03 | Unspecified dementia | 87 | 170 | 8.974 | 4.2039e-45 | 1.26117e-44 | 57.74 (7.08) | Down syndrome | Table_S1 | Direct comorbidity |
F03 | Unspecified dementia | 37 | 82 | 8.146 | 5.67e-19 | 2.01e-18 | 57.48 (6.64) | Down syndrome | Table_S3 | Female DS direct comorbidity |
F03 | Unspecified dementia | 50 | 83 | 10.353 | 1.04e-28 | 3.4e-28 | 57.84 (7.34) | Down syndrome | Table_S3 | Male DS direct comorbidity |
F03 | Unspecified dementia | 10 | 32 | 5.814 | 0.0000623 | 0.000173 | 58.1 (7.5) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
F10 | Mental and behavioural disorders due to use of alcohol | 68 | 637 | 1.752 | 0.0000215 | 0.00013 | 28.99 (14.4) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
F10 | Mental and behavioural disorders due to use of alcohol | 37 | 2170 | 0.305 | 1.29e-19 | 3e-19 | 44.37 (10.95) | Down syndrome | Table_S2 | Inverse comorbidity |
F10 | Mental and behavioural disorders due to use of alcohol | 9 | 369 | 0.466 | 0.00558 | 0.0238 | 22.35 (17.77) | Turner syndrome | Table_S2 | Inverse comorbidity |
F10 | Mental and behavioural disorders due to use of alcohol | 10 | 618 | 0.316 | 0.00000222 | 0.00000582 | 46.27 (8.41) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
F10 | Mental and behavioural disorders due to use of alcohol | 27 | 1519 | 0.314 | 0.000000000000028 | 0.0000000000000708 | 43.94 (11.69) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
F10 | Mental and behavioural disorders due to use of alcohol | 7 | 450 | 0.308 | 0.0000248 | 0.0000633 | 38.82 (9.16) | Down syndrome | Table_S6 | Non-mosaic DS inverse comorbidity |
F17 | Mental and behavioural disorders due to use of tobacco | 7 | 656 | 0.212 | 0.00000000411 | 0.00000000958 | 46.37 (7.78) | Down syndrome | Table_S2 | Inverse comorbidity |
F20 | Schizophrenia | 12 | 34 | 6.018 | 0.00000831 | 0.0000502 | 45.66 (15.01) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
F32 | Depressive episode | 5 | 299 | 0.356 | 0.00183 | 0.00481 | 53.55 (10.95) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
F41 | Other anxiety disorders | 8 | 350 | 0.447 | 0.00467 | 0.0109 | 46.91 (13.3) | Down syndrome | Table_S2 | Inverse comorbidity |
F43 | Reaction to severe stress. and adjustment disorders | 11 | 72 | 2.663 | 0.00824 | 0.0498 | 27.39 (15.18) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
F50 | Eating disorders | 26 | 112 | 4.167 | 0.0000000256 | 0.0000000846 | 2.38 (12.18) | Down syndrome | Table_S1 | Direct comorbidity |
F50 | Eating disorders | 12 | 44 | 4.980 | 0.00004 | 0.000184 | 11.76 (15.3) | Turner syndrome | Table_S1 | Direct comorbidity |
F50 | Eating disorders | 10 | 68 | 2.836 | 0.00819 | 0.029 | 1.07 (11.67) | Down syndrome | Table_S3 | Female DS direct comorbidity |
F50 | Eating disorders | 16 | 29 | 9.663 | 0.00000000102 | 0.00000000333 | 3.39 (12.45) | Down syndrome | Table_S3 | Male DS direct comorbidity |
F50 | Eating disorders | 17 | 52 | 5.923 | 0.000000107 | 0.000000297 | 1.28 (4.74) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
F70 | Mild mental retardation | 47 | 56 | 14.685 | 6.23e-32 | 2.06e-31 | 47.05 (20.8) | Down syndrome | Table_S1 | Direct comorbidity |
F70 | Mild mental retardation | 7 | 11 | 10.801 | 0.0000389 | 0.000235 | 18.6 (16.73) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
F70 | Mild mental retardation | 5 | 6 | 14.775 | 0.00017 | 0.000783 | 61.56 (19.92) | Turner syndrome | Table_S1 | Direct comorbidity |
F70 | Mild mental retardation | 13 | 3 | 60.392 | 0.000000000000012 | 0.000000000000116 | 8.86 (10.7) | Fragile X syndrome | Table_S1 | Direct comorbidity |
F70 | Mild mental retardation | 25 | 16 | 27.212 | 5.19e-22 | 1.84e-21 | 49.64 (19.37) | Down syndrome | Table_S3 | Female DS direct comorbidity |
F70 | Mild mental retardation | 22 | 28 | 13.524 | 0.0000000000000039 | 0.0000000000000128 | 36.21 (20.46) | Down syndrome | Table_S3 | Male DS direct comorbidity |
F70 | Mild mental retardation | 10 | 1 | 93.903 | 0.00000000000187 | 0.0000000000151 | 11.24 (11.12) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
F70 | Mild mental retardation | 14 | 21 | 11.892 | 0.00000000136 | 0.00000000377 | 11.28 (19.42) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
F71 | Moderate mental retardation | 46 | 23 | 34.151 | 1.52994e-41 | 5.07999e-41 | 38.64 (20.32) | Down syndrome | Table_S1 | Direct comorbidity |
F71 | Moderate mental retardation | 18 | 9 | 33.805 | 3.1e-17 | 1.1e-16 | 49.4 (19.97) | Down syndrome | Table_S3 | Female DS direct comorbidity |
F71 | Moderate mental retardation | 28 | 13 | 35.323 | 4.6e-26 | 1.51e-25 | 34.39 (19.6) | Down syndrome | Table_S3 | Male DS direct comorbidity |
F71 | Moderate mental retardation | 6 | 2 | 39.838 | 0.000000619 | 0.00000501 | 42.72 (16.83) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
F71 | Moderate mental retardation | 11 | 12 | 16.099 | 0.00000000823 | 0.0000000229 | 15.41 (12.66) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
F72 | Severe mental retardation | 45 | 19 | 40.109 | 2.57979e-42 | 8.5297e-42 | 32.02 (19.04) | Down syndrome | Table_S1 | Direct comorbidity |
F72 | Severe mental retardation | 16 | 12 | 23.267 | 0.0000000000000625 | 0.000000000000222 | 42.35 (20.12) | Down syndrome | Table_S3 | Female DS direct comorbidity |
F72 | Severe mental retardation | 29 | 15 | 31.973 | 2.94e-26 | 9.64e-26 | 31.67 (18.27) | Down syndrome | Table_S3 | Male DS direct comorbidity |
F72 | Severe mental retardation | 12 | 7 | 28.342 | 0.0000000000211 | 0.0000000000586 | 18.59 (8.6) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
F73 | Profound mental retardation | 15 | 8 | 31.002 | 0.0000000000000322 | 0.000000000000107 | 55.29 (20.38) | Down syndrome | Table_S1 | Direct comorbidity |
F73 | Profound mental retardation | 7 | 6 | 20.334 | 0.00000153 | 0.00000542 | 41.69 (19.73) | Down syndrome | Table_S3 | Female DS direct comorbidity |
F73 | Profound mental retardation | 8 | 10 | 13.952 | 0.0000023 | 0.00000754 | 58.15 (19.21) | Down syndrome | Table_S3 | Male DS direct comorbidity |
F73 | Profound mental retardation | 6 | 4 | 24.417 | 0.00000432 | 0.000012 | 44.55 (24.83) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
F78 | Other mental retardation | 13 | 9 | 24.414 | 0.0000000000107 | 0.0000000000354 | 54.36 (14.52) | Down syndrome | Table_S1 | Direct comorbidity |
F78 | Other mental retardation | 5 | 4 | 21.351 | 0.0000444 | 0.000157 | 54.9 (21.08) | Down syndrome | Table_S3 | Female DS direct comorbidity |
F78 | Other mental retardation | 8 | 2 | 51.157 | 0.00000000353 | 0.0000000116 | 53.58 (7.61) | Down syndrome | Table_S3 | Male DS direct comorbidity |
F79 | Unspecified mental retardation | 562 | 87 | 111.569 | 0 | 0 | 21.43 (20.62) | Down syndrome | Table_S1 | Direct comorbidity |
F79 | Unspecified mental retardation | 10 | 24 | 7.128 | 0.0000149 | 0.00009 | 24.84 (16.28) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
F79 | Unspecified mental retardation | 12 | 20 | 10.671 | 0.0000000546 | 0.000000252 | 12.73 (28.11) | Turner syndrome | Table_S1 | Direct comorbidity |
F79 | Unspecified mental retardation | 22 | 2 | 127.698 | 8.96e-28 | 2.87e-27 | 18.53 (15.33) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
F79 | Unspecified mental retardation | 33 | 4 | 117.333 | 7.51e-39 | 7.24e-38 | 16.66 (16.96) | Fragile X syndrome | Table_S1 | Direct comorbidity |
F79 | Unspecified mental retardation | 247 | 42 | 102.615 | 0 | 0 | 25.63 (20.82) | Down syndrome | Table_S3 | Female DS direct comorbidity |
F79 | Unspecified mental retardation | 315 | 48 | 109.970 | 0 | 0 | 19.38 (20.43) | Down syndrome | Table_S3 | Male DS direct comorbidity |
F79 | Unspecified mental retardation | 29 | 5 | 85.367 | 3.42e-33 | 2.77e-32 | 21.35 (17.25) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
F79 | Unspecified mental retardation | 227 | 34 | 113.616 | 0 | 0 | 9.22 (15.66) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
F79 | Unspecified mental retardation | 12 | 4 | 43.911 | 0.000000000000339 | 0.00000000000242 | 34.8 (22.13) | Down syndrome | Table_S6 | Mosaic DS direct comorbidity |
F79 | Unspecified mental retardation | 5 | 7 | 12.657 | 0.000291 | 0.00207 | 4.39 (6.89) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
F80 | Specific developmental disorders of speech and language | 10 | 45 | 4.170 | 0.000671 | 0.00222 | 9.49 (13.15) | Down syndrome | Table_S1 | Direct comorbidity |
F80 | Specific developmental disorders of speech and language | 5 | 11 | 8.896 | 0.00112 | 0.00399 | 9.78 (11.69) | Down syndrome | Table_S3 | Female DS direct comorbidity |
F80 | Specific developmental disorders of speech and language | 7 | 24 | 5.581 | 0.00112 | 0.00311 | 8.15 (13.09) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
F84 | Pervasive developmental disorders | 32 | 87 | 6.540 | 0.000000000000026 | 0.000000000000086 | 11.91 (14.47) | Down syndrome | Table_S1 | Direct comorbidity |
F84 | Pervasive developmental disorders | 5 | 7 | 12.928 | 0.000278 | 0.00128 | 8.44 (2.64) | Turner syndrome | Table_S1 | Direct comorbidity |
F84 | Pervasive developmental disorders | 21 | 3 | 94.901 | 1.75e-24 | 1.68e-23 | 6.36 (15.54) | Fragile X syndrome | Table_S1 | Direct comorbidity |
F84 | Pervasive developmental disorders | 27 | 84 | 5.617 | 0.0000000000508 | 0.000000000167 | 11.48 (14.3) | Down syndrome | Table_S3 | Male DS direct comorbidity |
F84 | Pervasive developmental disorders | 18 | 7 | 40.549 | 2.38e-18 | 1.92e-17 | 6.2 (12.89) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
F84 | Pervasive developmental disorders | 18 | 50 | 6.498 | 0.0000000134 | 0.0000000372 | 11.21 (4.62) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
F89 | Unspecified disorder of psychological development | 5 | 9 | 10.463 | 0.000618 | 0.00205 | 35.18 (15) | Down syndrome | Table_S1 | Direct comorbidity |
F90 | Hyperkinetic disorders | 6 | 11 | 10.065 | 0.000178 | 0.00172 | 4.84 (4.06) | Fragile X syndrome | Table_S1 | Direct comorbidity |
F90 | Hyperkinetic disorders | 5 | 7 | 12.805 | 0.000265 | 0.00214 | 4.74 (3.97) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
F98 | Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence | 26 | 183 | 2.559 | 0.0000729 | 0.000241 | 1.8 (10.6) | Down syndrome | Table_S1 | Direct comorbidity |
F98 | Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence | 9 | 36 | 4.659 | 0.00063 | 0.0029 | 7.7 (4.26) | Turner syndrome | Table_S1 | Direct comorbidity |
F98 | Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence | 12 | 69 | 3.304 | 0.00115 | 0.00407 | 1.63 (3.62) | Down syndrome | Table_S3 | Female DS direct comorbidity |
F98 | Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence | 14 | 103 | 2.459 | 0.0053 | 0.0174 | 2.96 (13.63) | Down syndrome | Table_S3 | Male DS direct comorbidity |
F98 | Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence | 15 | 118 | 2.345 | 0.0056 | 0.0156 | 2.63 (4.34) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
F99 | Mental disorder. not otherwise specified | 7 | 26 | 4.800 | 0.00244 | 0.0147 | 31.27 (17.66) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
G25 | Other extrapyramidal and movement disorders | 8 | 16 | 8.577 | 0.0000395 | 0.000239 | 40.57 (14.28) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
G30 | Alzheimer's disease | 139 | 56 | 42.832 | 0 | 0 | 54.71 (6.98) | Down syndrome | Table_S1 | Direct comorbidity |
G30 | Alzheimer's disease | 68 | 21 | 55.803 | 0 | 0 | 55.7 (6.6) | Down syndrome | Table_S3 | Female DS direct comorbidity |
G30 | Alzheimer's disease | 71 | 20 | 58.465 | 0 | 0 | 54.2 (7.3) | Down syndrome | Table_S3 | Male DS direct comorbidity |
G30 | Alzheimer's disease | 17 | 9 | 31.394 | 5.11e-16 | 0.00000000000000142 | 53.31 (6.36) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
G31 | Other degenerative diseases of nervous system. not elsewhere classified | 15 | 72 | 3.822 | 0.0000643 | 0.000213 | 52.55 (14.32) | Down syndrome | Table_S1 | Direct comorbidity |
G31 | Other degenerative diseases of nervous system. not elsewhere classified | 5 | 20 | 5.083 | 0.00919 | 0.0326 | 55.93 (3.99) | Down syndrome | Table_S3 | Female DS direct comorbidity |
G31 | Other degenerative diseases of nervous system. not elsewhere classified | 10 | 38 | 4.810 | 0.000249 | 0.000816 | 50.14 (16.67) | Down syndrome | Table_S3 | Male DS direct comorbidity |
G40 | Epilepsy | 6 | 24 | 4.957 | 0.00358 | 0.018 | 14.36 (8.57) | Patau syndrome | Table_S1 | Direct comorbidity |
G40 | Epilepsy | 10 | 52 | 3.753 | 0.00111 | 0.00538 | 13.38 (12.2) | Edwards syndrome | Table_S1 | Direct comorbidity |
G40 | Epilepsy | 643 | 1065 | 10.535 | 0 | 0 | 51.96 (18.2) | Down syndrome | Table_S1 | Direct comorbidity |
G40 | Epilepsy | 54 | 268 | 3.312 | 0.00000000000113 | 0.00000000000682 | 25.08 (18.93) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
G40 | Epilepsy | 33 | 229 | 2.548 | 0.00000677 | 0.0000312 | 32.21 (20.18) | Turner syndrome | Table_S1 | Direct comorbidity |
G40 | Epilepsy | 19 | 6 | 50.836 | 1.2e-21 | 2.93e-21 | 6.54 (15.18) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
G40 | Epilepsy | 11 | 18 | 10.520 | 0.0000000921 | 0.000000295 | 19.15 (13.82) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
G40 | Epilepsy | 51 | 17 | 51.859 | 0 | 0 | 5.56 (14.58) | Angelman syndrome | Table_S1 | Direct comorbidity |
G40 | Epilepsy | 30 | 51 | 10.287 | 1.78e-18 | 1.71e-17 | 12.7 (19.96) | Fragile X syndrome | Table_S1 | Direct comorbidity |
G40 | Epilepsy | 301 | 491 | 10.921 | 0 | 0 | 52.44 (17.54) | Down syndrome | Table_S3 | Female DS direct comorbidity |
G40 | Epilepsy | 342 | 670 | 8.717 | 0 | 0 | 50.27 (18.69) | Down syndrome | Table_S3 | Male DS direct comorbidity |
G40 | Epilepsy | 26 | 48 | 9.408 | 0.00000000000000126 | 0.0000000000000102 | 11.67 (20.92) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
G40 | Epilepsy | 130 | 307 | 7.418 | 0 | 0 | 33.94 (22.82) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
G40 | Epilepsy | 9 | 14 | 11.259 | 0.00000102 | 0.00000729 | 51.96 (20.55) | Down syndrome | Table_S6 | Mosaic DS direct comorbidity |
G41 | Status epilepticus | 17 | 63 | 4.905 | 0.00000111 | 0.00000368 | 50.49 (18.04) | Down syndrome | Table_S1 | Direct comorbidity |
G41 | Status epilepticus | 6 | 1 | 62.274 | 0.0000000929 | 0.000000228 | 1.47 (3.83) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
G41 | Status epilepticus | 5 | 3 | 25.882 | 0.0000221 | 0.000213 | 29.09 (18.19) | Fragile X syndrome | Table_S1 | Direct comorbidity |
G41 | Status epilepticus | 7 | 31 | 4.448 | 0.0035 | 0.0124 | 52.99 (18.11) | Down syndrome | Table_S3 | Female DS direct comorbidity |
G41 | Status epilepticus | 10 | 51 | 3.607 | 0.00179 | 0.00586 | 38.36 (17.49) | Down syndrome | Table_S3 | Male DS direct comorbidity |
G41 | Status epilepticus | 7 | 21 | 6.342 | 0.00058 | 0.00161 | 27.04 (19.1) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
G43 | Migraine | 22 | 105 | 3.515 | 0.00000349 | 0.0000211 | 23.74 (15.77) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
G43 | Migraine | 7 | 312 | 0.441 | 0.0059 | 0.0252 | 14.6 (13.84) | Turner syndrome | Table_S2 | Inverse comorbidity |
G44 | Other headache syndromes | 19 | 114 | 2.818 | 0.000236 | 0.00143 | 36.85 (10.49) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
G45 | Transient cerebral ischaemic attacks and related syndromes | 14 | 670 | 0.390 | 0.0000181 | 0.0000421 | 57.41 (13.9) | Down syndrome | Table_S2 | Inverse comorbidity |
G45 | Transient cerebral ischaemic attacks and related syndromes | 8 | 398 | 0.385 | 0.000625 | 0.00158 | 53.96 (10.08) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
G47 | Sleep disorders | 103 | 1136 | 1.595 | 0.0000137 | 0.0000453 | 20.04 (17.02) | Down syndrome | Table_S1 | Direct comorbidity |
G47 | Sleep disorders | 42 | 303 | 2.292 | 0.00000402 | 0.0000243 | 46.03 (11.83) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
G47 | Sleep disorders | 6 | 4 | 24.909 | 0.00000247 | 0.00000606 | 6.59 (3.66) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
G47 | Sleep disorders | 35 | 289 | 2.209 | 0.0000593 | 0.00021 | 23.72 (18.61) | Down syndrome | Table_S3 | Female DS direct comorbidity |
G47 | Sleep disorders | 68 | 757 | 1.552 | 0.000734 | 0.00241 | 16.65 (15.94) | Down syndrome | Table_S3 | Male DS direct comorbidity |
G47 | Sleep disorders | 41 | 191 | 3.815 | 0.0000000000172 | 0.0000000000479 | 9.24 (15.39) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
G54 | Nerve root and plexus disorders | 5 | 19 | 5.171 | 0.00864 | 0.0398 | 52.37 (22.71) | Turner syndrome | Table_S1 | Direct comorbidity |
G56 | Mononeuropathies of upper limb | 38 | 251 | 2.507 | 0.00000184 | 0.0000111 | 43.47 (11.82) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
G56 | Mononeuropathies of upper limb | 34 | 1536 | 0.397 | 0.000000000129 | 0.000000000299 | 41.93 (15.27) | Down syndrome | Table_S2 | Inverse comorbidity |
G56 | Mononeuropathies of upper limb | 10 | 425 | 0.445 | 0.00177 | 0.00757 | 53.63 (11.7) | Turner syndrome | Table_S2 | Inverse comorbidity |
G56 | Mononeuropathies of upper limb | 19 | 893 | 0.398 | 0.00000128 | 0.00000335 | 42.37 (11.66) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
G56 | Mononeuropathies of upper limb | 15 | 618 | 0.441 | 0.000144 | 0.000364 | 30.76 (18.42) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
G80 | Cerebral palsy | 5 | 4 | 21.243 | 0.0000361 | 0.000181 | 12.99 (2.83) | Patau syndrome | Table_S1 | Direct comorbidity |
G80 | Cerebral palsy | 6 | 12 | 9.738 | 0.000197 | 0.00095 | 8.95 (5.8) | Edwards syndrome | Table_S1 | Direct comorbidity |
G80 | Cerebral palsy | 62 | 131 | 8.323 | 4.27e-31 | 1.42e-30 | 10 (14.63) | Down syndrome | Table_S1 | Direct comorbidity |
G80 | Cerebral palsy | 6 | 26 | 4.469 | 0.00704 | 0.0324 | 10.1 (4.72) | Turner syndrome | Table_S1 | Direct comorbidity |
G80 | Cerebral palsy | 10 | 3 | 48.929 | 0.0000000000134 | 0.0000000000328 | 10.35 (5.58) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
G80 | Cerebral palsy | 6 | 3 | 29.148 | 0.00000162 | 0.00000519 | 2.84 (2.78) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
G80 | Cerebral palsy | 17 | 2 | 107.707 | 3.62e-21 | 1.01e-20 | 10.7 (15.4) | Angelman syndrome | Table_S1 | Direct comorbidity |
G80 | Cerebral palsy | 9 | 10 | 15.686 | 0.000000199 | 0.00000192 | 4.97 (4.5) | Fragile X syndrome | Table_S1 | Direct comorbidity |
G80 | Cerebral palsy | 26 | 58 | 8.142 | 0.000000000000105 | 0.000000000000374 | 9.98 (17) | Down syndrome | Table_S3 | Female DS direct comorbidity |
G80 | Cerebral palsy | 36 | 93 | 6.712 | 3.03e-16 | 9.95e-16 | 10 (12.44) | Down syndrome | Table_S3 | Male DS direct comorbidity |
G80 | Cerebral palsy | 7 | 8 | 15.176 | 0.00000564 | 0.0000457 | 5.75 (4.9) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
G80 | Cerebral palsy | 36 | 75 | 8.491 | 5.4e-19 | 1.5e-18 | 6.71 (8.07) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
G81 | Hemiplegia | 13 | 62 | 3.875 | 0.000183 | 0.000607 | 14.71 (15.61) | Down syndrome | Table_S1 | Direct comorbidity |
G81 | Hemiplegia | 10 | 37 | 4.936 | 0.000207 | 0.00068 | 18.93 (16.86) | Down syndrome | Table_S3 | Male DS direct comorbidity |
G82 | Paraplegia and tetraplegia | 5 | 5 | 18.085 | 0.0000723 | 0.000349 | 14.91 (6.03) | Edwards syndrome | Table_S1 | Direct comorbidity |
G82 | Paraplegia and tetraplegia | 17 | 145 | 2.150 | 0.00711 | 0.0235 | 27.04 (18.48) | Down syndrome | Table_S1 | Direct comorbidity |
G90 | Disorders of autonomic nervous system | 65 | 59 | 19.183 | 0 | 0 | 11.51 (24.19) | Down syndrome | Table_S1 | Direct comorbidity |
G90 | Disorders of autonomic nervous system | 22 | 25 | 15.739 | 3.27e-16 | 0.00000000000000116 | 7.01 (19.68) | Down syndrome | Table_S3 | Female DS direct comorbidity |
G90 | Disorders of autonomic nervous system | 43 | 21 | 34.105 | 7.42e-39 | 2.43e-38 | 18.26 (25.45) | Down syndrome | Table_S3 | Male DS direct comorbidity |
G90 | Disorders of autonomic nervous system | 33 | 12 | 45.615 | 1.52e-32 | 4.23e-32 | 5.86 (20.88) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
G91 | Hydrocephalus | 14 | 6 | 38.753 | 0.0000000000000181 | 0.0000000000000873 | 4.01 (13.52) | Edwards syndrome | Table_S1 | Direct comorbidity |
G96 | Other disorders of central nervous system | 54 | 381 | 2.511 | 0.0000000157 | 0.000000052 | 48.38 (18.58) | Down syndrome | Table_S1 | Direct comorbidity |
G96 | Other disorders of central nervous system | 12 | 89 | 2.490 | 0.00902 | 0.0416 | 20.43 (23.94) | Turner syndrome | Table_S1 | Direct comorbidity |
G96 | Other disorders of central nervous system | 6 | 2 | 41.886 | 0.000000406 | 0.00000113 | 3.16 (14.13) | Angelman syndrome | Table_S1 | Direct comorbidity |
G96 | Other disorders of central nervous system | 6 | 11 | 10.065 | 0.000178 | 0.00172 | 36.84 (25.46) | Fragile X syndrome | Table_S1 | Direct comorbidity |
G96 | Other disorders of central nervous system | 35 | 210 | 2.909 | 0.000000273 | 0.000000894 | 48.92 (19.81) | Down syndrome | Table_S3 | Male DS direct comorbidity |
G96 | Other disorders of central nervous system | 6 | 8 | 13.279 | 0.0000504 | 0.000408 | 36.84 (25.46) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
G96 | Other disorders of central nervous system | 14 | 95 | 2.725 | 0.00224 | 0.00624 | 19.92 (17.02) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
G98 | Other disorders of nervous system. not elsewhere classified | 5 | 3 | 26.927 | 0.0000161 | 0.0000447 | 3.92 (3.72) | Angelman syndrome | Table_S1 | Direct comorbidity |
H00 | Hordeolum and chalazion | 24 | 241 | 1.802 | 0.0101 | 0.0334 | 19.34 (14.49) | Down syndrome | Table_S1 | Direct comorbidity |
H00 | Hordeolum and chalazion | 16 | 125 | 2.301 | 0.00507 | 0.0166 | 19.86 (16.28) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H00 | Hordeolum and chalazion | 11 | 84 | 2.462 | 0.0136 | 0.0377 | 13.24 (9.8) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H01 | Other inflammation of eyelid | 50 | 104 | 8.470 | 1.32e-25 | 4.36e-25 | 33.13 (20.32) | Down syndrome | Table_S1 | Direct comorbidity |
H01 | Other inflammation of eyelid | 5 | 19 | 5.171 | 0.00864 | 0.0398 | 46.74 (22.01) | Turner syndrome | Table_S1 | Direct comorbidity |
H01 | Other inflammation of eyelid | 19 | 53 | 6.590 | 0.00000000433 | 0.0000000154 | 39.79 (22.74) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H01 | Other inflammation of eyelid | 31 | 53 | 10.105 | 4.57e-18 | 1.5e-17 | 23.27 (18.47) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H01 | Other inflammation of eyelid | 21 | 25 | 14.758 | 0.00000000000000396 | 0.000000000000011 | 13.3 (14.64) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H02 | Other disorders of eyelid | 14 | 103 | 2.486 | 0.00472 | 0.0217 | 41.18 (19.5) | Turner syndrome | Table_S1 | Direct comorbidity |
H02 | Other disorders of eyelid | 24 | 219 | 1.938 | 0.00449 | 0.0147 | 28.35 (21.14) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H02 | Other disorders of eyelid | 13 | 82 | 2.942 | 0.00179 | 0.00498 | 25.16 (17.46) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H04 | Disorders of lacrimal system | 78 | 132 | 10.358 | 5.46506e-44 | 1.79366e-43 | 7.7 (16.51) | Down syndrome | Table_S1 | Direct comorbidity |
H04 | Disorders of lacrimal system | 44 | 82 | 9.646 | 1.26e-24 | 4.48e-24 | 8.47 (17.46) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H04 | Disorders of lacrimal system | 34 | 63 | 9.325 | 7.44e-19 | 2.44e-18 | 6.83 (15.13) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H04 | Disorders of lacrimal system | 36 | 33 | 18.980 | 1.35e-27 | 3.75e-27 | 4.66 (5.21) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H05 | Disorders of orbit | 8 | 44 | 3.558 | 0.00584 | 0.0207 | 31.2 (19.25) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H10 | Conjunctivitis | 117 | 1285 | 1.600 | 0.00000309 | 0.0000102 | 17.51 (21.77) | Down syndrome | Table_S1 | Direct comorbidity |
H10 | Conjunctivitis | 6 | 14 | 8.303 | 0.000306 | 0.000751 | 3.31 (3.25) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
H10 | Conjunctivitis | 58 | 485 | 2.160 | 0.000000391 | 0.00000139 | 15.85 (21.87) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H10 | Conjunctivitis | 45 | 334 | 2.395 | 0.000000643 | 0.00000179 | 4.15 (16.07) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H11 | Other disorders of conjunctiva | 25 | 208 | 2.169 | 0.000945 | 0.00313 | 47.84 (16.8) | Down syndrome | Table_S1 | Direct comorbidity |
H11 | Other disorders of conjunctiva | 13 | 103 | 2.395 | 0.00874 | 0.031 | 43.13 (19.49) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H16 | Keratitis | 49 | 296 | 2.936 | 0.000000000861 | 0.00000000285 | 49.3 (13.71) | Down syndrome | Table_S1 | Direct comorbidity |
H16 | Keratitis | 23 | 127 | 3.336 | 0.00000456 | 0.0000162 | 46.11 (13.42) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H16 | Keratitis | 26 | 163 | 2.807 | 0.0000176 | 0.0000576 | 51.54 (13.95) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H17 | Corneal scars and opacities | 8 | 41 | 3.737 | 0.00455 | 0.0151 | 43.47 (16.78) | Down syndrome | Table_S1 | Direct comorbidity |
H17 | Corneal scars and opacities | 6 | 20 | 5.684 | 0.00252 | 0.00825 | 37.24 (15.47) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H18 | Other disorders of cornea | 124 | 147 | 14.729 | 0 | 0 | 42.69 (13.62) | Down syndrome | Table_S1 | Direct comorbidity |
H18 | Other disorders of cornea | 8 | 29 | 5.171 | 0.000727 | 0.00335 | 31.72 (15.38) | Turner syndrome | Table_S1 | Direct comorbidity |
H18 | Other disorders of cornea | 56 | 87 | 11.524 | 4.8e-34 | 1.7e-33 | 45.28 (13.74) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H18 | Other disorders of cornea | 68 | 103 | 11.314 | 2.00999e-40 | 6.6e-40 | 40.31 (13.47) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H18 | Other disorders of cornea | 22 | 32 | 12.156 | 0.0000000000000164 | 0.0000000000000456 | 27.7 (15.89) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H19 | Disorders of sclera and cornea in diseases classified elsewhere | 48 | 53 | 15.824 | 1.29e-33 | 4.27e-33 | 42.76 (11.25) | Down syndrome | Table_S1 | Direct comorbidity |
H19 | Disorders of sclera and cornea in diseases classified elsewhere | 26 | 29 | 16.013 | 4.79e-19 | 1.7e-18 | 42.52 (10.17) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H19 | Disorders of sclera and cornea in diseases classified elsewhere | 22 | 28 | 13.524 | 0.0000000000000039 | 0.0000000000000128 | 43.2 (12.36) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H19 | Disorders of sclera and cornea in diseases classified elsewhere | 11 | 16 | 12.311 | 0.000000065 | 0.000000181 | 35.1 (9.94) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H25 | Senile cataract | 303 | 1600 | 3.311 | 0 | 0 | 51.99 (12.19) | Down syndrome | Table_S1 | Direct comorbidity |
H25 | Senile cataract | 29 | 229 | 2.113 | 0.000482 | 0.00291 | 64.2 (11.53) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
H25 | Senile cataract | 54 | 331 | 2.856 | 0.000000000165 | 0.000000000761 | 60.59 (9.57) | Turner syndrome | Table_S1 | Direct comorbidity |
H25 | Senile cataract | 152 | 904 | 3.008 | 1.39e-29 | 4.93e-29 | 51.45 (12.02) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H25 | Senile cataract | 151 | 727 | 3.560 | 4.07e-36 | 1.34e-35 | 52.77 (12.36) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H25 | Senile cataract | 43 | 241 | 3.171 | 0.000000000921 | 0.00000000256 | 50.29 (16.71) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H25 | Senile cataract | 6 | 16 | 6.954 | 0.000757 | 0.00539 | 51.21 (16.9) | Down syndrome | Table_S6 | Mosaic DS direct comorbidity |
H26 | Other cataract | 381 | 549 | 12.112 | 0 | 0 | 44.38 (14.72) | Down syndrome | Table_S1 | Direct comorbidity |
H26 | Other cataract | 26 | 105 | 4.391 | 0.00000000854 | 0.0000000394 | 50.57 (15.81) | Turner syndrome | Table_S1 | Direct comorbidity |
H26 | Other cataract | 202 | 255 | 14.109 | 0 | 0 | 43.79 (14.72) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H26 | Other cataract | 179 | 264 | 11.583 | 0 | 0 | 45.07 (14.71) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H26 | Other cataract | 78 | 84 | 16.210 | 0 | 0 | 26.67 (16.53) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H26 | Other cataract | 5 | 4 | 20.267 | 0.0000429 | 0.000305 | 32.37 (22.58) | Down syndrome | Table_S6 | Mosaic DS direct comorbidity |
H27 | Other disorders of lens | 25 | 58 | 7.685 | 0.00000000000103 | 0.00000000000342 | 40.43 (17.08) | Down syndrome | Table_S1 | Direct comorbidity |
H27 | Other disorders of lens | 16 | 17 | 16.804 | 0.00000000000186 | 0.0000000000066 | 38.84 (15.11) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H27 | Other disorders of lens | 9 | 29 | 5.684 | 0.00018 | 0.000592 | 40.95 (20.05) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H31 | Other disorders of choroid | 6 | 21 | 5.549 | 0.00279 | 0.00923 | 40.46 (14.51) | Down syndrome | Table_S1 | Direct comorbidity |
H33 | Retinal detachments and breaks | 10 | 62 | 3.010 | 0.00562 | 0.0259 | 55.6 (14.13) | Turner syndrome | Table_S1 | Direct comorbidity |
H36 | Retinal disorders in diseases classified elsewhere | 18 | 54 | 5.955 | 0.0000000409 | 0.000000188 | 46.03 (12.35) | Turner syndrome | Table_S1 | Direct comorbidity |
H36 | Retinal disorders in diseases classified elsewhere | 11 | 47 | 4.360 | 0.000242 | 0.000674 | 40.75 (16.22) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H40 | Glaucoma | 15 | 53 | 5.107 | 0.00000304 | 0.000014 | 50.39 (13.36) | Turner syndrome | Table_S1 | Direct comorbidity |
H43 | Disorders of vitreous body | 10 | 55 | 3.386 | 0.00265 | 0.0122 | 57.92 (6.24) | Turner syndrome | Table_S1 | Direct comorbidity |
H43 | Disorders of vitreous body | 5 | 308 | 0.339 | 0.00101 | 0.00234 | 31.56 (18.8) | Down syndrome | Table_S2 | Inverse comorbidity |
H44 | Disorders of globe | 77 | 115 | 11.726 | 0 | 1.4013e-45 | 42.37 (16.55) | Down syndrome | Table_S1 | Direct comorbidity |
H44 | Disorders of globe | 41 | 57 | 12.884 | 1.23e-26 | 4.37e-26 | 40.38 (18.16) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H44 | Disorders of globe | 36 | 65 | 9.560 | 3.68e-20 | 1.21e-19 | 45.1 (14.18) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H44 | Disorders of globe | 16 | 19 | 14.825 | 0.00000000000745 | 0.0000000000207 | 28.73 (17.29) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H47 | Other disorders of optic [2nd] nerve and visual pathways | 27 | 110 | 4.399 | 0.00000000506 | 0.0000000167 | 16.73 (19.05) | Down syndrome | Table_S1 | Direct comorbidity |
H47 | Other disorders of optic [2nd] nerve and visual pathways | 6 | 1 | 62.274 | 0.0000000929 | 0.000000228 | 5.5 (5.1) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
H47 | Other disorders of optic [2nd] nerve and visual pathways | 6 | 1 | 62.829 | 0.000000106 | 0.000000295 | 8.55 (12.78) | Angelman syndrome | Table_S1 | Direct comorbidity |
H47 | Other disorders of optic [2nd] nerve and visual pathways | 13 | 39 | 6.227 | 0.00000234 | 0.00000828 | 12.13 (22.21) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H47 | Other disorders of optic [2nd] nerve and visual pathways | 14 | 58 | 4.335 | 0.0000348 | 0.000114 | 16.91 (15.31) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H47 | Other disorders of optic [2nd] nerve and visual pathways | 9 | 35 | 4.845 | 0.000492 | 0.00137 | 11.52 (13.22) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H49 | Paralytic strabismus | 6 | 14 | 8.044 | 0.000527 | 0.00243 | 21.01 (23.16) | Turner syndrome | Table_S1 | Direct comorbidity |
H49 | Paralytic strabismus | 5 | 19 | 5.232 | 0.00827 | 0.023 | 3.7 (2.65) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H50 | Other strabismus | 11 | 31 | 6.782 | 0.0000056 | 0.000027 | 2.08 (3.39) | Edwards syndrome | Table_S1 | Direct comorbidity |
H50 | Other strabismus | 372 | 529 | 12.273 | 0 | 0 | 8.98 (18.61) | Down syndrome | Table_S1 | Direct comorbidity |
H50 | Other strabismus | 33 | 144 | 4.042 | 0.000000000478 | 0.0000000022 | 10.82 (16.98) | Turner syndrome | Table_S1 | Direct comorbidity |
H50 | Other strabismus | 18 | 12 | 24.344 | 8.73e-17 | 2.8e-16 | 8.72 (16.69) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
H50 | Other strabismus | 24 | 14 | 29.919 | 1.9e-23 | 5.3e-23 | 3.93 (10.85) | Angelman syndrome | Table_S1 | Direct comorbidity |
H50 | Other strabismus | 15 | 44 | 6.135 | 0.000000303 | 0.00000292 | 13.8 (14.63) | Fragile X syndrome | Table_S1 | Direct comorbidity |
H50 | Other strabismus | 187 | 232 | 14.356 | 0 | 0 | 9.59 (19.62) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H50 | Other strabismus | 185 | 268 | 11.791 | 0 | 0 | 8.98 (17.38) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H50 | Other strabismus | 14 | 29 | 8.537 | 0.000000023 | 0.000000186 | 10.52 (15.14) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
H50 | Other strabismus | 151 | 204 | 12.932 | 0 | 0 | 6.08 (8.78) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H50 | Other strabismus | 10 | 9 | 18.578 | 0.00000000672 | 0.0000000479 | 6.92 (21.68) | Down syndrome | Table_S6 | Mosaic DS direct comorbidity |
H50 | Other strabismus | 18 | 55 | 5.726 | 0.0000000474 | 0.000000337 | 6.56 (9.9) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
H52 | Disorders of refraction and accommodation | 848 | 832 | 17.774 | 0 | 0 | 11.35 (18.41) | Down syndrome | Table_S1 | Direct comorbidity |
H52 | Disorders of refraction and accommodation | 5 | 14 | 7.206 | 0.002 | 0.0222 | 13.21 (8.69) | Triple X syndrome | Table_S1 | Direct comorbidity |
H52 | Disorders of refraction and accommodation | 43 | 234 | 3.227 | 0.00000000053 | 0.00000000244 | 14.74 (19.24) | Turner syndrome | Table_S1 | Direct comorbidity |
H52 | Disorders of refraction and accommodation | 11 | 13 | 15.251 | 0.00000000333 | 0.00000000817 | 3.56 (6.08) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
H52 | Disorders of refraction and accommodation | 17 | 20 | 14.277 | 0.000000000000286 | 0.000000000000916 | 20.79 (17.47) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
H52 | Disorders of refraction and accommodation | 26 | 14 | 32.312 | 6.14e-26 | 1.71e-25 | 3.73 (14.16) | Angelman syndrome | Table_S1 | Direct comorbidity |
H52 | Disorders of refraction and accommodation | 39 | 45 | 15.004 | 2.18e-28 | 2.1e-27 | 14.31 (18.14) | Fragile X syndrome | Table_S1 | Direct comorbidity |
H52 | Disorders of refraction and accommodation | 382 | 388 | 17.518 | 0 | 0 | 11.38 (18.53) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H52 | Disorders of refraction and accommodation | 466 | 416 | 19.097 | 0 | 0 | 11.35 (18.31) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H52 | Disorders of refraction and accommodation | 34 | 30 | 19.276 | 1.11e-27 | 8.95e-27 | 16.11 (18.73) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
H52 | Disorders of refraction and accommodation | 384 | 234 | 28.574 | 0 | 0 | 9.02 (12.87) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H52 | Disorders of refraction and accommodation | 14 | 15 | 15.833 | 0.0000000000177 | 0.000000000126 | 7.58 (21.67) | Down syndrome | Table_S6 | Mosaic DS direct comorbidity |
H52 | Disorders of refraction and accommodation | 24 | 70 | 5.942 | 0.000000000109 | 0.000000000774 | 10.49 (15.17) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
H53 | Visual disturbances | 68 | 452 | 2.656 | 0.0000000000237 | 0.0000000000786 | 11.85 (20.67) | Down syndrome | Table_S1 | Direct comorbidity |
H53 | Visual disturbances | 17 | 113 | 2.722 | 0.000727 | 0.00335 | 27.97 (23.87) | Turner syndrome | Table_S1 | Direct comorbidity |
H53 | Visual disturbances | 40 | 220 | 3.301 | 0.00000000149 | 0.00000000527 | 16.75 (21.77) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H53 | Visual disturbances | 28 | 217 | 2.268 | 0.000236 | 0.000773 | 10.19 (18.49) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H53 | Visual disturbances | 31 | 114 | 4.853 | 0.0000000000355 | 0.0000000000987 | 7.98 (13.05) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H53 | Visual disturbances | 8 | 33 | 4.467 | 0.00155 | 0.0111 | 14.4 (15.94) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
H54 | Blindness and low vision | 5 | 6 | 15.501 | 0.000127 | 0.000613 | 2.02 (7.3) | Edwards syndrome | Table_S1 | Direct comorbidity |
H54 | Blindness and low vision | 66 | 115 | 10.072 | 7.24e-37 | 2.4e-36 | 23.75 (22.6) | Down syndrome | Table_S1 | Direct comorbidity |
H54 | Blindness and low vision | 8 | 23 | 6.464 | 0.000199 | 0.000917 | 23.99 (24.02) | Turner syndrome | Table_S1 | Direct comorbidity |
H54 | Blindness and low vision | 6 | 1 | 62.829 | 0.000000106 | 0.000000295 | 0.54 (14.21) | Angelman syndrome | Table_S1 | Direct comorbidity |
H54 | Blindness and low vision | 31 | 60 | 9.334 | 2.07e-17 | 7.35e-17 | 14.54 (21.98) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H54 | Blindness and low vision | 35 | 66 | 9.162 | 3.5e-19 | 1.15e-18 | 27 (22.77) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H54 | Blindness and low vision | 23 | 33 | 12.311 | 0.00000000000000334 | 0.0000000000000093 | 9.82 (14.3) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H55 | Nystagmus and other irregular eye movements | 117 | 29 | 68.593 | 0 | 0 | 9.82 (17.47) | Down syndrome | Table_S1 | Direct comorbidity |
H55 | Nystagmus and other irregular eye movements | 6 | 1 | 62.829 | 0.000000106 | 0.000000295 | 2.82 (2.24) | Angelman syndrome | Table_S1 | Direct comorbidity |
H55 | Nystagmus and other irregular eye movements | 64 | 12 | 88.961 | 0 | 0 | 11.91 (18.2) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H55 | Nystagmus and other irregular eye movements | 53 | 19 | 46.041 | 0 | 0 | 8.23 (16.18) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H55 | Nystagmus and other irregular eye movements | 44 | 18 | 41.308 | 5.71029e-42 | 1.59005e-41 | 8.44 (13.13) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H57 | Other disorders of eye and adnexa | 82 | 387 | 3.730 | 6.85e-21 | 2.27e-20 | 6.04 (19.12) | Down syndrome | Table_S1 | Direct comorbidity |
H57 | Other disorders of eye and adnexa | 8 | 17 | 8.627 | 0.0000321 | 0.000309 | 11.58 (19.34) | Fragile X syndrome | Table_S1 | Direct comorbidity |
H57 | Other disorders of eye and adnexa | 39 | 178 | 3.976 | 0.000000000021 | 0.0000000000746 | 6.26 (19.23) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H57 | Other disorders of eye and adnexa | 43 | 217 | 3.442 | 0.000000000125 | 0.00000000041 | 5.04 (19) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H57 | Other disorders of eye and adnexa | 33 | 94 | 6.242 | 0.0000000000000231 | 0.0000000000000643 | 6.26 (11.27) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H59 | Postprocedural disorders of eye and adnexa. not elsewhere classified | 10 | 18 | 10.096 | 0.00000115 | 0.00000381 | 45.38 (14.18) | Down syndrome | Table_S1 | Direct comorbidity |
H59 | Postprocedural disorders of eye and adnexa. not elsewhere classified | 6 | 5 | 20.757 | 0.00000819 | 0.000029 | 47.07 (10.6) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H60 | Otitis externa | 79 | 312 | 4.457 | 3.02e-24 | 9.99e-24 | 32.76 (16.64) | Down syndrome | Table_S1 | Direct comorbidity |
H60 | Otitis externa | 17 | 83 | 3.694 | 0.0000276 | 0.000127 | 24.77 (19.23) | Turner syndrome | Table_S1 | Direct comorbidity |
H60 | Otitis externa | 38 | 141 | 4.887 | 0.000000000000182 | 0.000000000000645 | 33.32 (16.5) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H60 | Otitis externa | 41 | 165 | 4.314 | 0.000000000000761 | 0.0000000000025 | 28.74 (16.78) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H60 | Otitis externa | 25 | 84 | 5.335 | 0.000000000582 | 0.00000000162 | 18.46 (16.25) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H61 | Other disorders of external ear | 177 | 145 | 21.261 | 0 | 0 | 31.18 (17.83) | Down syndrome | Table_S1 | Direct comorbidity |
H61 | Other disorders of external ear | 14 | 30 | 8.341 | 0.000000048 | 0.000000221 | 16.34 (17.78) | Turner syndrome | Table_S1 | Direct comorbidity |
H61 | Other disorders of external ear | 6 | 6 | 17.255 | 0.0000168 | 0.000162 | 4.18 (7.5) | Fragile X syndrome | Table_S1 | Direct comorbidity |
H61 | Other disorders of external ear | 80 | 71 | 20.016 | 0 | 0 | 32.6 (18.61) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H61 | Other disorders of external ear | 97 | 86 | 19.208 | 0 | 0 | 29.89 (17.16) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H61 | Other disorders of external ear | 70 | 37 | 32.587 | 0 | 0 | 11.92 (16.67) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H61 | Other disorders of external ear | 6 | 5 | 19.689 | 0.0000101 | 0.0000717 | 14.66 (12.75) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
H62 | Disorders of external ear in diseases classified elsewhere | 6 | 15 | 7.629 | 0.000676 | 0.00224 | 28.32 (22.29) | Down syndrome | Table_S1 | Direct comorbidity |
H65 | Nonsuppurative otitis media | 15 | 103 | 2.782 | 0.000951 | 0.00459 | 2.31 (7.75) | Edwards syndrome | Table_S1 | Direct comorbidity |
H65 | Nonsuppurative otitis media | 692 | 1265 | 9.546 | 0 | 0 | 5.62 (11.91) | Down syndrome | Table_S1 | Direct comorbidity |
H65 | Nonsuppurative otitis media | 129 | 288 | 7.754 | 0 | 0 | 8.65 (13.59) | Turner syndrome | Table_S1 | Direct comorbidity |
H65 | Nonsuppurative otitis media | 19 | 29 | 11.862 | 0.0000000000000371 | 0.0000000000000909 | 1.98 (2.63) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
H65 | Nonsuppurative otitis media | 18 | 21 | 14.385 | 0.0000000000000444 | 0.000000000000142 | 2.42 (3.29) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
H65 | Nonsuppurative otitis media | 15 | 54 | 5.222 | 0.000000804 | 0.00000224 | 1.73 (0.87) | Angelman syndrome | Table_S1 | Direct comorbidity |
H65 | Nonsuppurative otitis media | 36 | 109 | 5.804 | 0.00000000000000136 | 0.0000000000000131 | 2.6 (3.1) | Fragile X syndrome | Table_S1 | Direct comorbidity |
H65 | Nonsuppurative otitis media | 313 | 521 | 10.703 | 0 | 0 | 5.85 (11.79) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H65 | Nonsuppurative otitis media | 379 | 747 | 8.663 | 0 | 0 | 5.26 (12) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H65 | Nonsuppurative otitis media | 8 | 27 | 5.625 | 0.000272 | 0.00438 | 2.61 (3.27) | Fragile X syndrome | Table_S5 | Female FXS direct comorbidity |
H65 | Nonsuppurative otitis media | 28 | 88 | 5.563 | 0.00000000000397 | 0.0000000000322 | 2.56 (3.05) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
H65 | Nonsuppurative otitis media | 341 | 563 | 10.576 | 0 | 0 | 4.93 (8.31) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H65 | Nonsuppurative otitis media | 13 | 22 | 10.280 | 0.00000000578 | 0.0000000412 | 4.59 (9.05) | Down syndrome | Table_S6 | Mosaic DS direct comorbidity |
H65 | Nonsuppurative otitis media | 60 | 84 | 12.111 | 1.26e-39 | 8.94e-39 | 7.82 (8.64) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
H66 | Suppurative and unspecified otitis media | 248 | 1228 | 3.533 | 0 | 0 | 9.18 (14.72) | Down syndrome | Table_S1 | Direct comorbidity |
H66 | Suppurative and unspecified otitis media | 7 | 33 | 4.239 | 0.00323 | 0.0357 | 4.09 (11.03) | Triple X syndrome | Table_S1 | Direct comorbidity |
H66 | Suppurative and unspecified otitis media | 90 | 282 | 5.543 | 2.34e-34 | 1.08e-33 | 9.16 (16.47) | Turner syndrome | Table_S1 | Direct comorbidity |
H66 | Suppurative and unspecified otitis media | 8 | 37 | 4.214 | 0.00139 | 0.0034 | 1.88 (3.07) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
H66 | Suppurative and unspecified otitis media | 10 | 26 | 6.786 | 0.0000102 | 0.0000326 | 1.72 (0.66) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
H66 | Suppurative and unspecified otitis media | 16 | 72 | 4.180 | 0.00000424 | 0.0000118 | 2.55 (12.96) | Angelman syndrome | Table_S1 | Direct comorbidity |
H66 | Suppurative and unspecified otitis media | 18 | 119 | 2.732 | 0.000356 | 0.00343 | 1.63 (2.58) | Fragile X syndrome | Table_S1 | Direct comorbidity |
H66 | Suppurative and unspecified otitis media | 96 | 497 | 3.466 | 1.2e-22 | 4.27e-22 | 9.94 (14.22) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H66 | Suppurative and unspecified otitis media | 152 | 673 | 3.871 | 5.33001e-40 | 1.75e-39 | 8.99 (15.03) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H66 | Suppurative and unspecified otitis media | 13 | 84 | 2.812 | 0.00197 | 0.016 | 1.82 (2.89) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
H66 | Suppurative and unspecified otitis media | 125 | 525 | 4.178 | 1.11e-36 | 3.08e-36 | 6.57 (11.26) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H66 | Suppurative and unspecified otitis media | 39 | 82 | 8.133 | 8.65e-21 | 6.16e-20 | 8.43 (13.71) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
H68 | Eustachian salpingitis and obstruction | 92 | 85 | 18.858 | 0 | 0 | 9.75 (13.73) | Down syndrome | Table_S1 | Direct comorbidity |
H68 | Eustachian salpingitis and obstruction | 20 | 22 | 15.738 | 0.00000000000000765 | 0.0000000000000353 | 10.37 (19.53) | Turner syndrome | Table_S1 | Direct comorbidity |
H68 | Eustachian salpingitis and obstruction | 30 | 43 | 12.535 | 1.35e-19 | 4.8e-19 | 8.92 (16.64) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H68 | Eustachian salpingitis and obstruction | 62 | 56 | 18.847 | 0 | 1.4013e-45 | 10.15 (11.93) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H68 | Eustachian salpingitis and obstruction | 56 | 37 | 26.162 | 0 | 0 | 8.96 (9.45) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H68 | Eustachian salpingitis and obstruction | 7 | 9 | 13.501 | 0.0000111 | 0.0000791 | 10.41 (19.33) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
H71 | Cholesteatoma of middle ear | 52 | 125 | 7.335 | 2.84e-24 | 9.4e-24 | 29.45 (15.23) | Down syndrome | Table_S1 | Direct comorbidity |
H71 | Cholesteatoma of middle ear | 40 | 36 | 19.101 | 1.33e-30 | 6.15e-30 | 18.85 (15.15) | Turner syndrome | Table_S1 | Direct comorbidity |
H71 | Cholesteatoma of middle ear | 25 | 59 | 7.710 | 0.000000000000845 | 0.000000000003 | 26.81 (15.16) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H71 | Cholesteatoma of middle ear | 27 | 76 | 6.201 | 0.00000000000771 | 0.0000000000253 | 34.88 (14.9) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H71 | Cholesteatoma of middle ear | 21 | 52 | 7.240 | 0.000000000152 | 0.000000000424 | 21.94 (15.14) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H71 | Cholesteatoma of middle ear | 20 | 12 | 27.262 | 4.48e-18 | 3.19e-17 | 13.8 (11.36) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
H72 | Perforation of tympanic membrane | 69 | 352 | 3.458 | 2.59e-16 | 8.59e-16 | 13.91 (12.29) | Down syndrome | Table_S1 | Direct comorbidity |
H72 | Perforation of tympanic membrane | 45 | 99 | 7.929 | 1.54e-22 | 7.09e-22 | 13.59 (11.64) | Turner syndrome | Table_S1 | Direct comorbidity |
H72 | Perforation of tympanic membrane | 29 | 165 | 3.215 | 0.000000476 | 0.00000169 | 13.24 (13.33) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H72 | Perforation of tympanic membrane | 40 | 179 | 3.884 | 0.0000000000243 | 0.0000000000797 | 14.14 (11.48) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H72 | Perforation of tympanic membrane | 33 | 155 | 3.801 | 0.00000000194 | 0.00000000538 | 10.89 (10.83) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H72 | Perforation of tympanic membrane | 23 | 29 | 13.501 | 3.98e-16 | 0.00000000000000284 | 12.5 (9.69) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
H74 | Other disorders of middle ear and mastoid | 21 | 44 | 8.526 | 0.0000000000147 | 0.0000000000486 | 32.46 (16.07) | Down syndrome | Table_S1 | Direct comorbidity |
H74 | Other disorders of middle ear and mastoid | 12 | 10 | 20.371 | 0.00000000026 | 0.0000000012 | 20.16 (13.71) | Turner syndrome | Table_S1 | Direct comorbidity |
H74 | Other disorders of middle ear and mastoid | 8 | 20 | 7.625 | 0.0000748 | 0.000265 | 32.61 (14.58) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H74 | Other disorders of middle ear and mastoid | 13 | 19 | 11.937 | 0.00000000565 | 0.0000000185 | 21.41 (16.92) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H74 | Other disorders of middle ear and mastoid | 5 | 4 | 20.252 | 0.0000531 | 0.000378 | 14.46 (15.26) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
H80 | Otosclerosis | 12 | 47 | 4.668 | 0.000069 | 0.000318 | 50.51 (9.71) | Turner syndrome | Table_S1 | Direct comorbidity |
H90 | Conductive and sensorineural hearing loss | 5 | 13 | 7.587 | 0.00169 | 0.00851 | 10.59 (16.65) | Patau syndrome | Table_S1 | Direct comorbidity |
H90 | Conductive and sensorineural hearing loss | 363 | 865 | 7.330 | 0 | 0 | 23.28 (19.89) | Down syndrome | Table_S1 | Direct comorbidity |
H90 | Conductive and sensorineural hearing loss | 165 | 177 | 16.075 | 0 | 0 | 33.94 (18) | Turner syndrome | Table_S1 | Direct comorbidity |
H90 | Conductive and sensorineural hearing loss | 10 | 7 | 24.465 | 0.00000000078 | 0.00000000191 | 3.78 (4.89) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
H90 | Conductive and sensorineural hearing loss | 9 | 6 | 23.795 | 0.0000000101 | 0.0000000322 | 3.98 (9.67) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
H90 | Conductive and sensorineural hearing loss | 166 | 363 | 8.163 | 0 | 0 | 23.02 (20.35) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H90 | Conductive and sensorineural hearing loss | 197 | 442 | 7.622 | 0 | 0 | 23.43 (19.5) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H90 | Conductive and sensorineural hearing loss | 141 | 203 | 12.140 | 0 | 0 | 14.16 (17.85) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H90 | Conductive and sensorineural hearing loss | 6 | 13 | 8.444 | 0.000313 | 0.00223 | 16.66 (10.17) | Down syndrome | Table_S6 | Mosaic DS direct comorbidity |
H90 | Conductive and sensorineural hearing loss | 61 | 39 | 26.159 | 0 | 0 | 24.79 (14.24) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
H91 | Other hearing loss | 10 | 33 | 5.851 | 0.0000469 | 0.000226 | 3.69 (16.82) | Edwards syndrome | Table_S1 | Direct comorbidity |
H91 | Other hearing loss | 401 | 1790 | 3.914 | 0 | 0 | 38.27 (21.33) | Down syndrome | Table_S1 | Direct comorbidity |
H91 | Other hearing loss | 178 | 328 | 9.378 | 0 | 0 | 44.64 (19.57) | Turner syndrome | Table_S1 | Direct comorbidity |
H91 | Other hearing loss | 6 | 4 | 24.909 | 0.00000247 | 0.00000606 | 11.43 (6.91) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
H91 | Other hearing loss | 6 | 11 | 9.716 | 0.000168 | 0.000539 | 18.24 (17.34) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
H91 | Other hearing loss | 11 | 55 | 3.697 | 0.000711 | 0.00685 | 3.89 (26.66) | Fragile X syndrome | Table_S1 | Direct comorbidity |
H91 | Other hearing loss | 177 | 691 | 4.577 | 0 | 0 | 39.58 (22.44) | Down syndrome | Table_S3 | Female DS direct comorbidity |
H91 | Other hearing loss | 224 | 1070 | 3.582 | 0 | 0 | 37.86 (20.39) | Down syndrome | Table_S3 | Male DS direct comorbidity |
H91 | Other hearing loss | 8 | 43 | 3.492 | 0.00565 | 0.0458 | 3.71 (27.71) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
H91 | Other hearing loss | 126 | 333 | 6.632 | 0 | 0 | 16.25 (17.71) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H91 | Other hearing loss | 8 | 24 | 6.080 | 0.000179 | 0.00128 | 11.71 (18.91) | Down syndrome | Table_S6 | Mosaic DS direct comorbidity |
H91 | Other hearing loss | 61 | 50 | 20.517 | 0 | 0 | 35.53 (18.61) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
H93 | Other disorders of ear. not elsewhere classified | 62 | 192 | 5.627 | 4.03e-24 | 1.86e-23 | 43.65 (16.07) | Turner syndrome | Table_S1 | Direct comorbidity |
H93 | Other disorders of ear. not elsewhere classified | 19 | 162 | 2.140 | 0.00441 | 0.0123 | 12.05 (13.61) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
H93 | Other disorders of ear. not elsewhere classified | 15 | 32 | 8.183 | 0.0000000146 | 0.000000104 | 37.1 (14.69) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
H94 | Other disorders of ear in diseases classified elsewhere | 8 | 45 | 3.412 | 0.00739 | 0.0245 | 30.78 (15.29) | Down syndrome | Table_S1 | Direct comorbidity |
H94 | Other disorders of ear in diseases classified elsewhere | 6 | 7 | 15.083 | 0.0000325 | 0.00015 | 39.55 (15.43) | Turner syndrome | Table_S1 | Direct comorbidity |
I08 | Multiple valve diseases | 6 | 11 | 10.173 | 0.000186 | 0.000616 | 24.35 (9.87) | Down syndrome | Table_S1 | Direct comorbidity |
I08 | Multiple valve diseases | 5 | 1 | 51.712 | 0.00000278 | 0.0000128 | 45.15 (12.54) | Turner syndrome | Table_S1 | Direct comorbidity |
I10 | Essential (primary) hypertension | 108 | 846 | 2.218 | 0.000000000000221 | 0.00000000000102 | 49.15 (14.66) | Turner syndrome | Table_S1 | Direct comorbidity |
I10 | Essential (primary) hypertension | 53 | 4468 | 0.211 | 0 | 0 | 52.67 (17.07) | Down syndrome | Table_S2 | Inverse comorbidity |
I10 | Essential (primary) hypertension | 25 | 2170 | 0.213 | 1.23e-26 | 3.23e-26 | 56.27 (20.16) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
I10 | Essential (primary) hypertension | 28 | 2431 | 0.203 | 8.98e-32 | 2.27e-31 | 51.57 (13.64) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
I10 | Essential (primary) hypertension | 5 | 644 | 0.161 | 0.000000000158 | 0.000000000402 | 45.65 (6.38) | Down syndrome | Table_S6 | Non-mosaic DS inverse comorbidity |
I10 | Essential (primary) hypertension | 27 | 126 | 3.721 | 0.0000000459 | 0.000000327 | 38.31 (13.57) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
I11 | Hypertensive heart disease | 9 | 19 | 8.619 | 0.0000113 | 0.0000523 | 53.33 (15.59) | Turner syndrome | Table_S1 | Direct comorbidity |
I15 | Secondary hypertension | 5 | 6 | 14.466 | 0.000178 | 0.00127 | 25.53 (6.62) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
I20 | Angina pectoris | 22 | 1878 | 0.213 | 4.45e-23 | 1.04e-22 | 46.66 (15.86) | Down syndrome | Table_S2 | Inverse comorbidity |
I20 | Angina pectoris | 9 | 678 | 0.262 | 0.0000000595 | 0.000000156 | 38.4 (17.77) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
I20 | Angina pectoris | 13 | 1264 | 0.189 | 8.42e-18 | 2.13e-17 | 47.45 (13.66) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
I20 | Angina pectoris | 5 | 242 | 0.428 | 0.0152 | 0.0387 | 45.88 (12.79) | Down syndrome | Table_S6 | Non-mosaic DS inverse comorbidity |
I21 | Acute myocardial infarction | 16 | 99 | 2.930 | 0.000519 | 0.00239 | 59.75 (13.4) | Turner syndrome | Table_S1 | Direct comorbidity |
I21 | Acute myocardial infarction | 25 | 1083 | 0.418 | 0.000000212 | 0.000000494 | 51.75 (16.98) | Down syndrome | Table_S2 | Inverse comorbidity |
I21 | Acute myocardial infarction | 15 | 808 | 0.337 | 0.000000112 | 0.000000283 | 47.23 (14.83) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
I25 | Chronic ischaemic heart disease | 28 | 157 | 3.164 | 0.000000932 | 0.0000043 | 62.9 (16.39) | Turner syndrome | Table_S1 | Direct comorbidity |
I25 | Chronic ischaemic heart disease | 38 | 1512 | 0.450 | 0.0000000107 | 0.000000025 | 52.33 (19.89) | Down syndrome | Table_S2 | Inverse comorbidity |
I25 | Chronic ischaemic heart disease | 21 | 1119 | 0.335 | 0.000000000374 | 0.000000000945 | 51.95 (18.75) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
I25 | Chronic ischaemic heart disease | 6 | 21 | 5.370 | 0.00304 | 0.0216 | 52.58 (9.31) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
I26 | Pulmonary embolism | 29 | 305 | 1.710 | 0.00896 | 0.0297 | 42.49 (16.28) | Down syndrome | Table_S1 | Direct comorbidity |
I26 | Pulmonary embolism | 16 | 66 | 4.111 | 0.0000159 | 0.0000963 | 45.16 (11.46) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
I26 | Pulmonary embolism | 8 | 41 | 3.737 | 0.00448 | 0.0124 | 21.35 (14.25) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
I27 | Other pulmonary heart diseases | 75 | 81 | 16.163 | 0 | 0 | 21.43 (21.65) | Down syndrome | Table_S1 | Direct comorbidity |
I27 | Other pulmonary heart diseases | 42 | 51 | 14.713 | 6.66e-29 | 2.36e-28 | 22.51 (21.88) | Down syndrome | Table_S3 | Female DS direct comorbidity |
I27 | Other pulmonary heart diseases | 33 | 40 | 14.141 | 1.83e-22 | 6e-22 | 17.38 (21.22) | Down syndrome | Table_S3 | Male DS direct comorbidity |
I27 | Other pulmonary heart diseases | 30 | 23 | 22.528 | 1.27e-24 | 3.54e-24 | 5.79 (20.19) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
I30 | Acute pericarditis | 7 | 35 | 3.954 | 0.00622 | 0.0221 | 25.02 (19.24) | Down syndrome | Table_S3 | Female DS direct comorbidity |
I31 | Other diseases of pericardium | 15 | 49 | 5.580 | 0.00000126 | 0.00000419 | 29.56 (24.77) | Down syndrome | Table_S1 | Direct comorbidity |
I31 | Other diseases of pericardium | 8 | 22 | 6.962 | 0.000128 | 0.000454 | 39.87 (24.81) | Down syndrome | Table_S3 | Female DS direct comorbidity |
I31 | Other diseases of pericardium | 7 | 37 | 3.590 | 0.00996 | 0.0327 | 24.87 (22.81) | Down syndrome | Table_S3 | Male DS direct comorbidity |
I33 | Acute and subacute endocarditis | 22 | 46 | 8.534 | 0.00000000000468 | 0.0000000000155 | 17.4 (20.89) | Down syndrome | Table_S1 | Direct comorbidity |
I33 | Acute and subacute endocarditis | 5 | 10 | 9.402 | 0.000919 | 0.00423 | 44.05 (7.18) | Turner syndrome | Table_S1 | Direct comorbidity |
I33 | Acute and subacute endocarditis | 10 | 16 | 11.513 | 0.000000425 | 0.00000151 | 15.99 (22.85) | Down syndrome | Table_S3 | Female DS direct comorbidity |
I33 | Acute and subacute endocarditis | 12 | 31 | 6.927 | 0.00000245 | 0.00000805 | 18.09 (19.06) | Down syndrome | Table_S3 | Male DS direct comorbidity |
I33 | Acute and subacute endocarditis | 14 | 15 | 16.351 | 0.0000000000616 | 0.000000000171 | 12.16 (22.28) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
I34 | Nonrheumatic mitral valve disorders | 55 | 200 | 4.859 | 1.11e-18 | 3.67e-18 | 25.02 (19.39) | Down syndrome | Table_S1 | Direct comorbidity |
I34 | Nonrheumatic mitral valve disorders | 8 | 38 | 3.978 | 0.00318 | 0.0147 | 58.79 (24.46) | Turner syndrome | Table_S1 | Direct comorbidity |
I34 | Nonrheumatic mitral valve disorders | 32 | 76 | 7.625 | 6.37e-16 | 0.00000000000000226 | 20.63 (17.97) | Down syndrome | Table_S3 | Female DS direct comorbidity |
I34 | Nonrheumatic mitral valve disorders | 23 | 93 | 4.354 | 0.0000000838 | 0.000000275 | 29.19 (20.67) | Down syndrome | Table_S3 | Male DS direct comorbidity |
I34 | Nonrheumatic mitral valve disorders | 23 | 35 | 11.627 | 0.00000000000000837 | 0.0000000000000233 | 16.77 (16.08) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
I35 | Nonrheumatic aortic valve disorders | 62 | 391 | 2.803 | 0.0000000000264 | 0.0000000000876 | 47.78 (19.09) | Down syndrome | Table_S1 | Direct comorbidity |
I35 | Nonrheumatic aortic valve disorders | 43 | 58 | 12.855 | 6.45e-28 | 2.97e-27 | 48.14 (18.91) | Turner syndrome | Table_S1 | Direct comorbidity |
I35 | Nonrheumatic aortic valve disorders | 31 | 183 | 3.094 | 0.000000396 | 0.0000014 | 46.79 (21.54) | Down syndrome | Table_S3 | Female DS direct comorbidity |
I35 | Nonrheumatic aortic valve disorders | 31 | 235 | 2.312 | 0.0000785 | 0.000258 | 48.78 (16.12) | Down syndrome | Table_S3 | Male DS direct comorbidity |
I35 | Nonrheumatic aortic valve disorders | 18 | 75 | 4.360 | 0.00000212 | 0.00000589 | 45.59 (24.63) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
I35 | Nonrheumatic aortic valve disorders | 15 | 10 | 24.548 | 0.000000000000191 | 0.00000000000136 | 34.85 (18.78) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
I36 | Nonrheumatic tricuspid valve disorders | 9 | 16 | 10.258 | 0.00000369 | 0.0000122 | 36.48 (18.95) | Down syndrome | Table_S1 | Direct comorbidity |
I36 | Nonrheumatic tricuspid valve disorders | 7 | 9 | 13.642 | 0.0000115 | 0.0000379 | 11.1 (19.47) | Down syndrome | Table_S3 | Male DS direct comorbidity |
I37 | Pulmonary valve disorders | 5 | 9 | 10.463 | 0.000618 | 0.00205 | 14.71 (16.43) | Down syndrome | Table_S1 | Direct comorbidity |
I37 | Pulmonary valve disorders | 5 | 8 | 11.368 | 0.000457 | 0.0015 | 14.71 (16.43) | Down syndrome | Table_S3 | Male DS direct comorbidity |
I38 | Endocarditis. valve unspecified | 5 | 17 | 5.813 | 0.00566 | 0.0187 | 19.45 (16.29) | Down syndrome | Table_S1 | Direct comorbidity |
I39 | Endocarditis and heart valve disorders in diseases classified elsewhere | 7 | 11 | 11.626 | 0.0000256 | 0.0000847 | 12.21 (19.58) | Down syndrome | Table_S1 | Direct comorbidity |
I42 | Cardiomyopathy | 9 | 30 | 5.560 | 0.000202 | 0.000932 | 33.73 (24.11) | Turner syndrome | Table_S1 | Direct comorbidity |
I44 | Atrioventricular and left bundle-branch block | 35 | 173 | 3.608 | 0.00000000255 | 0.00000000844 | 23.05 (20.34) | Down syndrome | Table_S1 | Direct comorbidity |
I44 | Atrioventricular and left bundle-branch block | 7 | 20 | 6.567 | 0.000485 | 0.00224 | 54.74 (22.12) | Turner syndrome | Table_S1 | Direct comorbidity |
I44 | Atrioventricular and left bundle-branch block | 17 | 69 | 4.575 | 0.0000024 | 0.0000085 | 21.23 (18.02) | Down syndrome | Table_S3 | Female DS direct comorbidity |
I44 | Atrioventricular and left bundle-branch block | 18 | 113 | 2.842 | 0.000331 | 0.00109 | 37.56 (19.95) | Down syndrome | Table_S3 | Male DS direct comorbidity |
I44 | Atrioventricular and left bundle-branch block | 13 | 29 | 8.139 | 0.000000187 | 0.00000052 | 17.3 (9.83) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
I45 | Other conduction disorders | 37 | 163 | 4.041 | 0.0000000000559 | 0.000000000185 | 50.63 (16.57) | Down syndrome | Table_S1 | Direct comorbidity |
I45 | Other conduction disorders | 6 | 25 | 4.641 | 0.00599 | 0.0276 | 50.44 (6.5) | Turner syndrome | Table_S1 | Direct comorbidity |
I45 | Other conduction disorders | 18 | 67 | 4.971 | 0.000000418 | 0.00000148 | 51.23 (17.91) | Down syndrome | Table_S3 | Female DS direct comorbidity |
I45 | Other conduction disorders | 19 | 88 | 3.832 | 0.00000608 | 0.0000199 | 49.3 (15.17) | Down syndrome | Table_S3 | Male DS direct comorbidity |
I45 | Other conduction disorders | 11 | 43 | 4.757 | 0.000124 | 0.000345 | 49.3 (18.21) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
I46 | Cardiac arrest | 42 | 238 | 3.138 | 0.00000000258 | 0.00000000855 | 45.77 (25.07) | Down syndrome | Table_S1 | Direct comorbidity |
I46 | Cardiac arrest | 16 | 83 | 3.601 | 0.000065 | 0.00023 | 37.51 (24.72) | Down syndrome | Table_S3 | Female DS direct comorbidity |
I46 | Cardiac arrest | 26 | 188 | 2.436 | 0.000146 | 0.000479 | 50.83 (25.05) | Down syndrome | Table_S3 | Male DS direct comorbidity |
I46 | Cardiac arrest | 10 | 32 | 5.814 | 0.0000623 | 0.000173 | 10.18 (21.24) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
I47 | Paroxysmal tachycardia | 5 | 5 | 17.703 | 0.0000692 | 0.000348 | 42.92 (20.44) | Patau syndrome | Table_S1 | Direct comorbidity |
I47 | Paroxysmal tachycardia | 17 | 139 | 2.216 | 0.0052 | 0.024 | 44.61 (13.93) | Turner syndrome | Table_S1 | Direct comorbidity |
I47 | Paroxysmal tachycardia | 17 | 668 | 0.469 | 0.000242 | 0.000563 | 47.09 (20.65) | Down syndrome | Table_S2 | Inverse comorbidity |
I47 | Paroxysmal tachycardia | 9 | 369 | 0.461 | 0.00441 | 0.0111 | 43.65 (17.34) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
I48 | Atrial fibrillation and flutter | 32 | 289 | 1.844 | 0.00195 | 0.0118 | 55.71 (14.21) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
I48 | Atrial fibrillation and flutter | 26 | 180 | 2.571 | 0.0000604 | 0.000278 | 63.68 (10.34) | Turner syndrome | Table_S1 | Direct comorbidity |
I48 | Atrial fibrillation and flutter | 35 | 1419 | 0.442 | 0.0000000205 | 0.0000000477 | 48.59 (16.48) | Down syndrome | Table_S2 | Inverse comorbidity |
I48 | Atrial fibrillation and flutter | 20 | 969 | 0.369 | 0.0000000416 | 0.000000105 | 47.46 (15.77) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
I49 | Other cardiac arrhythmias | 5 | 3 | 26.554 | 0.0000167 | 0.000084 | 24.58 (19.18) | Patau syndrome | Table_S1 | Direct comorbidity |
I49 | Other cardiac arrhythmias | 51 | 577 | 1.569 | 0.00293 | 0.00971 | 50.9 (14.74) | Down syndrome | Table_S1 | Direct comorbidity |
I49 | Other cardiac arrhythmias | 14 | 86 | 3.007 | 0.000969 | 0.00269 | 38.35 (16.52) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
I50 | Heart failure | 163 | 852 | 3.353 | 1.47e-35 | 4.88e-35 | 40.37 (23.9) | Down syndrome | Table_S1 | Direct comorbidity |
I50 | Heart failure | 27 | 108 | 4.428 | 0.00000000372 | 0.0000000171 | 59.41 (19.13) | Turner syndrome | Table_S1 | Direct comorbidity |
I50 | Heart failure | 86 | 283 | 5.450 | 6.77e-32 | 2.4e-31 | 42.77 (23.63) | Down syndrome | Table_S3 | Female DS direct comorbidity |
I50 | Heart failure | 77 | 595 | 2.232 | 0.00000000137 | 0.00000000449 | 34.46 (23.63) | Down syndrome | Table_S3 | Male DS direct comorbidity |
I50 | Heart failure | 55 | 111 | 8.721 | 7.08e-29 | 1.97e-28 | 12.68 (24.23) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
I50 | Heart failure | 5 | 9 | 10.126 | 0.00067 | 0.00478 | 44.94 (17.94) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
I51 | Complications and ill-defined descriptions of heart disease | 29 | 147 | 3.535 | 0.0000000908 | 0.000000301 | 18.53 (20.81) | Down syndrome | Table_S1 | Direct comorbidity |
I51 | Complications and ill-defined descriptions of heart disease | 8 | 37 | 3.837 | 0.00393 | 0.0238 | 41.07 (17.28) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
I51 | Complications and ill-defined descriptions of heart disease | 9 | 36 | 4.659 | 0.00063 | 0.0029 | 31.51 (17.32) | Turner syndrome | Table_S1 | Direct comorbidity |
I51 | Complications and ill-defined descriptions of heart disease | 17 | 69 | 4.575 | 0.0000024 | 0.0000085 | 31.71 (20.49) | Down syndrome | Table_S3 | Female DS direct comorbidity |
I51 | Complications and ill-defined descriptions of heart disease | 12 | 77 | 2.842 | 0.00362 | 0.0119 | 6.25 (19.92) | Down syndrome | Table_S3 | Male DS direct comorbidity |
I51 | Complications and ill-defined descriptions of heart disease | 11 | 22 | 9.100 | 0.000000714 | 0.00000199 | 15.98 (12.66) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
I61 | Intracerebral haemorrhage | 25 | 224 | 2.015 | 0.00237 | 0.00786 | 53.64 (20.66) | Down syndrome | Table_S1 | Direct comorbidity |
I61 | Intracerebral haemorrhage | 13 | 90 | 2.737 | 0.0032 | 0.0113 | 53.91 (19.7) | Down syndrome | Table_S3 | Female DS direct comorbidity |
I63 | Cerebral infarction | 17 | 117 | 2.629 | 0.00103 | 0.00473 | 61.82 (10.34) | Turner syndrome | Table_S1 | Direct comorbidity |
I64 | Stroke. not specified as haemorrhage or infarction | 12 | 484 | 0.457 | 0.00103 | 0.0026 | 51.79 (10.37) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
I69 | Sequelae of cerebrovascular disease | 25 | 121 | 3.674 | 0.000000336 | 0.00000155 | 61.97 (10.09) | Turner syndrome | Table_S1 | Direct comorbidity |
I70 | Atherosclerosis | 20 | 85 | 3.956 | 0.00000212 | 0.0000128 | 57.16 (11.38) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
I71 | Aortic aneurysm and dissection | 29 | 16 | 30.419 | 4.55e-26 | 2.1e-25 | 46.08 (14.8) | Turner syndrome | Table_S1 | Direct comorbidity |
I71 | Aortic aneurysm and dissection | 6 | 3 | 29.534 | 0.00000201 | 0.0000143 | 48.79 (12.7) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
I73 | Other peripheral vascular diseases | 14 | 95 | 2.531 | 0.00412 | 0.0249 | 60.19 (10.1) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
I73 | Other peripheral vascular diseases | 14 | 542 | 0.482 | 0.00128 | 0.00299 | 46.97 (15.55) | Down syndrome | Table_S2 | Inverse comorbidity |
I73 | Other peripheral vascular diseases | 6 | 345 | 0.345 | 0.000572 | 0.00145 | 48.07 (18.14) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
I80 | Phlebitis and thrombophlebitis | 92 | 703 | 2.304 | 0.00000000000912 | 0.0000000000302 | 51.49 (13.84) | Down syndrome | Table_S1 | Direct comorbidity |
I80 | Phlebitis and thrombophlebitis | 42 | 163 | 4.248 | 0.000000000000456 | 0.00000000000275 | 44.09 (13.14) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
I80 | Phlebitis and thrombophlebitis | 36 | 327 | 2.007 | 0.000261 | 0.000924 | 48.49 (13.9) | Down syndrome | Table_S3 | Female DS direct comorbidity |
I80 | Phlebitis and thrombophlebitis | 56 | 409 | 2.371 | 0.000000044 | 0.000000144 | 52.02 (13.8) | Down syndrome | Table_S3 | Male DS direct comorbidity |
I80 | Phlebitis and thrombophlebitis | 15 | 105 | 2.633 | 0.00209 | 0.0058 | 41.89 (17.31) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
I82 | Other venous embolism and thrombosis | 16 | 139 | 2.118 | 0.0103 | 0.034 | 43.71 (11.19) | Down syndrome | Table_S1 | Direct comorbidity |
I82 | Other venous embolism and thrombosis | 10 | 35 | 4.950 | 0.000203 | 0.00123 | 40.16 (10.82) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
I83 | Varicose veins of lower extremities | 55 | 161 | 5.600 | 2.29e-21 | 1.38e-20 | 44.13 (13.28) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
I83 | Varicose veins of lower extremities | 5 | 10 | 9.030 | 0.000919 | 0.00863 | 33.14 (8.65) | XYY syndrome | Table_S1 | Direct comorbidity |
I83 | Varicose veins of lower extremities | 6 | 463 | 0.260 | 0.00000401 | 0.0000171 | 55.58 (12.67) | Turner syndrome | Table_S2 | Inverse comorbidity |
I83 | Varicose veins of lower extremities | 81 | 477 | 2.925 | 0.0000000000000021 | 0.00000000000000687 | 44.11 (11.77) | Down syndrome | Table_S3 | Male DS direct comorbidity |
I83 | Varicose veins of lower extremities | 21 | 206 | 1.854 | 0.0118 | 0.0329 | 35.44 (12.37) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
I87 | Other disorders of veins | 12 | 94 | 2.386 | 0.0124 | 0.0409 | 52.88 (14.91) | Down syndrome | Table_S1 | Direct comorbidity |
I87 | Other disorders of veins | 17 | 14 | 19.441 | 0.0000000000000986 | 0.000000000000595 | 52.62 (11.7) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
I87 | Other disorders of veins | 8 | 35 | 4.263 | 0.00221 | 0.00726 | 49.13 (15.35) | Down syndrome | Table_S3 | Male DS direct comorbidity |
I89 | Other noninfective disorders of lymphatic vessels and lymph nodes | 6 | 17 | 6.300 | 0.00161 | 0.00971 | 37.22 (10.03) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
I89 | Other noninfective disorders of lymphatic vessels and lymph nodes | 10 | 31 | 5.925 | 0.0000543 | 0.00025 | 38.04 (22.01) | Turner syndrome | Table_S1 | Direct comorbidity |
I95 | Hypotension | 20 | 154 | 2.363 | 0.00127 | 0.00422 | 55.1 (13.02) | Down syndrome | Table_S1 | Direct comorbidity |
I95 | Hypotension | 17 | 90 | 3.373 | 0.0000802 | 0.000263 | 54.1 (12.82) | Down syndrome | Table_S3 | Male DS direct comorbidity |
I97 | Postprocedural disorders of circulatory system. not elsewhere classified | 7 | 35 | 3.875 | 0.00693 | 0.0229 | 0.3 (1.03) | Down syndrome | Table_S1 | Direct comorbidity |
I97 | Postprocedural disorders of circulatory system. not elsewhere classified | 7 | 6 | 19.933 | 0.00000172 | 0.00000478 | 0.3 (1.03) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
I99 | Other and unspecified disorders of circulatory system | 10 | 71 | 2.664 | 0.0121 | 0.0401 | 59.94 (10.68) | Down syndrome | Table_S1 | Direct comorbidity |
J00 | Acute nasopharyngitis [common cold] | 7 | 35 | 3.934 | 0.00487 | 0.0245 | 2.34 (4.49) | Patau syndrome | Table_S1 | Direct comorbidity |
J00 | Acute nasopharyngitis [common cold] | 224 | 851 | 4.605 | 0 | 0 | 1.46 (5.31) | Down syndrome | Table_S1 | Direct comorbidity |
J00 | Acute nasopharyngitis [common cold] | 23 | 188 | 2.189 | 0.00127 | 0.00587 | 1.05 (11.58) | Turner syndrome | Table_S1 | Direct comorbidity |
J00 | Acute nasopharyngitis [common cold] | 14 | 19 | 13.344 | 0.0000000000569 | 0.000000000139 | 1.4 (2.3) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
J00 | Acute nasopharyngitis [common cold] | 8 | 11 | 12.492 | 0.00000252 | 0.00000808 | 2.03 (1.94) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
J00 | Acute nasopharyngitis [common cold] | 8 | 37 | 4.252 | 0.00161 | 0.00447 | 0.89 (1.46) | Angelman syndrome | Table_S1 | Direct comorbidity |
J00 | Acute nasopharyngitis [common cold] | 14 | 91 | 2.813 | 0.0014 | 0.0136 | 1.59 (6.07) | Fragile X syndrome | Table_S1 | Direct comorbidity |
J00 | Acute nasopharyngitis [common cold] | 93 | 343 | 4.862 | 3.43e-31 | 1.22e-30 | 1.68 (6.32) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J00 | Acute nasopharyngitis [common cold] | 131 | 452 | 4.969 | 3.36312e-44 | 1.10703e-43 | 1.35 (4.43) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J00 | Acute nasopharyngitis [common cold] | 7 | 21 | 6.364 | 0.000378 | 0.00609 | 1.22 (0.9) | Fragile X syndrome | Table_S5 | Female FXS direct comorbidity |
J00 | Acute nasopharyngitis [common cold] | 145 | 396 | 6.414 | 0 | 0 | 1.46 (3.79) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J00 | Acute nasopharyngitis [common cold] | 15 | 80 | 3.334 | 0.000193 | 0.00137 | 0.97 (4.02) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
J01 | Acute sinusitis | 5 | 10 | 9.412 | 0.000864 | 0.00833 | 8.86 (15.38) | Fragile X syndrome | Table_S1 | Direct comorbidity |
J02 | Acute pharyngitis | 28 | 208 | 2.420 | 0.0000912 | 0.000302 | 3.73 (13.56) | Down syndrome | Table_S1 | Direct comorbidity |
J02 | Acute pharyngitis | 18 | 109 | 2.945 | 0.000224 | 0.000736 | 2.37 (12.83) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J02 | Acute pharyngitis | 20 | 70 | 5.159 | 0.0000000534 | 0.000000148 | 3.56 (6.36) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J03 | Acute tonsillitis | 179 | 1422 | 2.206 | 5.05e-20 | 1.67e-19 | 5.81 (11.57) | Down syndrome | Table_S1 | Direct comorbidity |
J03 | Acute tonsillitis | 7 | 28 | 4.908 | 0.00138 | 0.00339 | 4.71 (4.92) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
J03 | Acute tonsillitis | 73 | 653 | 2.013 | 0.000000145 | 0.000000515 | 6.06 (9.8) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J03 | Acute tonsillitis | 106 | 756 | 2.410 | 0.0000000000000112 | 0.0000000000000368 | 5.54 (12.59) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J03 | Acute tonsillitis | 92 | 595 | 2.722 | 5.5e-16 | 0.00000000000000153 | 5.01 (6.99) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J04 | Acute laryngitis and tracheitis | 26 | 139 | 3.363 | 0.000000993 | 0.00000329 | 5.12 (19.34) | Down syndrome | Table_S1 | Direct comorbidity |
J04 | Acute laryngitis and tracheitis | 17 | 70 | 4.323 | 0.00000488 | 0.000016 | 4.74 (14.12) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J04 | Acute laryngitis and tracheitis | 16 | 50 | 5.814 | 0.000000321 | 0.000000892 | 3.92 (5.26) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J05 | Acute obstructive laryngitis [croup] and epiglottitis | 254 | 916 | 4.849 | 0 | 0 | 2.63 (6.26) | Down syndrome | Table_S1 | Direct comorbidity |
J05 | Acute obstructive laryngitis [croup] and epiglottitis | 97 | 252 | 6.892 | 6.65617e-43 | 2.35979e-42 | 2.36 (7.15) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J05 | Acute obstructive laryngitis [croup] and epiglottitis | 157 | 616 | 4.367 | 0 | 0 | 2.68 (5.64) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J05 | Acute obstructive laryngitis [croup] and epiglottitis | 148 | 466 | 5.565 | 0 | 0 | 2.63 (3.03) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J06 | Acute upper respiratory infections of multiple and unspecified sites | 108 | 523 | 3.628 | 2.83e-26 | 9.36e-26 | 3.09 (15.02) | Down syndrome | Table_S1 | Direct comorbidity |
J06 | Acute upper respiratory infections of multiple and unspecified sites | 5 | 14 | 6.663 | 0.00275 | 0.00882 | 2.06 (4.51) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
J06 | Acute upper respiratory infections of multiple and unspecified sites | 48 | 232 | 3.742 | 0.000000000000646 | 0.00000000000229 | 4.18 (16.6) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J06 | Acute upper respiratory infections of multiple and unspecified sites | 60 | 313 | 3.313 | 0.000000000000102 | 0.000000000000335 | 2.28 (13.14) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J06 | Acute upper respiratory infections of multiple and unspecified sites | 58 | 184 | 5.562 | 2.46e-22 | 6.83e-22 | 3.87 (10.76) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J10 | Influenza due to other identified influenza virus | 13 | 41 | 5.813 | 0.00000464 | 0.0000154 | 6.68 (19.82) | Down syndrome | Table_S1 | Direct comorbidity |
J10 | Influenza due to other identified influenza virus | 6 | 17 | 6.919 | 0.00103 | 0.00366 | 7.51 (19.88) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J10 | Influenza due to other identified influenza virus | 7 | 26 | 5.053 | 0.00188 | 0.00618 | 6.68 (19.73) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J10 | Influenza due to other identified influenza virus | 6 | 17 | 6.783 | 0.00113 | 0.00314 | 3.85 (16.28) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J12 | Viral pneumonia. not elsewhere classified | 141 | 358 | 6.898 | 0 | 0 | 0.93 (4.51) | Down syndrome | Table_S1 | Direct comorbidity |
J12 | Viral pneumonia. not elsewhere classified | 7 | 13 | 10.167 | 0.0000291 | 0.0000713 | 0.97 (1.14) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
J12 | Viral pneumonia. not elsewhere classified | 5 | 10 | 9.085 | 0.000844 | 0.0027 | 1.89 (1.42) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
J12 | Viral pneumonia. not elsewhere classified | 5 | 23 | 4.488 | 0.0124 | 0.0346 | 0.5 (0.35) | Angelman syndrome | Table_S1 | Direct comorbidity |
J12 | Viral pneumonia. not elsewhere classified | 51 | 152 | 6.047 | 5.6e-21 | 1.99e-20 | 1.17 (7) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J12 | Viral pneumonia. not elsewhere classified | 90 | 222 | 6.959 | 7.9e-40 | 2.59e-39 | 0.87 (1.91) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J12 | Viral pneumonia. not elsewhere classified | 100 | 196 | 8.942 | 0 | 0 | 0.92 (2.16) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J13 | Pneumonia due to Streptococcus pneumoniae | 30 | 134 | 4.004 | 0.00000000462 | 0.0000000153 | 1.9 (14.7) | Down syndrome | Table_S1 | Direct comorbidity |
J13 | Pneumonia due to Streptococcus pneumoniae | 9 | 55 | 3.177 | 0.00651 | 0.0231 | 2.07 (3.76) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J13 | Pneumonia due to Streptococcus pneumoniae | 21 | 71 | 5.210 | 0.0000000232 | 0.0000000761 | 1.74 (16.86) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J13 | Pneumonia due to Streptococcus pneumoniae | 15 | 34 | 7.973 | 0.0000000252 | 0.0000000702 | 1.67 (5.07) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J14 | Pneumonia due to Haemophilus influenzae | 53 | 91 | 10.236 | 3.93e-30 | 1.3e-29 | 1.94 (14.38) | Down syndrome | Table_S1 | Direct comorbidity |
J14 | Pneumonia due to Haemophilus influenzae | 25 | 33 | 13.606 | 3.66e-17 | 1.3e-16 | 2.53 (18.02) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J14 | Pneumonia due to Haemophilus influenzae | 28 | 45 | 10.750 | 5.68e-17 | 1.86e-16 | 1.69 (8.76) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J14 | Pneumonia due to Haemophilus influenzae | 28 | 19 | 25.290 | 6.31e-24 | 1.75e-23 | 1.79 (2.12) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J15 | Bacterial pneumonia. not elsewhere classified | 8 | 12 | 12.256 | 0.00000284 | 0.0000143 | 11.48 (18.63) | Patau syndrome | Table_S1 | Direct comorbidity |
J15 | Bacterial pneumonia. not elsewhere classified | 329 | 844 | 6.810 | 0 | 0 | 40.88 (24.92) | Down syndrome | Table_S1 | Direct comorbidity |
J15 | Bacterial pneumonia. not elsewhere classified | 29 | 175 | 2.762 | 0.00000666 | 0.0000402 | 51.9 (27.47) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
J15 | Bacterial pneumonia. not elsewhere classified | 5 | 7 | 12.492 | 0.000253 | 0.000812 | 2.72 (20.1) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
J15 | Bacterial pneumonia. not elsewhere classified | 6 | 15 | 7.854 | 0.000456 | 0.00127 | 13.61 (18.68) | Angelman syndrome | Table_S1 | Direct comorbidity |
J15 | Bacterial pneumonia. not elsewhere classified | 7 | 33 | 4.060 | 0.00506 | 0.0488 | 63.8 (29.5) | Fragile X syndrome | Table_S1 | Direct comorbidity |
J15 | Bacterial pneumonia. not elsewhere classified | 149 | 361 | 7.372 | 0 | 0 | 42.58 (24.8) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J15 | Bacterial pneumonia. not elsewhere classified | 180 | 465 | 6.623 | 0 | 0 | 37.34 (24.99) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J15 | Bacterial pneumonia. not elsewhere classified | 6 | 24 | 4.781 | 0.0048 | 0.0389 | 58.13 (31.1) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
J15 | Bacterial pneumonia. not elsewhere classified | 115 | 201 | 10.016 | 0 | 0 | 8.6 (21.64) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J15 | Bacterial pneumonia. not elsewhere classified | 5 | 5 | 16.889 | 0.0000821 | 0.000585 | 35.63 (23.87) | Down syndrome | Table_S6 | Mosaic DS direct comorbidity |
J16 | Pneumonia due to other infectious organisms. not elsewhere classified | 20 | 34 | 10.463 | 0.00000000000245 | 0.0000000000081 | 24.24 (23.69) | Down syndrome | Table_S1 | Direct comorbidity |
J16 | Pneumonia due to other infectious organisms. not elsewhere classified | 8 | 10 | 14.557 | 0.0000017 | 0.00000602 | 32.61 (21.16) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J16 | Pneumonia due to other infectious organisms. not elsewhere classified | 12 | 24 | 8.867 | 0.000000287 | 0.000000943 | 13.4 (24.82) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J16 | Pneumonia due to other infectious organisms. not elsewhere classified | 7 | 6 | 19.933 | 0.00000172 | 0.00000478 | 1.04 (15.05) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J17 | Pneumonia in diseases classified elsewhere | 12 | 25 | 8.719 | 0.000000327 | 0.00000108 | 1.17 (8.55) | Down syndrome | Table_S1 | Direct comorbidity |
J17 | Pneumonia in diseases classified elsewhere | 9 | 20 | 8.120 | 0.0000174 | 0.0000571 | 1.19 (9.58) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J17 | Pneumonia in diseases classified elsewhere | 7 | 18 | 7.344 | 0.000271 | 0.000755 | 0.66 (0.36) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J18 | Pneumonia. organism unspecified | 15 | 59 | 4.721 | 0.00000217 | 0.0000109 | 3.66 (19.93) | Patau syndrome | Table_S1 | Direct comorbidity |
J18 | Pneumonia. organism unspecified | 18 | 135 | 2.527 | 0.000761 | 0.00367 | 2.15 (17.09) | Edwards syndrome | Table_S1 | Direct comorbidity |
J18 | Pneumonia. organism unspecified | 1045 | 3190 | 5.716 | 0 | 0 | 28.75 (24.83) | Down syndrome | Table_S1 | Direct comorbidity |
J18 | Pneumonia. organism unspecified | 73 | 641 | 1.867 | 0.00000129 | 0.00000781 | 34.24 (24.9) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
J18 | Pneumonia. organism unspecified | 13 | 54 | 4.214 | 0.0000421 | 0.000395 | 4.34 (11.29) | XYY syndrome | Table_S1 | Direct comorbidity |
J18 | Pneumonia. organism unspecified | 80 | 654 | 2.132 | 0.00000000226 | 0.0000000104 | 37.03 (27.19) | Turner syndrome | Table_S1 | Direct comorbidity |
J18 | Pneumonia. organism unspecified | 19 | 35 | 9.885 | 0.000000000000485 | 0.00000000000119 | 3.05 (11.94) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
J18 | Pneumonia. organism unspecified | 17 | 40 | 7.312 | 0.00000000113 | 0.00000000362 | 5.02 (20.27) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
J18 | Pneumonia. organism unspecified | 13 | 48 | 5.129 | 0.00000615 | 0.0000171 | 2.18 (19.71) | Angelman syndrome | Table_S1 | Direct comorbidity |
J18 | Pneumonia. organism unspecified | 22 | 171 | 2.307 | 0.000617 | 0.00595 | 6.87 (20.72) | Fragile X syndrome | Table_S1 | Direct comorbidity |
J18 | Pneumonia. organism unspecified | 455 | 1381 | 5.871 | 0 | 0 | 32.46 (24.89) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J18 | Pneumonia. organism unspecified | 590 | 1845 | 5.459 | 0 | 0 | 26.43 (24.78) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J18 | Pneumonia. organism unspecified | 18 | 138 | 2.334 | 0.00165 | 0.0134 | 10.7 (21.81) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
J18 | Pneumonia. organism unspecified | 398 | 867 | 8.017 | 0 | 0 | 4.43 (20.23) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J18 | Pneumonia. organism unspecified | 15 | 52 | 5.099 | 0.000000752 | 0.00000536 | 14.42 (24.07) | Down syndrome | Table_S6 | Mosaic DS direct comorbidity |
J18 | Pneumonia. organism unspecified | 23 | 169 | 2.383 | 0.000325 | 0.00232 | 5.28 (23.79) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
J20 | Acute bronchitis | 249 | 1311 | 3.323 | 0 | 0 | 1.69 (15.25) | Down syndrome | Table_S1 | Direct comorbidity |
J20 | Acute bronchitis | 9 | 48 | 3.378 | 0.00332 | 0.0312 | 2.53 (1.67) | XYY syndrome | Table_S1 | Direct comorbidity |
J20 | Acute bronchitis | 9 | 22 | 7.736 | 0.0000104 | 0.0000255 | 1.57 (1.12) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
J20 | Acute bronchitis | 8 | 34 | 4.283 | 0.00143 | 0.00458 | 1.35 (2.63) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
J20 | Acute bronchitis | 9 | 48 | 3.664 | 0.00196 | 0.00545 | 1.17 (0.87) | Angelman syndrome | Table_S1 | Direct comorbidity |
J20 | Acute bronchitis | 96 | 556 | 3.098 | 1.12e-19 | 3.98e-19 | 1.84 (17.28) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J20 | Acute bronchitis | 153 | 775 | 3.384 | 2.1e-34 | 6.88e-34 | 1.58 (13.76) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J20 | Acute bronchitis | 151 | 590 | 4.486 | 0 | 0 | 1.41 (7.02) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J21 | Acute bronchiolitis | 40 | 162 | 4.386 | 0.000000000001 | 0.00000000000331 | 1.27 (8.71) | Down syndrome | Table_S1 | Direct comorbidity |
J21 | Acute bronchiolitis | 5 | 9 | 10.675 | 0.000416 | 0.00102 | 0.64 (0.89) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
J21 | Acute bronchiolitis | 16 | 71 | 4.201 | 0.0000124 | 0.000044 | 1.47 (13.31) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J21 | Acute bronchiolitis | 24 | 115 | 3.675 | 0.000000655 | 0.00000215 | 1.12 (1.78) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J21 | Acute bronchiolitis | 25 | 68 | 6.572 | 0.0000000000143 | 0.0000000000399 | 1.24 (1.75) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J22 | Unspecified acute lower respiratory infection | 30 | 100 | 5.353 | 0.0000000000118 | 0.0000000000391 | 41.33 (21.31) | Down syndrome | Table_S1 | Direct comorbidity |
J22 | Unspecified acute lower respiratory infection | 15 | 49 | 5.693 | 0.000000968 | 0.00000343 | 42.28 (23.77) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J22 | Unspecified acute lower respiratory infection | 15 | 57 | 4.704 | 0.00000767 | 0.0000252 | 36.21 (18.1) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J22 | Unspecified acute lower respiratory infection | 12 | 22 | 9.858 | 0.000000108 | 0.000000299 | 10.4 (15.59) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J30 | Vasomotor and allergic rhinitis | 17 | 790 | 0.397 | 0.00000462 | 0.0000108 | 12.83 (12.26) | Down syndrome | Table_S2 | Inverse comorbidity |
J30 | Vasomotor and allergic rhinitis | 6 | 379 | 0.328 | 0.000222 | 0.000583 | 7.28 (17.55) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
J30 | Vasomotor and allergic rhinitis | 11 | 449 | 0.455 | 0.00139 | 0.00352 | 13.68 (7.93) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
J30 | Vasomotor and allergic rhinitis | 5 | 252 | 0.411 | 0.00814 | 0.0207 | 9.6 (4.06) | Down syndrome | Table_S6 | Non-mosaic DS inverse comorbidity |
J31 | Chronic rhinitis. nasopharyngitis and pharyngitis | 11 | 65 | 3.235 | 0.0022 | 0.00779 | 7.96 (15.83) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J31 | Chronic rhinitis. nasopharyngitis and pharyngitis | 6 | 31 | 3.815 | 0.0137 | 0.038 | 6.63 (12.52) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J34 | Other disorders of nose and nasal sinuses | 11 | 788 | 0.265 | 0.00000000378 | 0.00000000881 | 29.72 (14.02) | Down syndrome | Table_S2 | Inverse comorbidity |
J34 | Other disorders of nose and nasal sinuses | 7 | 581 | 0.234 | 0.0000000778 | 0.000000196 | 36.77 (11.99) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
J35 | Chronic diseases of tonsils and adenoids | 447 | 2089 | 3.738 | 0 | 0 | 5.48 (7.07) | Down syndrome | Table_S1 | Direct comorbidity |
J35 | Chronic diseases of tonsils and adenoids | 75 | 629 | 2.079 | 0.0000000196 | 0.0000000905 | 6.29 (8.75) | Turner syndrome | Table_S1 | Direct comorbidity |
J35 | Chronic diseases of tonsils and adenoids | 7 | 38 | 3.650 | 0.00626 | 0.0153 | 4.41 (1.89) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
J35 | Chronic diseases of tonsils and adenoids | 9 | 66 | 2.679 | 0.0127 | 0.0355 | 2.99 (2.65) | Angelman syndrome | Table_S1 | Direct comorbidity |
J35 | Chronic diseases of tonsils and adenoids | 21 | 166 | 2.273 | 0.001 | 0.00967 | 3.07 (2.26) | Fragile X syndrome | Table_S1 | Direct comorbidity |
J35 | Chronic diseases of tonsils and adenoids | 11 | 418 | 0.464 | 0.00214 | 0.0135 | 20.82 (10.35) | Klinefelter syndrome | Table_S2 | Inverse comorbidity |
J35 | Chronic diseases of tonsils and adenoids | 206 | 1006 | 3.657 | 0 | 0 | 5.82 (7.43) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J35 | Chronic diseases of tonsils and adenoids | 241 | 1037 | 3.976 | 0 | 0 | 5.3 (6.68) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J35 | Chronic diseases of tonsils and adenoids | 16 | 114 | 2.524 | 0.00153 | 0.0124 | 3.74 (2.09) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
J35 | Chronic diseases of tonsils and adenoids | 251 | 936 | 4.691 | 0 | 0 | 5.09 (5.08) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J35 | Chronic diseases of tonsils and adenoids | 37 | 232 | 2.752 | 0.00000013 | 0.000000929 | 4.8 (4.82) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
J38 | Diseases of vocal cords and larynx. not elsewhere classified | 10 | 70 | 2.702 | 0.0109 | 0.0304 | 7.47 (17.54) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J39 | Other diseases of upper respiratory tract | 37 | 117 | 5.616 | 0.0000000000000129 | 0.0000000000000427 | 2.46 (10.29) | Down syndrome | Table_S1 | Direct comorbidity |
J39 | Other diseases of upper respiratory tract | 15 | 54 | 5.176 | 0.00000268 | 0.0000095 | 1.98 (4.03) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J39 | Other diseases of upper respiratory tract | 22 | 61 | 6.326 | 0.00000000052 | 0.0000000017 | 2.79 (12.55) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J39 | Other diseases of upper respiratory tract | 21 | 54 | 6.976 | 0.000000000266 | 0.000000000741 | 2.97 (4.23) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J40 | Bronchitis. not specified as acute or chronic | 17 | 88 | 3.527 | 0.0000495 | 0.000164 | 2.84 (17.07) | Down syndrome | Table_S1 | Direct comorbidity |
J40 | Bronchitis. not specified as acute or chronic | 11 | 45 | 4.448 | 0.000215 | 0.000704 | 1.67 (20.15) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J40 | Bronchitis. not specified as acute or chronic | 8 | 30 | 5.064 | 0.000821 | 0.00228 | 1.77 (18.94) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J42 | Unspecified chronic bronchitis | 9 | 43 | 3.682 | 0.00275 | 0.0166 | 54.82 (6.97) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
J44 | Other chronic obstructive pulmonary disease | 38 | 235 | 2.677 | 0.000000439 | 0.00000265 | 56.15 (15.51) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
J45 | Asthma | 79 | 609 | 2.125 | 0.00000000302 | 0.0000000182 | 17.87 (18.99) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
J45 | Asthma | 12 | 48 | 4.779 | 0.0000236 | 0.000261 | 4.48 (14.48) | Triple X syndrome | Table_S1 | Direct comorbidity |
J45 | Asthma | 19 | 102 | 3.214 | 0.0000145 | 0.000137 | 4.31 (9.19) | XYY syndrome | Table_S1 | Direct comorbidity |
J45 | Asthma | 8 | 59 | 2.669 | 0.0174 | 0.0426 | 2 (4.89) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
J45 | Asthma | 11 | 87 | 2.448 | 0.0098 | 0.0273 | 1.17 (0.72) | Angelman syndrome | Table_S1 | Direct comorbidity |
J45 | Asthma | 175 | 1895 | 1.583 | 0.0000000119 | 0.0000000389 | 2.06 (13.71) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J45 | Asthma | 160 | 1239 | 2.265 | 3.11e-20 | 8.65e-20 | 1.95 (10.53) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J69 | Pneumonitis due to solids and liquids | 93 | 91 | 17.818 | 0 | 0 | 54.44 (17.51) | Down syndrome | Table_S1 | Direct comorbidity |
J69 | Pneumonitis due to solids and liquids | 32 | 30 | 18.940 | 1.17e-24 | 4.14e-24 | 52.63 (12.77) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J69 | Pneumonitis due to solids and liquids | 61 | 76 | 13.730 | 7.07e-40 | 2.32e-39 | 55.72 (19.48) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J69 | Pneumonitis due to solids and liquids | 19 | 18 | 18.359 | 0.00000000000000514 | 0.0000000000000143 | 50.17 (23.64) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J81 | Pulmonary oedema | 19 | 79 | 4.360 | 0.00000117 | 0.00000389 | 51.91 (18.69) | Down syndrome | Table_S1 | Direct comorbidity |
J81 | Pulmonary oedema | 14 | 33 | 7.849 | 0.0000000885 | 0.000000314 | 52.9 (19.52) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J84 | Other interstitial pulmonary diseases | 5 | 20 | 4.983 | 0.00989 | 0.0275 | 26.03 (18.97) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J85 | Abscess of lung and mediastinum | 11 | 35 | 5.813 | 0.0000267 | 0.0000883 | 48.28 (21.14) | Down syndrome | Table_S1 | Direct comorbidity |
J85 | Abscess of lung and mediastinum | 7 | 22 | 5.931 | 0.000835 | 0.00274 | 47.43 (21.01) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J86 | Pyothorax | 30 | 80 | 6.674 | 0.00000000000011 | 0.000000000000363 | 47.99 (16.08) | Down syndrome | Table_S1 | Direct comorbidity |
J86 | Pyothorax | 5 | 17 | 5.746 | 0.00586 | 0.027 | 36.2 (24.32) | Turner syndrome | Table_S1 | Direct comorbidity |
J86 | Pyothorax | 9 | 24 | 7.117 | 0.00004 | 0.000142 | 51.39 (16.52) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J86 | Pyothorax | 21 | 47 | 7.816 | 0.0000000000547 | 0.000000000179 | 47.43 (15.61) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J86 | Pyothorax | 10 | 16 | 11.285 | 0.000000497 | 0.00000138 | 43.37 (19.91) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J90 | Pleural effusion. not elsewhere classified | 23 | 154 | 2.700 | 0.0000953 | 0.000316 | 40.74 (20.81) | Down syndrome | Table_S1 | Direct comorbidity |
J90 | Pleural effusion. not elsewhere classified | 11 | 59 | 3.558 | 0.00111 | 0.00393 | 40.74 (19.75) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J90 | Pleural effusion. not elsewhere classified | 12 | 86 | 2.548 | 0.00788 | 0.0258 | 33.51 (21.36) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J91 | Pleural effusion in conditions classified elsewhere | 5 | 11 | 8.619 | 0.00128 | 0.00588 | 59.61 (23.4) | Turner syndrome | Table_S1 | Direct comorbidity |
J94 | Other pleural conditions | 16 | 65 | 4.492 | 0.00000623 | 0.0000206 | 0.34 (21.62) | Down syndrome | Table_S1 | Direct comorbidity |
J94 | Other pleural conditions | 11 | 43 | 4.651 | 0.000153 | 0.000501 | 0.35 (23.5) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J94 | Other pleural conditions | 5 | 4 | 20.929 | 0.0000483 | 0.000134 | 0.25 (19.97) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J95 | Postprocedural respiratory disorders. not elsewhere classified | 10 | 41 | 4.567 | 0.000357 | 0.00118 | 47 (19.77) | Down syndrome | Table_S1 | Direct comorbidity |
J95 | Postprocedural respiratory disorders. not elsewhere classified | 6 | 17 | 6.919 | 0.00103 | 0.00366 | 30.75 (19.1) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J96 | Respiratory failure. not elsewhere classified | 8 | 6 | 22.761 | 0.0000000872 | 0.000000439 | 2.47 (18.15) | Patau syndrome | Table_S1 | Direct comorbidity |
J96 | Respiratory failure. not elsewhere classified | 12 | 21 | 10.686 | 0.0000000357 | 0.000000172 | 1.87 (10.97) | Edwards syndrome | Table_S1 | Direct comorbidity |
J96 | Respiratory failure. not elsewhere classified | 256 | 753 | 5.944 | 0 | 0 | 34.54 (25.18) | Down syndrome | Table_S1 | Direct comorbidity |
J96 | Respiratory failure. not elsewhere classified | 21 | 179 | 1.980 | 0.00611 | 0.0369 | 52 (15.15) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
J96 | Respiratory failure. not elsewhere classified | 18 | 128 | 2.539 | 0.00104 | 0.00478 | 53.46 (27.73) | Turner syndrome | Table_S1 | Direct comorbidity |
J96 | Respiratory failure. not elsewhere classified | 9 | 4 | 35.585 | 0.000000000752 | 0.00000000184 | 4.92 (6.52) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
J96 | Respiratory failure. not elsewhere classified | 5 | 6 | 14.277 | 0.000154 | 0.000494 | 2.07 (12.44) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
J96 | Respiratory failure. not elsewhere classified | 114 | 315 | 6.475 | 0 | 0 | 38.7 (25.19) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J96 | Respiratory failure. not elsewhere classified | 142 | 450 | 5.407 | 0 | 0 | 30.98 (25.15) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J96 | Respiratory failure. not elsewhere classified | 97 | 149 | 11.395 | 0 | 0 | 4.19 (21.31) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
J98 | Other respiratory disorders | 80 | 285 | 4.939 | 5.56e-27 | 1.84e-26 | 2.71 (20.35) | Down syndrome | Table_S1 | Direct comorbidity |
J98 | Other respiratory disorders | 11 | 49 | 3.888 | 0.000585 | 0.00353 | 40.53 (22.7) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
J98 | Other respiratory disorders | 5 | 2 | 33.312 | 0.00000834 | 0.0000267 | 2.69 (5.76) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
J98 | Other respiratory disorders | 41 | 108 | 6.856 | 1.08e-18 | 3.82e-18 | 2.61 (18.21) | Down syndrome | Table_S3 | Female DS direct comorbidity |
J98 | Other respiratory disorders | 39 | 169 | 4.012 | 0.0000000000188 | 0.0000000000616 | 3.23 (22.05) | Down syndrome | Table_S3 | Male DS direct comorbidity |
J98 | Other respiratory disorders | 43 | 82 | 9.246 | 1.37e-23 | 3.82e-23 | 1.23 (8.94) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K00 | Disorders of tooth development and eruption | 128 | 395 | 5.681 | 0 | 0 | 16.56 (9.25) | Down syndrome | Table_S1 | Direct comorbidity |
K00 | Disorders of tooth development and eruption | 19 | 76 | 4.208 | 0.00000177 | 0.0000107 | 16.12 (3.98) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
K00 | Disorders of tooth development and eruption | 9 | 8 | 18.394 | 0.0000000566 | 0.000000531 | 16.7 (4.29) | XYY syndrome | Table_S1 | Direct comorbidity |
K00 | Disorders of tooth development and eruption | 63 | 166 | 6.819 | 5.55e-28 | 1.97e-27 | 16.94 (10.2) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K00 | Disorders of tooth development and eruption | 65 | 181 | 6.184 | 1.06e-26 | 3.48e-26 | 15.84 (8.22) | Down syndrome | Table_S3 | Male DS direct comorbidity |
K00 | Disorders of tooth development and eruption | 55 | 177 | 5.487 | 5.29e-21 | 1.47e-20 | 16.48 (6.49) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K00 | Disorders of tooth development and eruption | 6 | 12 | 9.094 | 0.000224 | 0.00159 | 15.95 (5.65) | Down syndrome | Table_S6 | Mosaic DS direct comorbidity |
K01 | Embedded and impacted teeth | 59 | 288 | 3.621 | 0.00000000000000683 | 0.0000000000000226 | 16.7 (11.93) | Down syndrome | Table_S1 | Direct comorbidity |
K01 | Embedded and impacted teeth | 12 | 82 | 2.700 | 0.00511 | 0.0236 | 16.68 (11.95) | Turner syndrome | Table_S1 | Direct comorbidity |
K01 | Embedded and impacted teeth | 26 | 146 | 3.268 | 0.00000147 | 0.00000523 | 15.71 (12.38) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K01 | Embedded and impacted teeth | 33 | 182 | 3.168 | 0.000000108 | 0.000000355 | 19.03 (11.41) | Down syndrome | Table_S3 | Male DS direct comorbidity |
K01 | Embedded and impacted teeth | 22 | 105 | 3.784 | 0.00000118 | 0.00000329 | 16.44 (11.95) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K01 | Embedded and impacted teeth | 7 | 29 | 4.500 | 0.00311 | 0.0222 | 15.79 (9.08) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
K02 | Dental caries | 358 | 333 | 18.744 | 0 | 0 | 30.88 (18.09) | Down syndrome | Table_S1 | Direct comorbidity |
K02 | Dental caries | 27 | 81 | 5.532 | 0.0000000000617 | 0.000000000372 | 26 (11.52) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
K02 | Dental caries | 13 | 63 | 3.771 | 0.000223 | 0.00103 | 22.57 (26.28) | Turner syndrome | Table_S1 | Direct comorbidity |
K02 | Dental caries | 5 | 7 | 13.344 | 0.000178 | 0.000436 | 14.85 (16.61) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
K02 | Dental caries | 13 | 4 | 46.637 | 0.0000000000000239 | 0.0000000000000765 | 14.6 (9.65) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
K02 | Dental caries | 12 | 9 | 23.337 | 0.0000000000316 | 0.0000000000881 | 15.12 (13.39) | Angelman syndrome | Table_S1 | Direct comorbidity |
K02 | Dental caries | 23 | 11 | 34.510 | 4.04e-22 | 3.9e-21 | 13.84 (13.66) | Fragile X syndrome | Table_S1 | Direct comorbidity |
K02 | Dental caries | 150 | 136 | 19.610 | 0 | 0 | 27.81 (17.41) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K02 | Dental caries | 208 | 218 | 16.274 | 0 | 0 | 31.36 (18.53) | Down syndrome | Table_S3 | Male DS direct comorbidity |
K02 | Dental caries | 20 | 19 | 17.927 | 4.54e-16 | 0.00000000000000367 | 15.8 (13.66) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
K02 | Dental caries | 98 | 109 | 15.697 | 0 | 0 | 10.88 (13.38) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K03 | Other diseases of hard tissues of teeth | 28 | 90 | 5.557 | 0.0000000000278 | 0.000000000092 | 23.66 (13.27) | Down syndrome | Table_S1 | Direct comorbidity |
K03 | Other diseases of hard tissues of teeth | 13 | 38 | 6.387 | 0.00000184 | 0.00000653 | 23.62 (11.46) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K03 | Other diseases of hard tissues of teeth | 15 | 48 | 5.568 | 0.0000013 | 0.00000425 | 23.7 (14.6) | Down syndrome | Table_S3 | Male DS direct comorbidity |
K03 | Other diseases of hard tissues of teeth | 8 | 30 | 5.064 | 0.000821 | 0.00228 | 15.44 (2.52) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K04 | Diseases of pulp and periapical tissues | 68 | 370 | 3.243 | 0.00000000000000676 | 0.0000000000000224 | 36.29 (15.38) | Down syndrome | Table_S1 | Direct comorbidity |
K04 | Diseases of pulp and periapical tissues | 13 | 65 | 3.437 | 0.000504 | 0.00304 | 36.53 (13.43) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
K04 | Diseases of pulp and periapical tissues | 28 | 147 | 3.486 | 0.000000178 | 0.000000633 | 35.55 (16.32) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K04 | Diseases of pulp and periapical tissues | 40 | 202 | 3.444 | 0.000000000557 | 0.00000000183 | 37.83 (14.63) | Down syndrome | Table_S3 | Male DS direct comorbidity |
K04 | Diseases of pulp and periapical tissues | 17 | 69 | 4.485 | 0.00000299 | 0.0000083 | 30.9 (12.42) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K05 | Gingivitis and periodontal diseases | 118 | 263 | 7.861 | 0 | 0 | 38.3 (14.06) | Down syndrome | Table_S1 | Direct comorbidity |
K05 | Gingivitis and periodontal diseases | 14 | 59 | 4.050 | 0.0000653 | 0.000395 | 37.62 (16.65) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
K05 | Gingivitis and periodontal diseases | 64 | 114 | 10.056 | 4.31e-36 | 1.53e-35 | 35.51 (13.98) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K05 | Gingivitis and periodontal diseases | 54 | 180 | 5.182 | 1.78e-19 | 5.83e-19 | 40.98 (14.1) | Down syndrome | Table_S3 | Male DS direct comorbidity |
K05 | Gingivitis and periodontal diseases | 20 | 50 | 7.182 | 0.000000000477 | 0.00000000132 | 25.68 (11.74) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K07 | Dentofacial anomalies [including malocclusion] | 75 | 721 | 1.836 | 0.000003 | 0.00000994 | 15.84 (8.02) | Down syndrome | Table_S1 | Direct comorbidity |
K07 | Dentofacial anomalies [including malocclusion] | 32 | 122 | 4.347 | 0.000000000195 | 0.00000000118 | 18.75 (6.37) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
K07 | Dentofacial anomalies [including malocclusion] | 31 | 235 | 2.337 | 0.0000585 | 0.000269 | 18.66 (12.12) | Turner syndrome | Table_S1 | Direct comorbidity |
K07 | Dentofacial anomalies [including malocclusion] | 6 | 10 | 11.322 | 0.0000742 | 0.000182 | 12.7 (4.64) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
K07 | Dentofacial anomalies [including malocclusion] | 35 | 384 | 1.664 | 0.00581 | 0.0206 | 15.8 (5.42) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K07 | Dentofacial anomalies [including malocclusion] | 40 | 292 | 2.386 | 0.0000035 | 0.0000115 | 15.92 (9.73) | Down syndrome | Table_S3 | Male DS direct comorbidity |
K07 | Dentofacial anomalies [including malocclusion] | 25 | 216 | 2.090 | 0.00142 | 0.00395 | 14.78 (4.2) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K07 | Dentofacial anomalies [including malocclusion] | 13 | 74 | 3.150 | 0.000886 | 0.00631 | 17.94 (9.29) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
K08 | Other disorders of teeth and supporting structures | 99 | 288 | 6.034 | 4.09e-39 | 1.36e-38 | 41.2 (17.92) | Down syndrome | Table_S1 | Direct comorbidity |
K08 | Other disorders of teeth and supporting structures | 44 | 129 | 6.159 | 1.63e-18 | 5.8e-18 | 43.1 (17.41) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K08 | Other disorders of teeth and supporting structures | 55 | 158 | 6.006 | 2.77e-22 | 9.1e-22 | 39.83 (18.19) | Down syndrome | Table_S3 | Male DS direct comorbidity |
K08 | Other disorders of teeth and supporting structures | 27 | 68 | 7.078 | 0.000000000000508 | 0.00000000000141 | 22.76 (16.76) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K09 | Cysts of oral region. not elsewhere classified | 8 | 33 | 4.710 | 0.00124 | 0.00441 | 13.42 (29.86) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K12 | Stomatitis and related lesions | 39 | 194 | 3.577 | 0.00000000038 | 0.00000000126 | 5.63 (20.06) | Down syndrome | Table_S1 | Direct comorbidity |
K12 | Stomatitis and related lesions | 18 | 82 | 4.073 | 0.00000498 | 0.0000177 | 5.99 (18.64) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K12 | Stomatitis and related lesions | 21 | 98 | 3.789 | 0.00000223 | 0.00000732 | 5.63 (21.18) | Down syndrome | Table_S3 | Male DS direct comorbidity |
K12 | Stomatitis and related lesions | 18 | 58 | 5.617 | 0.0000000872 | 0.000000242 | 2.93 (7.29) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K13 | Other diseases of lip and oral mucosa | 29 | 147 | 3.535 | 0.0000000908 | 0.000000301 | 48.84 (18.89) | Down syndrome | Table_S1 | Direct comorbidity |
K13 | Other diseases of lip and oral mucosa | 13 | 75 | 3.277 | 0.000746 | 0.00265 | 35.13 (17.89) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K13 | Other diseases of lip and oral mucosa | 16 | 73 | 3.917 | 0.0000275 | 0.0000902 | 49.58 (19.42) | Down syndrome | Table_S3 | Male DS direct comorbidity |
K13 | Other diseases of lip and oral mucosa | 6 | 30 | 3.938 | 0.012 | 0.0333 | 20.92 (23.55) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K14 | Diseases of tongue | 12 | 56 | 3.977 | 0.00027 | 0.000893 | 33.18 (18.78) | Down syndrome | Table_S1 | Direct comorbidity |
K14 | Diseases of tongue | 7 | 19 | 7.117 | 0.000318 | 0.00113 | 38.76 (12.97) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K14 | Diseases of tongue | 5 | 17 | 5.684 | 0.00617 | 0.0202 | 6.73 (24.04) | Down syndrome | Table_S3 | Male DS direct comorbidity |
K20 | Oesophagitis | 30 | 331 | 1.628 | 0.0141 | 0.0467 | 42.64 (20.99) | Down syndrome | Table_S1 | Direct comorbidity |
K20 | Oesophagitis | 14 | 83 | 2.893 | 0.00136 | 0.00823 | 44.9 (14.91) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
K20 | Oesophagitis | 12 | 68 | 3.286 | 0.00119 | 0.0033 | 16.27 (21.95) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K21 | Gastro-oesophageal reflux disease | 31 | 280 | 1.845 | 0.00228 | 0.0137 | 41.56 (12.82) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
K21 | Gastro-oesophageal reflux disease | 6 | 8 | 13.839 | 0.0000301 | 0.0000739 | 8.65 (4.75) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
K21 | Gastro-oesophageal reflux disease | 5 | 11 | 8.328 | 0.00118 | 0.00377 | 3.06 (16.76) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
K21 | Gastro-oesophageal reflux disease | 6 | 18 | 6.614 | 0.000999 | 0.00278 | 0.5 (0.63) | Angelman syndrome | Table_S1 | Direct comorbidity |
K22 | Other diseases of oesophagus | 41 | 293 | 2.491 | 0.00000106 | 0.0000035 | 47.7 (19.97) | Down syndrome | Table_S1 | Direct comorbidity |
K22 | Other diseases of oesophagus | 10 | 46 | 4.034 | 0.00082 | 0.00378 | 49.75 (16.83) | Turner syndrome | Table_S1 | Direct comorbidity |
K22 | Other diseases of oesophagus | 13 | 98 | 2.516 | 0.00608 | 0.0215 | 48.21 (25.49) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K22 | Other diseases of oesophagus | 28 | 194 | 2.536 | 0.0000427 | 0.00014 | 45.64 (16.78) | Down syndrome | Table_S3 | Male DS direct comorbidity |
K22 | Other diseases of oesophagus | 9 | 57 | 3.007 | 0.00888 | 0.0247 | 27.15 (19.99) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K25 | Gastric ulcer | 17 | 84 | 3.431 | 0.0000644 | 0.000389 | 47.39 (11.49) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
K27 | Peptic ulcer. site unspecified | 8 | 44 | 3.558 | 0.00584 | 0.0207 | 48.71 (14.31) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K29 | Gastritis and duodenitis | 30 | 246 | 2.033 | 0.00068 | 0.00411 | 48.46 (13.13) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
K30 | Dyspepsia | 26 | 227 | 1.919 | 0.0033 | 0.0199 | 41.13 (13.36) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
K30 | Dyspepsia | 6 | 319 | 0.377 | 0.00184 | 0.00784 | 44.07 (15.22) | Turner syndrome | Table_S2 | Inverse comorbidity |
K31 | Other diseases of stomach and duodenum | 19 | 112 | 3.087 | 0.0000866 | 0.000287 | 26.28 (21.08) | Down syndrome | Table_S1 | Direct comorbidity |
K31 | Other diseases of stomach and duodenum | 11 | 39 | 5.338 | 0.0000506 | 0.00018 | 42.95 (23.84) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K31 | Other diseases of stomach and duodenum | 8 | 18 | 8.262 | 0.0000468 | 0.00013 | 14.53 (17.35) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K35 | Acute appendicitis | 34 | 1506 | 0.405 | 0.000000000385 | 0.000000000896 | 31.04 (17.18) | Down syndrome | Table_S2 | Inverse comorbidity |
K35 | Acute appendicitis | 13 | 649 | 0.383 | 0.0000215 | 0.0000563 | 34.63 (16.02) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
K35 | Acute appendicitis | 21 | 805 | 0.465 | 0.0000396 | 0.0000999 | 23.32 (17) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
K35 | Acute appendicitis | 13 | 514 | 0.472 | 0.00121 | 0.00309 | 13.63 (13.57) | Down syndrome | Table_S6 | Non-mosaic DS inverse comorbidity |
K40 | Inguinal hernia | 9 | 49 | 3.311 | 0.00376 | 0.0353 | 3.63 (16.65) | XYY syndrome | Table_S1 | Direct comorbidity |
K43 | Ventral hernia | 69 | 455 | 2.677 | 0.0000000000124 | 0.000000000041 | 40.5 (18.6) | Down syndrome | Table_S1 | Direct comorbidity |
K43 | Ventral hernia | 23 | 195 | 2.179 | 0.0014 | 0.00496 | 46.87 (16.64) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K43 | Ventral hernia | 46 | 187 | 4.263 | 0.0000000000000423 | 0.000000000000139 | 35.61 (18.93) | Down syndrome | Table_S3 | Male DS direct comorbidity |
K43 | Ventral hernia | 13 | 63 | 3.815 | 0.000202 | 0.000562 | 7.96 (18.71) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K44 | Diaphragmatic hernia | 20 | 811 | 0.451 | 0.0000276 | 0.0000643 | 51.95 (25.78) | Down syndrome | Table_S2 | Inverse comorbidity |
K44 | Diaphragmatic hernia | 8 | 379 | 0.421 | 0.00196 | 0.00515 | 51.95 (29.36) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
K45 | Other abdominal hernia | 21 | 123 | 3.094 | 0.0000348 | 0.000115 | 29.56 (16.47) | Down syndrome | Table_S1 | Direct comorbidity |
K45 | Other abdominal hernia | 14 | 67 | 3.762 | 0.000133 | 0.000437 | 30.57 (13.63) | Down syndrome | Table_S3 | Male DS direct comorbidity |
K45 | Other abdominal hernia | 8 | 31 | 4.905 | 0.000985 | 0.00274 | 14.19 (14.3) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K46 | Unspecified abdominal hernia | 13 | 45 | 5.307 | 0.0000108 | 0.0000357 | 34.56 (19.65) | Down syndrome | Table_S1 | Direct comorbidity |
K46 | Unspecified abdominal hernia | 5 | 20 | 5.083 | 0.00919 | 0.0326 | 29.06 (20.25) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K46 | Unspecified abdominal hernia | 8 | 22 | 6.673 | 0.000169 | 0.000556 | 42.96 (17.13) | Down syndrome | Table_S3 | Male DS direct comorbidity |
K52 | Other noninfective gastroenteritis and colitis | 72 | 755 | 1.684 | 0.0000626 | 0.000207 | 35.56 (21.42) | Down syndrome | Table_S1 | Direct comorbidity |
K52 | Other noninfective gastroenteritis and colitis | 5 | 10 | 9.705 | 0.000599 | 0.00147 | 3.59 (2.49) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
K52 | Other noninfective gastroenteritis and colitis | 44 | 395 | 1.938 | 0.000114 | 0.000375 | 32.9 (21.3) | Down syndrome | Table_S3 | Male DS direct comorbidity |
K52 | Other noninfective gastroenteritis and colitis | 23 | 203 | 2.052 | 0.00276 | 0.00766 | 8.62 (15.36) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K56 | Paralytic ileus and intestinal obstruction without hernia | 14 | 80 | 3.230 | 0.000516 | 0.00143 | 1.43 (15.2) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K57 | Diverticular disease of intestine | 16 | 904 | 0.328 | 0.0000000177 | 0.0000000412 | 57.07 (11.8) | Down syndrome | Table_S2 | Inverse comorbidity |
K57 | Diverticular disease of intestine | 9 | 462 | 0.384 | 0.000262 | 0.000689 | 55.51 (15.4) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
K57 | Diverticular disease of intestine | 7 | 451 | 0.302 | 0.0000197 | 0.0000498 | 58.42 (3.38) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
K58 | Irritable bowel syndrome | 11 | 431 | 0.494 | 0.0052 | 0.0137 | 30.35 (18.21) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
K59 | Other functional intestinal disorders | 259 | 2255 | 2.010 | 2.15e-23 | 7.13e-23 | 19.76 (24.02) | Down syndrome | Table_S1 | Direct comorbidity |
K59 | Other functional intestinal disorders | 48 | 374 | 2.117 | 0.00000562 | 0.0000339 | 37.75 (21.76) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
K59 | Other functional intestinal disorders | 11 | 44 | 4.804 | 0.0000543 | 0.000601 | 7.82 (8.94) | Triple X syndrome | Table_S1 | Direct comorbidity |
K59 | Other functional intestinal disorders | 6 | 33 | 3.663 | 0.0121 | 0.0296 | 7.86 (15.05) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
K59 | Other functional intestinal disorders | 14 | 41 | 5.949 | 0.000000412 | 0.00000132 | 7.43 (14.77) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
K59 | Other functional intestinal disorders | 9 | 58 | 3.043 | 0.00608 | 0.0169 | 14.34 (17.54) | Angelman syndrome | Table_S1 | Direct comorbidity |
K59 | Other functional intestinal disorders | 115 | 1250 | 1.650 | 0.00000068 | 0.00000241 | 20.28 (24.66) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K59 | Other functional intestinal disorders | 144 | 1019 | 2.424 | 8.03e-20 | 2.63e-19 | 19.38 (23.48) | Down syndrome | Table_S3 | Male DS direct comorbidity |
K59 | Other functional intestinal disorders | 107 | 665 | 2.828 | 1.42e-19 | 3.95e-19 | 5.38 (18.43) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K61 | Abscess of anal and rectal regions | 8 | 332 | 0.461 | 0.0081 | 0.0205 | 33.54 (15.72) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
K62 | Other diseases of anus and rectum | 50 | 500 | 1.736 | 0.000432 | 0.00142 | 42.46 (18.29) | Down syndrome | Table_S3 | Male DS direct comorbidity |
K62 | Other diseases of anus and rectum | 23 | 180 | 2.313 | 0.00066 | 0.00184 | 16.18 (22.6) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K63 | Other diseases of intestine | 6 | 29 | 4.070 | 0.0105 | 0.0291 | 6.56 (7.9) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K64 | Haemorrhoids and perianal venous thrombosis | 7 | 377 | 0.369 | 0.000622 | 0.00145 | 44.97 (15.59) | Down syndrome | Table_S2 | Inverse comorbidity |
K73 | Chronic hepatitis. not elsewhere classified | 9 | 48 | 3.559 | 0.00339 | 0.0112 | 40.22 (12) | Down syndrome | Table_S1 | Direct comorbidity |
K73 | Chronic hepatitis. not elsewhere classified | 7 | 11 | 11.492 | 0.0000268 | 0.000123 | 37.37 (12.21) | Turner syndrome | Table_S1 | Direct comorbidity |
K73 | Chronic hepatitis. not elsewhere classified | 7 | 17 | 7.908 | 0.000184 | 0.000652 | 43.58 (5.76) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K74 | Fibrosis and cirrhosis of liver | 7 | 25 | 5.304 | 0.00145 | 0.00667 | 55.45 (10.75) | Turner syndrome | Table_S1 | Direct comorbidity |
K76 | Other diseases of liver | 16 | 67 | 4.309 | 0.0000092 | 0.0000424 | 51.64 (18.83) | Turner syndrome | Table_S1 | Direct comorbidity |
K80 | Cholelithiasis | 42 | 201 | 3.449 | 0.000000000148 | 0.000000000893 | 43.7 (14.21) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
K80 | Cholelithiasis | 30 | 1243 | 0.443 | 0.000000137 | 0.000000359 | 44.04 (13.26) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
K81 | Cholecystitis | 10 | 44 | 3.960 | 0.000949 | 0.00573 | 41.04 (15.46) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
K83 | Other diseases of biliary tract | 19 | 150 | 2.310 | 0.00214 | 0.0071 | 45 (20.78) | Down syndrome | Table_S1 | Direct comorbidity |
K83 | Other diseases of biliary tract | 12 | 76 | 3.004 | 0.00237 | 0.0084 | 44.29 (21.27) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K83 | Other diseases of biliary tract | 5 | 16 | 6.156 | 0.00453 | 0.0126 | 0.93 (26.8) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K85 | Acute pancreatitis | 6 | 317 | 0.384 | 0.00196 | 0.00457 | 57.75 (18.7) | Down syndrome | Table_S2 | Inverse comorbidity |
K90 | Intestinal malabsorption | 127 | 165 | 13.447 | 0 | 0 | 18.49 (19.41) | Down syndrome | Table_S1 | Direct comorbidity |
K90 | Intestinal malabsorption | 25 | 45 | 9.743 | 0.0000000000000124 | 0.0000000000000573 | 24.65 (18.28) | Turner syndrome | Table_S1 | Direct comorbidity |
K90 | Intestinal malabsorption | 52 | 105 | 8.896 | 1.4e-27 | 4.96e-27 | 18.03 (20.36) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K90 | Intestinal malabsorption | 75 | 53 | 23.999 | 0 | 0 | 18.49 (18.68) | Down syndrome | Table_S3 | Male DS direct comorbidity |
K90 | Intestinal malabsorption | 60 | 42 | 24.742 | 0 | 0 | 13.1 (13.72) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K90 | Intestinal malabsorption | 9 | 18 | 8.882 | 0.0000084 | 0.0000599 | 16.65 (12.23) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
K91 | Postprocedural disorders of digestive system. not elsewhere classified | 9 | 41 | 4.060 | 0.00153 | 0.005 | 0.85 (6.08) | Down syndrome | Table_S3 | Male DS direct comorbidity |
K91 | Postprocedural disorders of digestive system. not elsewhere classified | 8 | 11 | 13.081 | 0.00000318 | 0.00000883 | 1.17 (4.53) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
K92 | Other diseases of digestive system | 64 | 558 | 2.028 | 0.000000873 | 0.00000289 | 49.83 (19.79) | Down syndrome | Table_S1 | Direct comorbidity |
K92 | Other diseases of digestive system | 20 | 142 | 2.379 | 0.00112 | 0.00674 | 37.82 (14.55) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
K92 | Other diseases of digestive system | 28 | 196 | 2.619 | 0.0000245 | 0.0000868 | 49.18 (21.34) | Down syndrome | Table_S3 | Female DS direct comorbidity |
K92 | Other diseases of digestive system | 36 | 337 | 1.867 | 0.000909 | 0.00298 | 50.12 (18.18) | Down syndrome | Table_S3 | Male DS direct comorbidity |
K92 | Other diseases of digestive system | 19 | 88 | 3.919 | 0.00000428 | 0.0000119 | 30.83 (25.61) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
L01 | Impetigo | 31 | 179 | 3.100 | 0.000000421 | 0.0000014 | 6.57 (12) | Down syndrome | Table_S1 | Direct comorbidity |
L01 | Impetigo | 20 | 90 | 4.106 | 0.00000128 | 0.00000455 | 8.59 (10.16) | Down syndrome | Table_S3 | Female DS direct comorbidity |
L01 | Impetigo | 18 | 74 | 4.418 | 0.0000018 | 0.000005 | 6.36 (8.36) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
L02 | Cutaneous abscess. furuncle and carbuncle | 147 | 1381 | 1.868 | 0.000000000016 | 0.0000000000529 | 29.83 (17.86) | Down syndrome | Table_S1 | Direct comorbidity |
L02 | Cutaneous abscess. furuncle and carbuncle | 40 | 368 | 1.800 | 0.000785 | 0.00474 | 38.41 (14.26) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
L02 | Cutaneous abscess. furuncle and carbuncle | 5 | 18 | 5.260 | 0.00671 | 0.0215 | 18.05 (16.28) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
L02 | Cutaneous abscess. furuncle and carbuncle | 62 | 562 | 1.991 | 0.00000185 | 0.00000656 | 28.12 (18.24) | Down syndrome | Table_S3 | Female DS direct comorbidity |
L02 | Cutaneous abscess. furuncle and carbuncle | 85 | 851 | 1.721 | 0.00000555 | 0.0000182 | 34.21 (17.48) | Down syndrome | Table_S3 | Male DS direct comorbidity |
L02 | Cutaneous abscess. furuncle and carbuncle | 9 | 53 | 3.162 | 0.00575 | 0.0465 | 21.08 (15.28) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
L02 | Cutaneous abscess. furuncle and carbuncle | 46 | 365 | 2.240 | 0.00000252 | 0.000007 | 18.12 (15.35) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
L03 | Cellulitis | 111 | 746 | 2.615 | 2.69e-17 | 8.91e-17 | 21.83 (19.83) | Down syndrome | Table_S1 | Direct comorbidity |
L03 | Cellulitis | 7 | 29 | 4.601 | 0.00273 | 0.0263 | 14.99 (10.07) | Fragile X syndrome | Table_S1 | Direct comorbidity |
L03 | Cellulitis | 46 | 290 | 2.874 | 0.00000000429 | 0.0000000152 | 17.48 (21.07) | Down syndrome | Table_S3 | Female DS direct comorbidity |
L03 | Cellulitis | 65 | 441 | 2.546 | 0.000000000266 | 0.000000000872 | 22.11 (18.84) | Down syndrome | Table_S3 | Male DS direct comorbidity |
L03 | Cellulitis | 39 | 168 | 4.128 | 0.00000000000703 | 0.0000000000195 | 8.48 (15.49) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
L08 | Other local infections of skin and subcutaneous tissue | 70 | 726 | 1.703 | 0.0000578 | 0.000191 | 19.48 (19.68) | Down syndrome | Table_S1 | Direct comorbidity |
L08 | Other local infections of skin and subcutaneous tissue | 5 | 9 | 10.675 | 0.000416 | 0.00102 | 6.68 (14.32) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
L08 | Other local infections of skin and subcutaneous tissue | 33 | 328 | 1.839 | 0.00183 | 0.00648 | 32.26 (20.75) | Down syndrome | Table_S3 | Female DS direct comorbidity |
L08 | Other local infections of skin and subcutaneous tissue | 41 | 206 | 3.539 | 0.000000000131 | 0.000000000363 | 13.07 (16.08) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
L20 | Atopic dermatitis | 22 | 199 | 2.006 | 0.00439 | 0.0122 | 4.88 (10.49) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
L21 | Seborrhoeic dermatitis | 15 | 104 | 2.657 | 0.00199 | 0.0066 | 25.85 (16.56) | Down syndrome | Table_S1 | Direct comorbidity |
L21 | Seborrhoeic dermatitis | 12 | 81 | 2.703 | 0.0052 | 0.017 | 23.69 (16.71) | Down syndrome | Table_S3 | Male DS direct comorbidity |
L27 | Dermatitis due to substances taken internally | 5 | 13 | 7.475 | 0.00218 | 0.00607 | 3.46 (12.73) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
L30 | Other dermatitis | 21 | 114 | 3.337 | 0.0000118 | 0.0000329 | 11.25 (8.98) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
L40 | Psoriasis | 15 | 87 | 3.134 | 0.000422 | 0.00194 | 27.95 (14.84) | Turner syndrome | Table_S1 | Direct comorbidity |
L40 | Psoriasis | 9 | 57 | 3.007 | 0.00888 | 0.0247 | 30.54 (15.91) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
L40 | Psoriasis | 8 | 23 | 6.329 | 0.000208 | 0.00148 | 27.19 (10.54) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
L50 | Urticaria | 16 | 123 | 2.221 | 0.00668 | 0.0403 | 29.73 (16.02) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
L50 | Urticaria | 7 | 325 | 0.437 | 0.00628 | 0.0165 | 15.82 (10.99) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
L52 | Erythema nodosum | 13 | 47 | 5.086 | 0.000016 | 0.0000529 | 9.47 (8.67) | Down syndrome | Table_S1 | Direct comorbidity |
L52 | Erythema nodosum | 9 | 29 | 5.931 | 0.000133 | 0.000471 | 9.47 (9.77) | Down syndrome | Table_S3 | Female DS direct comorbidity |
L52 | Erythema nodosum | 7 | 11 | 11.627 | 0.0000251 | 0.0000697 | 9.02 (10.83) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
L60 | Nail disorders | 16 | 71 | 4.070 | 0.0000172 | 0.000079 | 13.23 (15.08) | Turner syndrome | Table_S1 | Direct comorbidity |
L60 | Nail disorders | 9 | 30 | 5.566 | 0.000176 | 0.0017 | 31.41 (18.76) | Fragile X syndrome | Table_S1 | Direct comorbidity |
L60 | Nail disorders | 9 | 25 | 6.567 | 0.0000554 | 0.000449 | 31.41 (18.76) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
L63 | Alopecia areata | 11 | 37 | 5.507 | 0.0000409 | 0.000135 | 8.58 (9.67) | Down syndrome | Table_S1 | Direct comorbidity |
L63 | Alopecia areata | 5 | 15 | 6.672 | 0.00334 | 0.0119 | 6.07 (1.64) | Down syndrome | Table_S3 | Female DS direct comorbidity |
L63 | Alopecia areata | 6 | 15 | 7.460 | 0.000752 | 0.00247 | 16.58 (9.38) | Down syndrome | Table_S3 | Male DS direct comorbidity |
L63 | Alopecia areata | 6 | 2 | 40.696 | 0.000000633 | 0.00000176 | 10.88 (12.1) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
L65 | Other nonscarring hair loss | 6 | 12 | 9.390 | 0.000266 | 0.000881 | 14.51 (15.37) | Down syndrome | Table_S1 | Direct comorbidity |
L66 | Cicatricial alopecia [scarring hair loss] | 5 | 5 | 17.237 | 0.000097 | 0.000447 | 36.53 (13.13) | Turner syndrome | Table_S1 | Direct comorbidity |
L70 | Acne | 6 | 24 | 4.536 | 0.00669 | 0.0404 | 23.18 (11.04) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
L70 | Acne | 7 | 35 | 3.876 | 0.00683 | 0.019 | 15.34 (12.41) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
L73 | Other follicular disorders | 44 | 150 | 5.197 | 4.25e-16 | 0.00000000000000141 | 20.39 (10.76) | Down syndrome | Table_S1 | Direct comorbidity |
L73 | Other follicular disorders | 22 | 83 | 4.872 | 0.0000000275 | 0.0000000976 | 22.58 (12.2) | Down syndrome | Table_S3 | Female DS direct comorbidity |
L73 | Other follicular disorders | 22 | 76 | 5.094 | 0.000000015 | 0.0000000492 | 19.77 (8.31) | Down syndrome | Table_S3 | Male DS direct comorbidity |
L73 | Other follicular disorders | 19 | 40 | 8.508 | 0.00000000013 | 0.000000000362 | 21.22 (7.58) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
L89 | Decubitus ulcer | 41 | 150 | 4.851 | 0.0000000000000308 | 0.000000000000102 | 58.89 (9.25) | Down syndrome | Table_S1 | Direct comorbidity |
L89 | Decubitus ulcer | 17 | 40 | 7.811 | 0.00000000364 | 0.0000000129 | 59.93 (6.6) | Down syndrome | Table_S3 | Female DS direct comorbidity |
L89 | Decubitus ulcer | 24 | 83 | 5.075 | 0.00000000343 | 0.0000000112 | 56.95 (9.99) | Down syndrome | Table_S3 | Male DS direct comorbidity |
L89 | Decubitus ulcer | 9 | 17 | 9.689 | 0.00000522 | 0.0000145 | 59.05 (15.97) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
L90 | Atrophic disorders of skin | 9 | 487 | 0.357 | 0.0000867 | 0.000202 | 23.9 (16.35) | Down syndrome | Table_S2 | Inverse comorbidity |
L90 | Atrophic disorders of skin | 6 | 341 | 0.364 | 0.00105 | 0.00274 | 23.15 (17.46) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
L97 | Ulcer of lower limb. not elsewhere classified | 18 | 42 | 7.159 | 0.00000000417 | 0.0000000252 | 55.16 (9.85) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
L98 | Other disorders of skin and subcutaneous tissue. not elsewhere classified | 31 | 310 | 1.794 | 0.00367 | 0.0122 | 34.23 (22.44) | Down syndrome | Table_S1 | Direct comorbidity |
M05 | Seropositive rheumatoid arthritis | 6 | 266 | 0.457 | 0.0149 | 0.0348 | 42.99 (7.89) | Down syndrome | Table_S2 | Inverse comorbidity |
M08 | Juvenile arthritis | 7 | 34 | 3.940 | 0.00631 | 0.0291 | 22.06 (12.1) | Turner syndrome | Table_S1 | Direct comorbidity |
M10 | Gout | 51 | 335 | 2.699 | 0.00000000489 | 0.0000000162 | 46.69 (11.64) | Down syndrome | Table_S1 | Direct comorbidity |
M10 | Gout | 13 | 54 | 4.529 | 0.0000444 | 0.000157 | 48.05 (16.31) | Down syndrome | Table_S3 | Female DS direct comorbidity |
M10 | Gout | 38 | 244 | 2.714 | 0.000000392 | 0.00000129 | 45.7 (9.24) | Down syndrome | Table_S3 | Male DS direct comorbidity |
M10 | Gout | 10 | 47 | 3.997 | 0.000875 | 0.00243 | 47.37 (14.02) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
M16 | Coxarthrosis [arthrosis of hip] | 27 | 217 | 2.214 | 0.000398 | 0.00183 | 53.82 (11.07) | Turner syndrome | Table_S1 | Direct comorbidity |
M16 | Coxarthrosis [arthrosis of hip] | 42 | 425 | 1.796 | 0.000666 | 0.00236 | 44.16 (10.71) | Down syndrome | Table_S3 | Female DS direct comorbidity |
M16 | Coxarthrosis [arthrosis of hip] | 18 | 156 | 2.111 | 0.00638 | 0.0177 | 36.22 (13.3) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
M16 | Coxarthrosis [arthrosis of hip] | 8 | 30 | 4.900 | 0.00092 | 0.00655 | 53.36 (10.97) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
M17 | Gonarthrosis [arthrosis of knee] | 42 | 314 | 2.212 | 0.00000886 | 0.0000535 | 55.19 (10.99) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
M17 | Gonarthrosis [arthrosis of knee] | 36 | 2122 | 0.304 | 2.14e-19 | 4.98e-19 | 48.58 (7.73) | Down syndrome | Table_S2 | Inverse comorbidity |
M17 | Gonarthrosis [arthrosis of knee] | 16 | 1016 | 0.297 | 0.000000000321 | 0.000000000842 | 47.94 (6.58) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
M17 | Gonarthrosis [arthrosis of knee] | 20 | 1084 | 0.330 | 0.000000000477 | 0.0000000012 | 48.68 (8.43) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
M19 | Other arthrosis | 19 | 1076 | 0.324 | 0.000000000604 | 0.00000000141 | 51.55 (12.28) | Down syndrome | Table_S2 | Inverse comorbidity |
M19 | Other arthrosis | 13 | 524 | 0.474 | 0.00128 | 0.00336 | 53.95 (10.56) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
M19 | Other arthrosis | 6 | 552 | 0.216 | 0.0000000588 | 0.000000149 | 42.42 (10.04) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
M20 | Acquired deformities of fingers and toes | 136 | 991 | 2.408 | 3.21e-18 | 1.06e-17 | 43.67 (15.27) | Down syndrome | Table_S1 | Direct comorbidity |
M20 | Acquired deformities of fingers and toes | 17 | 87 | 3.314 | 0.000094 | 0.000568 | 28.7 (11.93) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
M20 | Acquired deformities of fingers and toes | 71 | 633 | 2.021 | 0.000000192 | 0.00000068 | 41.28 (16.23) | Down syndrome | Table_S3 | Female DS direct comorbidity |
M20 | Acquired deformities of fingers and toes | 65 | 259 | 4.329 | 1.02e-19 | 3.35e-19 | 44.68 (13.42) | Down syndrome | Table_S3 | Male DS direct comorbidity |
M20 | Acquired deformities of fingers and toes | 32 | 159 | 3.597 | 0.000000011 | 0.0000000306 | 27.46 (20.16) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
M21 | Other acquired deformities of limbs | 167 | 604 | 4.843 | 0 | 0 | 15.51 (17.87) | Down syndrome | Table_S1 | Direct comorbidity |
M21 | Other acquired deformities of limbs | 21 | 82 | 4.294 | 0.000000363 | 0.00000219 | 27.78 (18.82) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
M21 | Other acquired deformities of limbs | 20 | 178 | 2.022 | 0.00607 | 0.028 | 20.22 (20.13) | Turner syndrome | Table_S1 | Direct comorbidity |
M21 | Other acquired deformities of limbs | 5 | 13 | 7.625 | 0.00152 | 0.00372 | 3.25 (5.98) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
M21 | Other acquired deformities of limbs | 9 | 12 | 12.812 | 0.000000454 | 0.00000146 | 23.51 (16.09) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
M21 | Other acquired deformities of limbs | 13 | 10 | 22.847 | 0.00000000000524 | 0.0000000000146 | 6.39 (3.85) | Angelman syndrome | Table_S1 | Direct comorbidity |
M21 | Other acquired deformities of limbs | 81 | 319 | 4.559 | 1.03e-25 | 3.65e-25 | 15.42 (16.37) | Down syndrome | Table_S3 | Female DS direct comorbidity |
M21 | Other acquired deformities of limbs | 86 | 279 | 5.298 | 6.24e-31 | 2.05e-30 | 15.55 (19.02) | Down syndrome | Table_S3 | Male DS direct comorbidity |
M21 | Other acquired deformities of limbs | 67 | 139 | 8.471 | 2.24e-34 | 6.22e-34 | 11.99 (10.96) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
M23 | Internal derangement of knee | 65 | 4194 | 0.274 | 3.42996e-41 | 7.99006e-41 | 32.42 (15.69) | Down syndrome | Table_S2 | Inverse comorbidity |
M23 | Internal derangement of knee | 23 | 1751 | 0.244 | 9.64e-20 | 2.53e-19 | 29.4 (14.41) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
M23 | Internal derangement of knee | 42 | 2380 | 0.308 | 3.74e-22 | 9.45e-22 | 32.64 (16.23) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
M23 | Internal derangement of knee | 23 | 907 | 0.458 | 0.0000106 | 0.0000269 | 26.78 (16.68) | Down syndrome | Table_S6 | Non-mosaic DS inverse comorbidity |
M24 | Other specific joint derangements | 10 | 407 | 0.460 | 0.00333 | 0.0084 | 14.12 (15.38) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
M25 | Other joint disorders. not elsewhere classified | 5 | 247 | 0.420 | 0.0111 | 0.0282 | 33.75 (16.23) | Down syndrome | Table_S6 | Non-mosaic DS inverse comorbidity |
M35 | Other systemic involvement of connective tissue | 69 | 504 | 2.417 | 0.000000000644 | 0.00000000213 | 4.5 (13.62) | Down syndrome | Table_S1 | Direct comorbidity |
M35 | Other systemic involvement of connective tissue | 9 | 19 | 8.627 | 0.00000967 | 0.0000933 | 2.05 (23.55) | Fragile X syndrome | Table_S1 | Direct comorbidity |
M35 | Other systemic involvement of connective tissue | 39 | 329 | 2.157 | 0.0000355 | 0.000126 | 4.67 (14.8) | Down syndrome | Table_S3 | Female DS direct comorbidity |
M35 | Other systemic involvement of connective tissue | 30 | 116 | 4.518 | 0.000000000387 | 0.00000000127 | 4.29 (11.65) | Down syndrome | Table_S3 | Male DS direct comorbidity |
M35 | Other systemic involvement of connective tissue | 5 | 13 | 7.317 | 0.00219 | 0.0177 | 1.85 (28.25) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
M35 | Other systemic involvement of connective tissue | 39 | 122 | 5.672 | 0.00000000000000131 | 0.00000000000000364 | 4.22 (7.77) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
M41 | Scoliosis | 6 | 12 | 9.532 | 0.000185 | 0.000929 | 13.78 (13.98) | Patau syndrome | Table_S1 | Direct comorbidity |
M41 | Scoliosis | 7 | 29 | 4.823 | 0.00208 | 0.01 | 11.53 (11.67) | Edwards syndrome | Table_S1 | Direct comorbidity |
M41 | Scoliosis | 69 | 408 | 2.985 | 0.000000000000146 | 0.000000000000483 | 14.83 (15.13) | Down syndrome | Table_S1 | Direct comorbidity |
M41 | Scoliosis | 18 | 64 | 4.736 | 0.000000789 | 0.00000476 | 15.48 (7.6) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
M41 | Scoliosis | 19 | 115 | 2.972 | 0.000125 | 0.000578 | 15.87 (15.32) | Turner syndrome | Table_S1 | Direct comorbidity |
M41 | Scoliosis | 7 | 11 | 11.104 | 0.0000216 | 0.0000692 | 16.2 (6.42) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
M41 | Scoliosis | 18 | 2 | 113.691 | 1.65e-22 | 4.61e-22 | 10.74 (6.24) | Angelman syndrome | Table_S1 | Direct comorbidity |
M41 | Scoliosis | 36 | 243 | 2.698 | 0.000000857 | 0.00000304 | 14.83 (15.75) | Down syndrome | Table_S3 | Female DS direct comorbidity |
M41 | Scoliosis | 33 | 171 | 3.371 | 0.0000000299 | 0.0000000979 | 14.93 (14.38) | Down syndrome | Table_S3 | Male DS direct comorbidity |
M41 | Scoliosis | 35 | 150 | 4.158 | 0.0000000000745 | 0.000000000207 | 14.07 (10.21) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
M42 | Spinal osteochondrosis | 5 | 16 | 6.084 | 0.00474 | 0.0218 | 15.9 (7.56) | Turner syndrome | Table_S1 | Direct comorbidity |
M43 | Other deforming dorsopathies | 11 | 76 | 2.718 | 0.00717 | 0.0199 | 19.56 (13.26) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
M47 | Spondylosis | 16 | 792 | 0.374 | 0.00000145 | 0.00000339 | 51.52 (10.35) | Down syndrome | Table_S2 | Inverse comorbidity |
M47 | Spondylosis | 8 | 352 | 0.454 | 0.00609 | 0.016 | 52.79 (10.74) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
M47 | Spondylosis | 8 | 415 | 0.369 | 0.000353 | 0.000892 | 51.29 (9.9) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
M48 | Other spondylopathies | 14 | 656 | 0.398 | 0.0000232 | 0.0000542 | 52.88 (9.46) | Down syndrome | Table_S2 | Inverse comorbidity |
M48 | Other spondylopathies | 6 | 327 | 0.380 | 0.00193 | 0.00506 | 54.58 (5.64) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
M48 | Other spondylopathies | 8 | 343 | 0.446 | 0.00456 | 0.0115 | 49.51 (11.1) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
M50 | Cervical disc disorders | 5 | 754 | 0.139 | 0.00000000000118 | 0.00000000000276 | 48.84 (14.24) | Down syndrome | Table_S2 | Inverse comorbidity |
M50 | Cervical disc disorders | 5 | 369 | 0.277 | 0.0000539 | 0.000136 | 48.84 (14.24) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
M51 | Other intervertebral disc disorders | 9 | 2239 | 0.078 | 2.39062e-42 | 5.57016e-42 | 41.6 (6.72) | Down syndrome | Table_S2 | Inverse comorbidity |
M51 | Other intervertebral disc disorders | 10 | 492 | 0.385 | 0.000132 | 0.000566 | 46.99 (13.41) | Turner syndrome | Table_S2 | Inverse comorbidity |
M51 | Other intervertebral disc disorders | 9 | 979 | 0.182 | 0.00000000000006 | 0.000000000000158 | 41.6 (6.72) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
M53 | Other dorsopathies. not elsewhere classified | 9 | 409 | 0.425 | 0.00153 | 0.00356 | 13.98 (19.51) | Down syndrome | Table_S2 | Inverse comorbidity |
M54 | Dorsalgia | 86 | 851 | 1.654 | 0.0000116 | 0.0000702 | 35.62 (13.85) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
M54 | Dorsalgia | 40 | 3590 | 0.199 | 4.2039e-45 | 9.80909e-45 | 37.85 (15.35) | Down syndrome | Table_S2 | Inverse comorbidity |
M54 | Dorsalgia | 13 | 1683 | 0.148 | 1.49e-25 | 3.91e-25 | 44.13 (9.93) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
M54 | Dorsalgia | 27 | 1851 | 0.258 | 1.62e-20 | 4.1e-20 | 36.96 (17.16) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
M54 | Dorsalgia | 12 | 689 | 0.327 | 0.000000638 | 0.00000163 | 37.35 (15.25) | Down syndrome | Table_S6 | Non-mosaic DS inverse comorbidity |
M62 | Other disorders of muscle | 41 | 381 | 1.781 | 0.000811 | 0.0049 | 38.8 (15.58) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
M62 | Other disorders of muscle | 6 | 23 | 4.828 | 0.00421 | 0.0396 | 14.09 (5.07) | XYY syndrome | Table_S1 | Direct comorbidity |
M62 | Other disorders of muscle | 40 | 1863 | 0.384 | 0.000000000000383 | 0.000000000000893 | 36.96 (14.47) | Down syndrome | Table_S2 | Inverse comorbidity |
M62 | Other disorders of muscle | 14 | 612 | 0.422 | 0.000072 | 0.000308 | 28.59 (14.03) | Turner syndrome | Table_S2 | Inverse comorbidity |
M62 | Other disorders of muscle | 17 | 1100 | 0.291 | 0.0000000000384 | 0.000000000101 | 31.21 (17.54) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
M62 | Other disorders of muscle | 23 | 818 | 0.500 | 0.000123 | 0.00031 | 37.66 (11.15) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
M65 | Synovitis and tenosynovitis | 30 | 294 | 1.702 | 0.00765 | 0.0462 | 42.84 (15.25) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
M65 | Synovitis and tenosynovitis | 37 | 1529 | 0.433 | 0.00000000233 | 0.00000000543 | 43.29 (14.12) | Down syndrome | Table_S2 | Inverse comorbidity |
M65 | Synovitis and tenosynovitis | 13 | 643 | 0.371 | 0.0000089 | 0.0000225 | 49.75 (12.69) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
M67 | Other disorders of synovium and tendon | 34 | 1387 | 0.440 | 0.0000000206 | 0.000000048 | 26.1 (17.7) | Down syndrome | Table_S2 | Inverse comorbidity |
M67 | Other disorders of synovium and tendon | 12 | 654 | 0.338 | 0.00000192 | 0.00000486 | 24.5 (15.25) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
M70 | Soft tissue disorders related to use. overuse and pressure | 27 | 258 | 1.751 | 0.00826 | 0.0499 | 35.95 (13.71) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
M70 | Soft tissue disorders related to use. overuse and pressure | 20 | 961 | 0.381 | 0.000000164 | 0.000000381 | 50.96 (13) | Down syndrome | Table_S2 | Inverse comorbidity |
M70 | Soft tissue disorders related to use. overuse and pressure | 6 | 359 | 0.346 | 0.000572 | 0.0015 | 49.45 (13.12) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
M70 | Soft tissue disorders related to use. overuse and pressure | 14 | 540 | 0.473 | 0.000955 | 0.00241 | 50.96 (12.9) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
M71 | Other bursopathies | 6 | 270 | 0.450 | 0.0154 | 0.0358 | 33.57 (17.43) | Down syndrome | Table_S2 | Inverse comorbidity |
M72 | Fibroblastic disorders | 16 | 105 | 2.764 | 0.000912 | 0.0042 | 53.13 (15.61) | Turner syndrome | Table_S1 | Direct comorbidity |
M72 | Fibroblastic disorders | 5 | 579 | 0.180 | 0.00000000608 | 0.0000000142 | 47.81 (26.22) | Down syndrome | Table_S2 | Inverse comorbidity |
M75 | Shoulder lesions | 17 | 3029 | 0.104 | 0 | 0 | 46.49 (12.37) | Down syndrome | Table_S2 | Inverse comorbidity |
M75 | Shoulder lesions | 12 | 651 | 0.344 | 0.000002 | 0.00000856 | 46.15 (11.65) | Turner syndrome | Table_S2 | Inverse comorbidity |
M75 | Shoulder lesions | 9 | 1340 | 0.133 | 1.26e-21 | 3.32e-21 | 50.04 (14.25) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
M75 | Shoulder lesions | 8 | 1569 | 0.098 | 3.9e-29 | 9.84e-29 | 44.91 (9.82) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
M75 | Shoulder lesions | 6 | 437 | 0.277 | 0.0000165 | 0.000042 | 42.26 (7.65) | Down syndrome | Table_S6 | Non-mosaic DS inverse comorbidity |
M76 | Enthesopathies of lower limb. excluding foot | 11 | 799 | 0.262 | 0.00000000278 | 0.00000000647 | 31.43 (16.11) | Down syndrome | Table_S2 | Inverse comorbidity |
M76 | Enthesopathies of lower limb. excluding foot | 7 | 360 | 0.394 | 0.00146 | 0.00383 | 31.43 (19.06) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
M77 | Other enthesopathies | 14 | 870 | 0.300 | 0.00000000834 | 0.0000000194 | 29.65 (15.75) | Down syndrome | Table_S2 | Inverse comorbidity |
M77 | Other enthesopathies | 9 | 452 | 0.393 | 0.000484 | 0.00127 | 30.83 (13.14) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
M77 | Other enthesopathies | 5 | 359 | 0.284 | 0.0000741 | 0.000187 | 19.95 (19.6) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
M79 | Other soft tissue disorders. not elsewhere classified | 86 | 790 | 1.782 | 0.00000078 | 0.00000471 | 36.15 (15.3) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
M80 | Osteoporosis with pathological fracture | 11 | 64 | 3.182 | 0.00244 | 0.0112 | 65.87 (10.38) | Turner syndrome | Table_S1 | Direct comorbidity |
M81 | Osteoporosis without pathological fracture | 40 | 63 | 10.379 | 2.42e-23 | 1.46e-22 | 54.21 (15.6) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
M81 | Osteoporosis without pathological fracture | 68 | 261 | 4.540 | 6.07e-22 | 2.79e-21 | 52.65 (15.99) | Turner syndrome | Table_S1 | Direct comorbidity |
M81 | Osteoporosis without pathological fracture | 13 | 626 | 0.397 | 0.0000368 | 0.0000967 | 47.56 (14.86) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
M81 | Osteoporosis without pathological fracture | 11 | 36 | 5.473 | 0.0000361 | 0.000257 | 34.7 (14.22) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
M82 | Osteoporosis in diseases classified elsewhere | 17 | 1 | 145.809 | 1.37e-20 | 8.27e-20 | 48.12 (11.18) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
M82 | Osteoporosis in diseases classified elsewhere | 5 | 2 | 34.475 | 0.00000929 | 0.0000428 | 52.38 (12.7) | Turner syndrome | Table_S1 | Direct comorbidity |
M85 | Other disorders of bone density and structure | 25 | 45 | 9.157 | 0.0000000000000445 | 0.000000000000269 | 38.43 (13.43) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
M85 | Other disorders of bone density and structure | 31 | 180 | 3.047 | 0.000000482 | 0.00000222 | 46.74 (15.52) | Turner syndrome | Table_S1 | Direct comorbidity |
M85 | Other disorders of bone density and structure | 9 | 557 | 0.313 | 0.00000576 | 0.0000134 | 39.64 (13.9) | Down syndrome | Table_S2 | Inverse comorbidity |
M91 | Juvenile osteochondrosis of hip and pelvis | 16 | 42 | 6.894 | 0.0000000485 | 0.000000161 | 9.97 (15.52) | Down syndrome | Table_S1 | Direct comorbidity |
M91 | Juvenile osteochondrosis of hip and pelvis | 12 | 42 | 5.155 | 0.0000311 | 0.000102 | 9.68 (17.14) | Down syndrome | Table_S3 | Male DS direct comorbidity |
M91 | Juvenile osteochondrosis of hip and pelvis | 7 | 21 | 6.342 | 0.00058 | 0.00161 | 11.25 (11.25) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
M95 | Other acquired deformities of musculoskeletal system and connective tissue | 11 | 84 | 2.512 | 0.012 | 0.0427 | 2.82 (13.14) | Down syndrome | Table_S3 | Female DS direct comorbidity |
N04 | Nephrotic syndrome | 8 | 44 | 3.488 | 0.00658 | 0.0218 | 44.21 (10.95) | Down syndrome | Table_S1 | Direct comorbidity |
N04 | Nephrotic syndrome | 7 | 24 | 5.457 | 0.00128 | 0.00419 | 44.72 (11.67) | Down syndrome | Table_S3 | Male DS direct comorbidity |
N10 | Acute tubulo-interstitial nephritis | 21 | 200 | 1.887 | 0.00987 | 0.0455 | 3.12 (16.77) | Turner syndrome | Table_S1 | Direct comorbidity |
N17 | Acute renal failure | 6 | 20 | 5.814 | 0.00224 | 0.00624 | 28.07 (19.54) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
N18 | Chronic renal failure | 48 | 437 | 1.951 | 0.0000506 | 0.000168 | 43.64 (14.37) | Down syndrome | Table_S1 | Direct comorbidity |
N18 | Chronic renal failure | 17 | 80 | 3.600 | 0.0000378 | 0.000228 | 54.84 (14.64) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
N18 | Chronic renal failure | 16 | 140 | 2.145 | 0.00905 | 0.0321 | 44.88 (13.02) | Down syndrome | Table_S3 | Female DS direct comorbidity |
N18 | Chronic renal failure | 32 | 229 | 2.447 | 0.0000224 | 0.0000735 | 43.55 (14.96) | Down syndrome | Table_S3 | Male DS direct comorbidity |
N18 | Chronic renal failure | 10 | 63 | 2.998 | 0.00578 | 0.0161 | 45.27 (14.09) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
N19 | Unspecified renal failure | 24 | 194 | 2.236 | 0.000825 | 0.00273 | 43.48 (16.21) | Down syndrome | Table_S1 | Direct comorbidity |
N19 | Unspecified renal failure | 9 | 39 | 4.050 | 0.00154 | 0.00931 | 56.63 (19.84) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
N19 | Unspecified renal failure | 17 | 128 | 2.379 | 0.00281 | 0.00922 | 43.68 (17.78) | Down syndrome | Table_S3 | Male DS direct comorbidity |
N20 | Calculus of kidney and ureter | 16 | 931 | 0.318 | 0.00000000735 | 0.0000000171 | 47.98 (17.56) | Down syndrome | Table_S2 | Inverse comorbidity |
N20 | Calculus of kidney and ureter | 5 | 345 | 0.309 | 0.000274 | 0.00072 | 49.52 (20.75) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
N20 | Calculus of kidney and ureter | 11 | 571 | 0.358 | 0.0000147 | 0.0000372 | 47.69 (15.79) | Down syndrome | Table_S4 | Male DS inverse comorbidity |
N28 | Other disorders of kidney and ureter. not elsewhere classified | 11 | 84 | 2.462 | 0.0138 | 0.0458 | 51.43 (15) | Down syndrome | Table_S1 | Direct comorbidity |
N28 | Other disorders of kidney and ureter. not elsewhere classified | 8 | 46 | 3.265 | 0.00929 | 0.0305 | 53.74 (15.03) | Down syndrome | Table_S3 | Male DS direct comorbidity |
N30 | Cystitis | 190 | 1856 | 1.794 | 0.000000000000414 | 0.00000000000137 | 51.56 (19.75) | Down syndrome | Table_S1 | Direct comorbidity |
N30 | Cystitis | 5 | 20 | 5.129 | 0.00759 | 0.0212 | 4.56 (20.7) | Angelman syndrome | Table_S1 | Direct comorbidity |
N30 | Cystitis | 96 | 555 | 2.975 | 1.74e-18 | 5.7e-18 | 54.31 (19.88) | Down syndrome | Table_S3 | Male DS direct comorbidity |
N30 | Cystitis | 51 | 447 | 2.024 | 0.00000946 | 0.0000263 | 39.46 (22.58) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
N31 | Neuromuscular dysfunction of bladder. not elsewhere classified | 20 | 189 | 1.927 | 0.0101 | 0.0336 | 44.35 (22.06) | Down syndrome | Table_S1 | Direct comorbidity |
N31 | Neuromuscular dysfunction of bladder. not elsewhere classified | 17 | 96 | 3.164 | 0.00016 | 0.000524 | 42.99 (21.86) | Down syndrome | Table_S3 | Male DS direct comorbidity |
N31 | Neuromuscular dysfunction of bladder. not elsewhere classified | 6 | 33 | 3.591 | 0.0175 | 0.0487 | 9.23 (19.35) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
N35 | Urethral stricture | 40 | 138 | 5.144 | 0.0000000000000125 | 0.0000000000000415 | 50.11 (14.58) | Down syndrome | Table_S1 | Direct comorbidity |
N35 | Urethral stricture | 40 | 113 | 6.133 | 8.44e-17 | 2.77e-16 | 50.11 (14.58) | Down syndrome | Table_S3 | Male DS direct comorbidity |
N35 | Urethral stricture | 8 | 20 | 7.475 | 0.0000845 | 0.000235 | 31.06 (16.67) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
N39 | Other disorders of urinary system | 5 | 15 | 6.639 | 0.00282 | 0.0142 | 2.52 (27.03) | Patau syndrome | Table_S1 | Direct comorbidity |
N39 | Other disorders of urinary system | 137 | 1495 | 1.609 | 0.000000333 | 0.0000011 | 49.52 (21.49) | Down syndrome | Table_S1 | Direct comorbidity |
N39 | Other disorders of urinary system | 19 | 109 | 2.946 | 0.000142 | 0.000856 | 54.98 (23) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
N39 | Other disorders of urinary system | 7 | 24 | 5.765 | 0.000658 | 0.00728 | 14.2 (12.05) | Triple X syndrome | Table_S1 | Direct comorbidity |
N39 | Other disorders of urinary system | 5 | 11 | 8.896 | 0.000838 | 0.00205 | 9.85 (20.82) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
N39 | Other disorders of urinary system | 5 | 17 | 5.984 | 0.00425 | 0.0118 | 0.94 (1.9) | Angelman syndrome | Table_S1 | Direct comorbidity |
N39 | Other disorders of urinary system | 66 | 410 | 2.780 | 0.0000000000068 | 0.0000000000223 | 49.42 (22.12) | Down syndrome | Table_S3 | Male DS direct comorbidity |
N39 | Other disorders of urinary system | 36 | 344 | 1.870 | 0.000815 | 0.00227 | 22.72 (23.29) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
N46 | Male infertility | 156 | 335 | 7.570 | 0 | 0 | 32.49 (6.88) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
N46 | Male infertility | 6 | 23 | 4.828 | 0.00421 | 0.0396 | 32.61 (5.66) | XYY syndrome | Table_S1 | Direct comorbidity |
N47 | Redundant prepuce. phimosis and paraphimosis | 143 | 997 | 2.516 | 1.32e-20 | 4.38e-20 | 22.46 (19.9) | Down syndrome | Table_S1 | Direct comorbidity |
N47 | Redundant prepuce. phimosis and paraphimosis | 143 | 1002 | 2.448 | 4.96e-20 | 1.63e-19 | 22.46 (19.9) | Down syndrome | Table_S3 | Male DS direct comorbidity |
N47 | Redundant prepuce. phimosis and paraphimosis | 40 | 389 | 1.834 | 0.000591 | 0.00164 | 10.23 (13.97) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
N48 | Other disorders of penis | 20 | 148 | 2.283 | 0.00174 | 0.0105 | 37.39 (17.3) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
N50 | Other disorders of male genital organs | 25 | 114 | 3.663 | 0.000000366 | 0.00000221 | 34.33 (9.96) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
N62 | Hypertrophy of breast | 86 | 145 | 9.654 | 0 | 0 | 32.01 (11.96) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
N62 | Hypertrophy of breast | 5 | 534 | 0.196 | 0.0000000483 | 0.000000113 | 28.62 (11.76) | Down syndrome | Table_S2 | Inverse comorbidity |
N63 | Unspecified lump in breast | 6 | 10 | 10.310 | 0.000181 | 0.00109 | 33.82 (11.13) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
N83 | Noninflammatory disorders of ovary. fallopian tube and broad ligament | 9 | 742 | 0.235 | 0.00000000182 | 0.00000000424 | 41.54 (12.8) | Down syndrome | Table_S2 | Inverse comorbidity |
N83 | Noninflammatory disorders of ovary. fallopian tube and broad ligament | 9 | 696 | 0.255 | 0.000000021 | 0.0000000553 | 41.54 (12.8) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
N84 | Polyp of female genital tract | 43 | 262 | 2.884 | 0.0000000106 | 0.000000049 | 42.38 (10.7) | Turner syndrome | Table_S1 | Direct comorbidity |
N84 | Polyp of female genital tract | 9 | 587 | 0.297 | 0.00000165 | 0.00000385 | 45.63 (5.38) | Down syndrome | Table_S2 | Inverse comorbidity |
N84 | Polyp of female genital tract | 9 | 557 | 0.319 | 0.00000695 | 0.0000183 | 45.63 (5.38) | Down syndrome | Table_S4 | Female DS inverse comorbidity |
N84 | Polyp of female genital tract | 11 | 53 | 3.750 | 0.000665 | 0.00474 | 36.67 (8.98) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
N91 | Absent. scanty and rare menstruation | 18 | 54 | 5.955 | 0.0000000409 | 0.000000188 | 21.78 (7.93) | Turner syndrome | Table_S1 | Direct comorbidity |
N93 | Other abnormal uterine and vaginal bleeding | 5 | 247 | 0.422 | 0.0114 | 0.0265 | 33.71 (11.32) | Down syndrome | Table_S2 | Inverse comorbidity |
N94 | Pain and other conditions associated with female genital organs and menstrual cycle | 15 | 558 | 0.499 | 0.00155 | 0.00361 | 17.08 (9.9) | Down syndrome | Table_S2 | Inverse comorbidity |
N96 | Habitual aborter | 8 | 47 | 3.232 | 0.00965 | 0.0445 | 33.51 (4.27) | Turner syndrome | Table_S1 | Direct comorbidity |
N97 | Female infertility | 124 | 616 | 3.492 | 3.15e-30 | 1.45e-29 | 28.7 (5.81) | Turner syndrome | Table_S1 | Direct comorbidity |
N97 | Female infertility | 39 | 160 | 4.193 | 0.000000000001 | 0.00000000000716 | 27.75 (4.64) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
N99 | Postprocedural disorders of genitourinary system. not elsewhere classified | 15 | 55 | 4.872 | 0.00000532 | 0.0000174 | 49.8 (12.4) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q02 | Microcephaly | 5 | 8 | 11.626 | 0.000416 | 0.00138 | 1.02 (15.5) | Down syndrome | Table_S1 | Direct comorbidity |
Q03 | Congenital hydrocephalus | 9 | 2 | 60.282 | 0.000000000112 | 0.00000000054 | 0.76 (12.36) | Edwards syndrome | Table_S1 | Direct comorbidity |
Q04 | Other congenital malformations of brain | 6 | 5 | 21.099 | 0.00000665 | 0.0000321 | 0 (13.66) | Edwards syndrome | Table_S1 | Direct comorbidity |
Q10 | Congenital malformations of eyelid. lacrimal apparatus and orbit | 31 | 47 | 11.626 | 2.17e-19 | 7.18e-19 | 6.55 (7.38) | Down syndrome | Table_S1 | Direct comorbidity |
Q10 | Congenital malformations of eyelid. lacrimal apparatus and orbit | 6 | 15 | 7.541 | 0.000704 | 0.00324 | 9.33 (6.51) | Turner syndrome | Table_S1 | Direct comorbidity |
Q10 | Congenital malformations of eyelid. lacrimal apparatus and orbit | 18 | 20 | 16.098 | 0.000000000000127 | 0.000000000000449 | 6.22 (5.05) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q10 | Congenital malformations of eyelid. lacrimal apparatus and orbit | 13 | 27 | 8.526 | 0.000000129 | 0.000000423 | 6.87 (9.5) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q10 | Congenital malformations of eyelid. lacrimal apparatus and orbit | 21 | 24 | 15.348 | 0.00000000000000227 | 0.0000000000000063 | 5.12 (8.5) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q12 | Congenital lens malformations | 65 | 24 | 46.039 | 0 | 0 | 23.81 (17.52) | Down syndrome | Table_S1 | Direct comorbidity |
Q12 | Congenital lens malformations | 28 | 7 | 64.496 | 7.72e-30 | 2.74e-29 | 24.54 (16.6) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q12 | Congenital lens malformations | 37 | 9 | 64.799 | 1.5e-38 | 4.92e-38 | 22.28 (18.17) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q12 | Congenital lens malformations | 22 | 11 | 33.429 | 1.21e-20 | 3.37e-20 | 16.49 (12.67) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q13 | Congenital malformations of anterior segment of eye | 12 | 29 | 7.557 | 0.00000114 | 0.00000378 | 4.68 (19.79) | Down syndrome | Table_S1 | Direct comorbidity |
Q13 | Congenital malformations of anterior segment of eye | 7 | 11 | 11.861 | 0.0000224 | 0.0000795 | 18.78 (22.58) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q13 | Congenital malformations of anterior segment of eye | 5 | 16 | 6.018 | 0.00499 | 0.0164 | 3.67 (2.84) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q13 | Congenital malformations of anterior segment of eye | 7 | 5 | 23.255 | 0.000000832 | 0.00000231 | 5.12 (22.58) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q14 | Congenital malformations of posterior segment of eye | 8 | 21 | 7.134 | 0.000114 | 0.000376 | 14.22 (13.79) | Down syndrome | Table_S1 | Direct comorbidity |
Q14 | Congenital malformations of posterior segment of eye | 5 | 11 | 8.896 | 0.00112 | 0.00399 | 13.69 (16.71) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q16 | Congenital malformations of ear causing impairment of hearing | 18 | 24 | 13.254 | 0.00000000000158 | 0.00000000000522 | 28.97 (17.54) | Down syndrome | Table_S1 | Direct comorbidity |
Q16 | Congenital malformations of ear causing impairment of hearing | 10 | 14 | 13.048 | 0.000000173 | 0.000000613 | 12.62 (18.89) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q16 | Congenital malformations of ear causing impairment of hearing | 8 | 15 | 9.592 | 0.0000201 | 0.0000659 | 33.02 (14.54) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q16 | Congenital malformations of ear causing impairment of hearing | 7 | 9 | 13.953 | 0.00000992 | 0.0000276 | 10.62 (15.87) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q17 | Other congenital malformations of ear | 6 | 302 | 0.403 | 0.00354 | 0.00825 | 2.52 (5.00) | Down syndrome | Table_S2 | Inverse comorbidity |
Q18 | Other congenital malformations of face and neck | 14 | 63 | 4.040 | 0.000065 | 0.000299 | 12.04 (14.3) | Turner syndrome | Table_S1 | Direct comorbidity |
Q18 | Other congenital malformations of face and neck | 9 | 20 | 8.036 | 0.0000163 | 0.000116 | 11.43 (8.31) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
Q20 | Congenital malformations of cardiac chambers and connections | 12 | 1 | 117.551 | 0.00000000000000326 | 0.0000000000000157 | 0 (2.58) | Edwards syndrome | Table_S1 | Direct comorbidity |
Q20 | Congenital malformations of cardiac chambers and connections | 54 | 23 | 39.964 | 0 | 0 | 1.29 (9.85) | Down syndrome | Table_S1 | Direct comorbidity |
Q20 | Congenital malformations of cardiac chambers and connections | 32 | 7 | 73.393 | 1.31e-34 | 4.65e-34 | 0.82 (9.72) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q20 | Congenital malformations of cardiac chambers and connections | 22 | 21 | 17.827 | 6.74e-17 | 2.21e-16 | 1.53 (9.95) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q20 | Congenital malformations of cardiac chambers and connections | 33 | 16 | 34.882 | 1.44e-30 | 3.99e-30 | 0.19 (4.92) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q21 | Congenital malformations of cardiac septa | 17 | 12 | 24.511 | 7.25e-16 | 0.00000000000000365 | 0 (3.74) | Patau syndrome | Table_S1 | Direct comorbidity |
Q21 | Congenital malformations of cardiac septa | 66 | 34 | 34.619 | 0 | 0 | 0 (4.8) | Edwards syndrome | Table_S1 | Direct comorbidity |
Q21 | Congenital malformations of cardiac septa | 931 | 259 | 62.512 | 0 | 0 | 1.78 (14.54) | Down syndrome | Table_S1 | Direct comorbidity |
Q21 | Congenital malformations of cardiac septa | 10 | 41 | 4.243 | 0.000593 | 0.00358 | 12.6 (17.35) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
Q21 | Congenital malformations of cardiac septa | 8 | 13 | 11.581 | 0.00000367 | 0.0000406 | 0.1 (10.29) | Triple X syndrome | Table_S1 | Direct comorbidity |
Q21 | Congenital malformations of cardiac septa | 5 | 13 | 7.095 | 0.0023 | 0.0216 | 2.57 (7.77) | XYY syndrome | Table_S1 | Direct comorbidity |
Q21 | Congenital malformations of cardiac septa | 37 | 60 | 10.738 | 3.53e-22 | 1.63e-21 | 3.5 (13.7) | Turner syndrome | Table_S1 | Direct comorbidity |
Q21 | Congenital malformations of cardiac septa | 18 | 6 | 48.294 | 2.67e-20 | 6.54e-20 | 0.53 (2.51) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
Q21 | Congenital malformations of cardiac septa | 10 | 7 | 22.902 | 0.00000000178 | 0.0000000057 | 0.39 (4.55) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
Q21 | Congenital malformations of cardiac septa | 466 | 134 | 61.548 | 0 | 0 | 2.55 (15.1) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q21 | Congenital malformations of cardiac septa | 465 | 137 | 57.582 | 0 | 0 | 1.2 (13.94) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q21 | Congenital malformations of cardiac septa | 441 | 107 | 71.379 | 0 | 0 | 1.24 (9.77) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q21 | Congenital malformations of cardiac septa | 16 | 2 | 95.704 | 1.04e-19 | 7.44e-19 | 6.41 (16.6) | Down syndrome | Table_S6 | Mosaic DS direct comorbidity |
Q21 | Congenital malformations of cardiac septa | 11 | 23 | 8.438 | 0.00000113 | 0.00000806 | 2.38 (5.28) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
Q22 | Congenital malformations of pulmonary and tricuspid valves | 7 | 7 | 18.085 | 0.00000226 | 0.0000109 | 0.04 (0.78) | Edwards syndrome | Table_S1 | Direct comorbidity |
Q22 | Congenital malformations of pulmonary and tricuspid valves | 43 | 39 | 19.183 | 1.36e-32 | 4.49e-32 | 0.54 (13.1) | Down syndrome | Table_S1 | Direct comorbidity |
Q22 | Congenital malformations of pulmonary and tricuspid valves | 19 | 21 | 16.175 | 0.0000000000000247 | 0.0000000000000876 | 1.19 (17.08) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q22 | Congenital malformations of pulmonary and tricuspid valves | 24 | 25 | 16.396 | 9.74e-18 | 3.19e-17 | 0.53 (7.62) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q22 | Congenital malformations of pulmonary and tricuspid valves | 27 | 19 | 24.417 | 7.12e-23 | 1.98e-22 | 1.19 (13.73) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q23 | Congenital malformations of aortic and mitral valves | 5 | 5 | 18.085 | 0.0000723 | 0.000349 | 0.24 (19.16) | Edwards syndrome | Table_S1 | Direct comorbidity |
Q23 | Congenital malformations of aortic and mitral valves | 90 | 67 | 23.337 | 0 | 0 | 8.82 (13.24) | Down syndrome | Table_S1 | Direct comorbidity |
Q23 | Congenital malformations of aortic and mitral valves | 66 | 16 | 67.936 | 0 | 0 | 15.47 (15.94) | Turner syndrome | Table_S1 | Direct comorbidity |
Q23 | Congenital malformations of aortic and mitral valves | 50 | 29 | 30.247 | 6.72623e-44 | 2.38221e-43 | 8.27 (14.06) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q23 | Congenital malformations of aortic and mitral valves | 40 | 40 | 17.052 | 4.34e-29 | 1.42e-28 | 9.53 (12.1) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q23 | Congenital malformations of aortic and mitral valves | 56 | 31 | 31.067 | 0 | 0 | 7.95 (9.68) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q23 | Congenital malformations of aortic and mitral valves | 34 | 3 | 147.670 | 1.36999e-40 | 9.76e-40 | 14.83 (14.18) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
Q24 | Other congenital malformations of heart | 18 | 10 | 31.237 | 2.6e-17 | 1.26e-16 | 0 (0.47) | Edwards syndrome | Table_S1 | Direct comorbidity |
Q24 | Other congenital malformations of heart | 179 | 78 | 39.734 | 0 | 0 | 1.09 (14.2) | Down syndrome | Table_S1 | Direct comorbidity |
Q24 | Other congenital malformations of heart | 41 | 20 | 34.475 | 1.62e-37 | 7.48e-37 | 17.48 (16.03) | Turner syndrome | Table_S1 | Direct comorbidity |
Q24 | Other congenital malformations of heart | 73 | 43 | 29.923 | 0 | 0 | 1.94 (15.4) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q24 | Other congenital malformations of heart | 106 | 51 | 35.088 | 0 | 0 | 1 (13.14) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q24 | Other congenital malformations of heart | 93 | 40 | 39.987 | 0 | 0 | 0.31 (8.39) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q24 | Other congenital malformations of heart | 24 | 9 | 42.191 | 5.95e-24 | 4.24e-23 | 17.14 (12.15) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
Q25 | Congenital malformations of great arteries | 11 | 6 | 30.347 | 0.000000000035 | 0.000000000176 | 0 (0.59) | Patau syndrome | Table_S1 | Direct comorbidity |
Q25 | Congenital malformations of great arteries | 36 | 16 | 39.361 | 7.31e-36 | 3.52e-35 | 0 (0.72) | Edwards syndrome | Table_S1 | Direct comorbidity |
Q25 | Congenital malformations of great arteries | 240 | 126 | 33.093 | 0 | 0 | 0.12 (8.36) | Down syndrome | Table_S1 | Direct comorbidity |
Q25 | Congenital malformations of great arteries | 61 | 30 | 34.475 | 0 | 0 | 18.73 (19.13) | Turner syndrome | Table_S1 | Direct comorbidity |
Q25 | Congenital malformations of great arteries | 7 | 4 | 28.468 | 0.000000177 | 0.000000435 | 0.73 (1.13) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
Q25 | Congenital malformations of great arteries | 8 | 3 | 37.477 | 0.00000000782 | 0.0000000251 | 0.47 (0.72) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
Q25 | Congenital malformations of great arteries | 133 | 66 | 35.584 | 0 | 0 | 0.2 (9.49) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q25 | Congenital malformations of great arteries | 107 | 71 | 25.578 | 0 | 0 | 0.07 (6.57) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q25 | Congenital malformations of great arteries | 97 | 52 | 32.250 | 0 | 0 | 0.09 (5.18) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q25 | Congenital malformations of great arteries | 32 | 10 | 50.630 | 7.9e-33 | 5.62e-32 | 14.25 (15.57) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
Q26 | Congenital malformations of great veins | 10 | 17 | 10.657 | 0.000000777 | 0.00000257 | 0.89 (13.23) | Down syndrome | Table_S1 | Direct comorbidity |
Q26 | Congenital malformations of great veins | 6 | 5 | 20.757 | 0.00000819 | 0.000029 | 1.4 (16.44) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q26 | Congenital malformations of great veins | 6 | 4 | 24.417 | 0.00000432 | 0.000012 | 2.02 (1.42) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q31 | Congenital malformations of larynx | 22 | 25 | 15.427 | 5.24e-16 | 0.00000000000000173 | 0.43 (10.38) | Down syndrome | Table_S1 | Direct comorbidity |
Q31 | Congenital malformations of larynx | 18 | 13 | 23.142 | 0.00000000000000226 | 0.00000000000000742 | 0.47 (11.37) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q31 | Congenital malformations of larynx | 11 | 19 | 10.465 | 0.000000234 | 0.000000651 | 0.46 (2.74) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q32 | Congenital malformations of trachea and bronchus | 9 | 10 | 15.853 | 0.000000225 | 0.000000744 | 1.16 (4.58) | Down syndrome | Table_S1 | Direct comorbidity |
Q32 | Congenital malformations of trachea and bronchus | 6 | 5 | 19.894 | 0.0000103 | 0.0000339 | 1.47 (5.09) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q32 | Congenital malformations of trachea and bronchus | 6 | 7 | 15.261 | 0.0000306 | 0.0000852 | 1.47 (5.24) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q33 | Congenital malformations of lung | 5 | 13 | 7.474 | 0.00221 | 0.0073 | 1.36 (6.51) | Down syndrome | Table_S1 | Direct comorbidity |
Q35 | Cleft palate | 8 | 2 | 53.108 | 0.00000000155 | 0.00000000779 | 0 (8.34) | Patau syndrome | Table_S1 | Direct comorbidity |
Q35 | Cleft palate | 6 | 4 | 25.319 | 0.00000316 | 0.0000152 | 0.57 (9.15) | Edwards syndrome | Table_S1 | Direct comorbidity |
Q35 | Cleft palate | 12 | 44 | 5.038 | 0.0000378 | 0.000125 | 3.8 (13.86) | Down syndrome | Table_S1 | Direct comorbidity |
Q35 | Cleft palate | 7 | 1 | 71.170 | 0.00000000485 | 0.0000000119 | 1.15 (4.39) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
Q35 | Cleft palate | 9 | 15 | 10.658 | 0.00000292 | 0.00000959 | 5.09 (15.47) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q35 | Cleft palate | 6 | 16 | 7.182 | 0.000875 | 0.00243 | 4.18 (3.08) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q37 | Cleft palate with cleft lip | 21 | 3 | 97.365 | 9.64e-26 | 4.85e-25 | 0 (0.78) | Patau syndrome | Table_S1 | Direct comorbidity |
Q37 | Cleft palate with cleft lip | 10 | 4 | 39.786 | 0.0000000000917 | 0.000000000442 | 0 (0.08) | Edwards syndrome | Table_S1 | Direct comorbidity |
Q38 | Other congenital malformations of tongue. mouth and pharynx | 14 | 86 | 3.007 | 0.00101 | 0.00333 | 7.07 (14.06) | Down syndrome | Table_S1 | Direct comorbidity |
Q38 | Other congenital malformations of tongue. mouth and pharynx | 9 | 26 | 6.590 | 0.0000665 | 0.000236 | 9.49 (15.23) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q38 | Other congenital malformations of tongue. mouth and pharynx | 7 | 29 | 4.651 | 0.0028 | 0.00779 | 5.72 (5.53) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q39 | Congenital malformations of oesophagus | 11 | 2 | 72.339 | 0.000000000000384 | 0.00000000000185 | 0 (0) | Edwards syndrome | Table_S1 | Direct comorbidity |
Q39 | Congenital malformations of oesophagus | 10 | 6 | 27.404 | 0.00000000128 | 0.00000000424 | 5.96 (7.48) | Down syndrome | Table_S1 | Direct comorbidity |
Q39 | Congenital malformations of oesophagus | 6 | 4 | 23.873 | 0.00000493 | 0.0000162 | 0.97 (8.56) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q39 | Congenital malformations of oesophagus | 5 | 2 | 34.882 | 0.00000883 | 0.0000245 | 1.07 (5.66) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q40 | Other congenital malformations of upper alimentary tract | 13 | 73 | 3.299 | 0.000724 | 0.0024 | 5.19 (10.81) | Down syndrome | Table_S1 | Direct comorbidity |
Q40 | Other congenital malformations of upper alimentary tract | 6 | 25 | 4.790 | 0.00523 | 0.0185 | 7.41 (11.97) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q40 | Other congenital malformations of upper alimentary tract | 7 | 39 | 3.410 | 0.0126 | 0.0415 | 5.19 (9.2) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q40 | Other congenital malformations of upper alimentary tract | 8 | 24 | 6.279 | 0.000236 | 0.000655 | 7.3 (10.07) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q41 | Congenital absence. atresia and stenosis of small intestine | 41 | 7 | 91.554 | 5.60519e-45 | 1.68156e-44 | 0 (3.01) | Down syndrome | Table_S1 | Direct comorbidity |
Q41 | Congenital absence. atresia and stenosis of small intestine | 20 | 1 | 186.817 | 5.78e-25 | 2.05e-24 | 0 (3.8) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q41 | Congenital absence. atresia and stenosis of small intestine | 21 | 1 | 187.575 | 7.54e-26 | 2.47e-25 | 0 (1.9) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q41 | Congenital absence. atresia and stenosis of small intestine | 21 | 4 | 76.741 | 2.15e-23 | 5.97e-23 | 0 (3.34) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q42 | Congenital absence. atresia and stenosis of large intestine | 13 | 6 | 34.878 | 0.00000000000068 | 0.00000000000225 | 1.24 (8.76) | Down syndrome | Table_S1 | Direct comorbidity |
Q42 | Congenital absence. atresia and stenosis of large intestine | 7 | 3 | 35.584 | 0.000000123 | 0.000000437 | 1.24 (5.23) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q42 | Congenital absence. atresia and stenosis of large intestine | 6 | 4 | 23.873 | 0.00000493 | 0.0000162 | 1.41 (11.28) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q42 | Congenital absence. atresia and stenosis of large intestine | 5 | 8 | 11.627 | 0.000411 | 0.00114 | 0.07 (3.03) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q43 | Other congenital malformations of intestine | 42 | 38 | 19.227 | 6.75e-32 | 2.23e-31 | 1.55 (9.99) | Down syndrome | Table_S1 | Direct comorbidity |
Q43 | Other congenital malformations of intestine | 12 | 12 | 17.792 | 0.000000000727 | 0.00000000258 | 1.25 (14.84) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q43 | Other congenital malformations of intestine | 30 | 20 | 25.172 | 2.5e-25 | 8.21e-25 | 2.3 (7.16) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q43 | Other congenital malformations of intestine | 22 | 12 | 30.857 | 3.26e-20 | 9.06e-20 | 1.95 (3.89) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q45 | Other congenital malformations of digestive system | 10 | 6 | 27.404 | 0.00000000128 | 0.00000000424 | 0 (2.94) | Down syndrome | Table_S1 | Direct comorbidity |
Q45 | Other congenital malformations of digestive system | 6 | 1 | 62.272 | 0.000000149 | 0.00000053 | 0.04 (3.64) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q45 | Other congenital malformations of digestive system | 6 | 1 | 61.044 | 0.000000166 | 0.000000461 | 0 (0.04) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q53 | Undescended testicle | 5 | 18 | 5.590 | 0.00541 | 0.0272 | 0 (1.25) | Patau syndrome | Table_S1 | Direct comorbidity |
Q53 | Undescended testicle | 92 | 528 | 3.066 | 2.59e-18 | 8.56e-18 | 7.73 (11.79) | Down syndrome | Table_S1 | Direct comorbidity |
Q53 | Undescended testicle | 51 | 173 | 4.842 | 1.24e-17 | 7.48e-17 | 12.79 (15.12) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
Q53 | Undescended testicle | 6 | 11 | 10.379 | 0.00011 | 0.00027 | 4.52 (4.07) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
Q53 | Undescended testicle | 6 | 28 | 4.333 | 0.00659 | 0.0184 | 11.89 (5.38) | Angelman syndrome | Table_S1 | Direct comorbidity |
Q53 | Undescended testicle | 92 | 516 | 3.067 | 1.65e-18 | 5.42e-18 | 7.73 (11.79) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q53 | Undescended testicle | 52 | 229 | 4.019 | 0.00000000000000466 | 0.000000000000013 | 7.89 (9.99) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q55 | Other congenital malformations of male genital organs | 14 | 53 | 4.844 | 0.0000119 | 0.0000393 | 6.73 (10.89) | Down syndrome | Table_S1 | Direct comorbidity |
Q55 | Other congenital malformations of male genital organs | 11 | 15 | 12.151 | 0.0000000806 | 0.000000487 | 24.17 (17.44) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
Q55 | Other congenital malformations of male genital organs | 14 | 50 | 5.015 | 0.00000844 | 0.0000277 | 6.73 (10.89) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q62 | Congenital obstructive defects of renal pelvis and congenital malformations of ureter | 14 | 95 | 2.725 | 0.00232 | 0.00768 | 0.86 (12.87) | Down syndrome | Table_S1 | Direct comorbidity |
Q64 | Other congenital malformations of urinary system | 7 | 36 | 3.771 | 0.0079 | 0.0262 | 8.57 (18.2) | Down syndrome | Table_S1 | Direct comorbidity |
Q64 | Other congenital malformations of urinary system | 7 | 30 | 4.401 | 0.00374 | 0.0123 | 8.57 (18.2) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q65 | Congenital deformities of hip | 67 | 378 | 3.129 | 0.0000000000000478 | 0.000000000000158 | 12.43 (15.11) | Down syndrome | Table_S1 | Direct comorbidity |
Q65 | Congenital deformities of hip | 6 | 12 | 9.666 | 0.000177 | 0.000493 | 14.7 (10.39) | Angelman syndrome | Table_S1 | Direct comorbidity |
Q65 | Congenital deformities of hip | 40 | 232 | 3.131 | 0.00000000562 | 0.0000000199 | 11.52 (15.79) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q65 | Congenital deformities of hip | 27 | 107 | 4.421 | 0.0000000045 | 0.0000000148 | 13.49 (14.04) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q65 | Congenital deformities of hip | 31 | 149 | 3.721 | 0.00000000952 | 0.0000000265 | 10.61 (14.05) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q65 | Congenital deformities of hip | 7 | 31 | 4.219 | 0.00428 | 0.0305 | 0.24 (1.91) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
Q66 | Congenital deformities of feet | 9 | 12 | 13.617 | 0.000000309 | 0.00000155 | 0 (14.99) | Patau syndrome | Table_S1 | Direct comorbidity |
Q66 | Congenital deformities of feet | 12 | 49 | 4.702 | 0.0000487 | 0.000235 | 0.44 (8.46) | Edwards syndrome | Table_S1 | Direct comorbidity |
Q66 | Congenital deformities of feet | 220 | 483 | 7.963 | 0 | 0 | 12 (14.06) | Down syndrome | Table_S1 | Direct comorbidity |
Q66 | Congenital deformities of feet | 22 | 86 | 4.283 | 0.000000195 | 0.00000118 | 6.92 (18.79) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
Q66 | Congenital deformities of feet | 8 | 19 | 7.449 | 0.0000617 | 0.000579 | 11.67 (6.36) | XYY syndrome | Table_S1 | Direct comorbidity |
Q66 | Congenital deformities of feet | 14 | 108 | 2.372 | 0.00683 | 0.0315 | 9.41 (18.16) | Turner syndrome | Table_S1 | Direct comorbidity |
Q66 | Congenital deformities of feet | 6 | 6 | 17.792 | 0.00001 | 0.0000246 | 4.56 (14.32) | Wolf Hirschhorn syndrome | Table_S1 | Direct comorbidity |
Q66 | Congenital deformities of feet | 5 | 12 | 7.688 | 0.0016 | 0.00511 | 3.07 (9.21) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
Q66 | Congenital deformities of feet | 14 | 9 | 26.927 | 0.000000000000171 | 0.000000000000475 | 6.28 (6.47) | Angelman syndrome | Table_S1 | Direct comorbidity |
Q66 | Congenital deformities of feet | 10 | 33 | 5.582 | 0.000071 | 0.000685 | 4.56 (4.13) | Fragile X syndrome | Table_S1 | Direct comorbidity |
Q66 | Congenital deformities of feet | 110 | 208 | 9.449 | 0 | 0 | 12.25 (14.44) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q66 | Congenital deformities of feet | 110 | 278 | 6.784 | 0 | 0 | 11.43 (13.63) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q66 | Congenital deformities of feet | 10 | 28 | 6.476 | 0.0000222 | 0.00018 | 4.56 (4.13) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
Q66 | Congenital deformities of feet | 105 | 196 | 9.385 | 0 | 0 | 10.17 (11.64) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q66 | Congenital deformities of feet | 6 | 10 | 10.747 | 0.000105 | 0.000749 | 12.43 (5.46) | Down syndrome | Table_S6 | Mosaic DS direct comorbidity |
Q67 | Congenital musculoskeletal deformities of head. face. spine and chest | 5 | 15 | 6.471 | 0.00357 | 0.0344 | 0.3 (0.19) | Fragile X syndrome | Table_S1 | Direct comorbidity |
Q67 | Congenital musculoskeletal deformities of head. face. spine and chest | 8 | 40 | 3.906 | 0.00353 | 0.0125 | 0.77 (19.44) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q67 | Congenital musculoskeletal deformities of head. face. spine and chest | 5 | 14 | 6.829 | 0.00284 | 0.023 | 0.3 (0.19) | Fragile X syndrome | Table_S5 | Male FXS direct comorbidity |
Q69 | Polydactyly | 14 | 1 | 132.770 | 4.41e-18 | 2.22e-17 | 0 (2.25) | Patau syndrome | Table_S1 | Direct comorbidity |
Q70 | Syndactyly | 9 | 39 | 4.360 | 0.000979 | 0.00324 | 1.74 (17.85) | Down syndrome | Table_S1 | Direct comorbidity |
Q70 | Syndactyly | 6 | 21 | 5.549 | 0.00275 | 0.00766 | 1.95 (20.96) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q72 | Reduction defects of lower limb | 6 | 25 | 4.790 | 0.00523 | 0.0185 | 25.18 (18.78) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q72 | Reduction defects of lower limb | 5 | 16 | 6.156 | 0.00453 | 0.0126 | 13.25 (11.7) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q74 | Other congenital malformations of limb(s) | 20 | 92 | 3.938 | 0.0000024 | 0.00000794 | 9.58 (10.79) | Down syndrome | Table_S1 | Direct comorbidity |
Q74 | Other congenital malformations of limb(s) | 5 | 14 | 6.480 | 0.00381 | 0.023 | 9.03 (10.02) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
Q74 | Other congenital malformations of limb(s) | 13 | 23 | 10.055 | 0.0000000257 | 0.000000119 | 15.52 (8.36) | Turner syndrome | Table_S1 | Direct comorbidity |
Q74 | Other congenital malformations of limb(s) | 11 | 54 | 3.882 | 0.000584 | 0.00207 | 11.38 (11.44) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q74 | Other congenital malformations of limb(s) | 9 | 51 | 3.279 | 0.00549 | 0.018 | 7.77 (9.77) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q74 | Other congenital malformations of limb(s) | 12 | 43 | 5.153 | 0.00003 | 0.0000834 | 8.82 (4.79) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q79 | Congenital malformations of the musculoskeletal system. not elsewhere classified | 8 | 1 | 79.662 | 0.000000000323 | 0.00000000162 | 0 (15.92) | Patau syndrome | Table_S1 | Direct comorbidity |
Q79 | Congenital malformations of the musculoskeletal system. not elsewhere classified | 11 | 5 | 36.169 | 0.0000000000187 | 0.0000000000904 | 0 (13.21) | Edwards syndrome | Table_S1 | Direct comorbidity |
Q79 | Congenital malformations of the musculoskeletal system. not elsewhere classified | 11 | 53 | 3.875 | 0.000606 | 0.00201 | 4.58 (18.16) | Down syndrome | Table_S1 | Direct comorbidity |
Q79 | Congenital malformations of the musculoskeletal system. not elsewhere classified | 6 | 30 | 4.018 | 0.011 | 0.0392 | 9.73 (14.37) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q79 | Congenital malformations of the musculoskeletal system. not elsewhere classified | 7 | 25 | 5.366 | 0.00136 | 0.00379 | 6.72 (14.41) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q82 | Other congenital malformations of skin | 13 | 75 | 3.175 | 0.000957 | 0.00441 | 11.18 (10.36) | Turner syndrome | Table_S1 | Direct comorbidity |
Q82 | Other congenital malformations of skin | 6 | 16 | 6.949 | 0.000968 | 0.00689 | 15.56 (6.62) | Turner syndrome | Table_S7 | Non-mosaic TS direct comorbidity |
Q87 | Other specified congenital malformation syndromes affecting multiple systems | 6 | 4 | 25.319 | 0.00000316 | 0.0000152 | 1.27 (7.2) | Edwards syndrome | Table_S1 | Direct comorbidity |
Q87 | Other specified congenital malformation syndromes affecting multiple systems | 15 | 85 | 3.244 | 0.000319 | 0.00106 | 6.54 (15.44) | Down syndrome | Table_S1 | Direct comorbidity |
Q87 | Other specified congenital malformation syndromes affecting multiple systems | 8 | 15 | 9.113 | 0.0000277 | 0.000168 | 15.42 (11.78) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
Q87 | Other specified congenital malformation syndromes affecting multiple systems | 11 | 1 | 99.938 | 0.0000000000000664 | 0.000000000000213 | 2.64 (6.53) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
Q87 | Other specified congenital malformation syndromes affecting multiple systems | 9 | 4 | 35.902 | 0.00000000101 | 0.0000000028 | 2.06 (3.17) | Angelman syndrome | Table_S1 | Direct comorbidity |
Q87 | Other specified congenital malformation syndromes affecting multiple systems | 5 | 11 | 8.627 | 0.0012 | 0.0116 | 0.75 (1.58) | Fragile X syndrome | Table_S1 | Direct comorbidity |
Q87 | Other specified congenital malformation syndromes affecting multiple systems | 7 | 30 | 4.592 | 0.00299 | 0.0106 | 11.31 (13.55) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q87 | Other specified congenital malformation syndromes affecting multiple systems | 8 | 32 | 4.651 | 0.00136 | 0.00446 | 5.12 (16.91) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q87 | Other specified congenital malformation syndromes affecting multiple systems | 7 | 29 | 4.651 | 0.0028 | 0.00779 | 5.93 (7.38) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q89 | Other congenital malformations. not elsewhere classified | 12 | 1 | 115.068 | 0.00000000000000202 | 0.0000000000000102 | 0 (1.09) | Patau syndrome | Table_S1 | Direct comorbidity |
Q89 | Other congenital malformations. not elsewhere classified | 26 | 7 | 61.036 | 1.9e-28 | 9.14e-28 | 0 (2.74) | Edwards syndrome | Table_S1 | Direct comorbidity |
Q89 | Other congenital malformations. not elsewhere classified | 35 | 61 | 10.126 | 3.01e-20 | 9.97e-20 | 0 (8.82) | Down syndrome | Table_S1 | Direct comorbidity |
Q89 | Other congenital malformations. not elsewhere classified | 20 | 23 | 15.568 | 0.00000000000000855 | 0.0000000000000303 | 0 (11.42) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q89 | Other congenital malformations. not elsewhere classified | 15 | 34 | 7.795 | 0.0000000349 | 0.000000114 | 0 (0.06) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q89 | Other congenital malformations. not elsewhere classified | 17 | 28 | 10.825 | 0.0000000000678 | 0.000000000188 | 0 (1.73) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q90 | Down's syndrome | 9 | 4 | 36.169 | 0.00000000133 | 0.00000000641 | 11.99 (24.48) | Edwards syndrome | Table_S1 | Direct comorbidity |
Q90 | Down's syndrome | 8 | 6 | 22.162 | 0.000000174 | 0.000000802 | 8.1 (6.22) | Turner syndrome | Table_S1 | Direct comorbidity |
Q91 | Edwards' syndrome and Patau's syndrome | 10 | 2 | 63.942 | 0.0000000000129 | 0.0000000000428 | 1.65 (24.45) | Down syndrome | Table_S1 | Direct comorbidity |
Q91 | Edwards' syndrome and Patau's syndrome | 6 | 1 | 62.272 | 0.000000149 | 0.00000053 | 5.68 (28.85) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q92 | Other trisomies and partial trisomies of the autosomes. not elsewhere classified | 22 | 2 | 133.698 | 3.28e-26 | 1.09e-25 | 6.07 (20.08) | Down syndrome | Table_S1 | Direct comorbidity |
Q92 | Other trisomies and partial trisomies of the autosomes. not elsewhere classified | 10 | 2 | 65.238 | 0.0000000000105 | 0.0000000000372 | 4.71 (24.72) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q92 | Other trisomies and partial trisomies of the autosomes. not elsewhere classified | 12 | 1 | 110.840 | 0.00000000000000985 | 0.0000000000000323 | 8.61 (15.05) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q92 | Other trisomies and partial trisomies of the autosomes. not elsewhere classified | 7 | 6 | 19.933 | 0.00000172 | 0.00000478 | 3.69 (5.38) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q93 | Monosomies and deletions from the autosomes. not elsewhere classified | 12 | 9 | 22.671 | 0.000000000117 | 0.000000000388 | 7.21 (19.33) | Down syndrome | Table_S1 | Direct comorbidity |
Q93 | Monosomies and deletions from the autosomes. not elsewhere classified | 5 | 4 | 21.351 | 0.0000444 | 0.000157 | 4.01 (12.35) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q93 | Monosomies and deletions from the autosomes. not elsewhere classified | 7 | 6 | 19.488 | 0.00000201 | 0.00000658 | 18.54 (20.94) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q95 | Balanced rearrangements and structural markers. not elsewhere classified | 6 | 3 | 30.165 | 0.00000192 | 0.00000886 | 11.92 (10.2) | Turner syndrome | Table_S1 | Direct comorbidity |
Q96 | Turner's syndrome | 8 | 10 | 14.268 | 0.00000198 | 0.00000656 | 12.69 (5.74) | Down syndrome | Table_S1 | Direct comorbidity |
Q96 | Turner's syndrome | 8 | 11 | 13.344 | 0.00000279 | 0.00000991 | 12.69 (5.74) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q96 | Turner's syndrome | 5 | 6 | 14.949 | 0.000162 | 0.00045 | 11.92 (4.74) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Q97 | Other sex chromosome abnormalities. female phenotype. not elsewhere classified | 16 | 1 | 146.518 | 9.15e-20 | 4.21e-19 | 12.37 (13.84) | Turner syndrome | Table_S1 | Direct comorbidity |
Q98 | Other sex chromosome abnormalities. male phenotype. not elsewhere classified | 5 | 16 | 6.155 | 0.00457 | 0.0151 | 11.12 (20.4) | Down syndrome | Table_S1 | Direct comorbidity |
Q98 | Other sex chromosome abnormalities. male phenotype. not elsewhere classified | 5 | 19 | 5.116 | 0.00908 | 0.0298 | 11.12 (20.4) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q99 | Other chromosome abnormalities. not elsewhere classified | 8 | 1 | 79.662 | 0.000000000323 | 0.00000000162 | 10.13 (16.34) | Patau syndrome | Table_S1 | Direct comorbidity |
Q99 | Other chromosome abnormalities. not elsewhere classified | 15 | 1 | 144.678 | 4.5e-19 | 2.17e-18 | 0.39 (6.05) | Edwards syndrome | Table_S1 | Direct comorbidity |
Q99 | Other chromosome abnormalities. not elsewhere classified | 36 | 27 | 23.044 | 2.58e-29 | 8.55e-29 | 16.79 (19.46) | Down syndrome | Table_S1 | Direct comorbidity |
Q99 | Other chromosome abnormalities. not elsewhere classified | 12 | 8 | 23.402 | 0.000000000109 | 0.000000000659 | 21.41 (11.96) | Klinefelter syndrome | Table_S1 | Direct comorbidity |
Q99 | Other chromosome abnormalities. not elsewhere classified | 11 | 1 | 99.325 | 0.0000000000000946 | 0.000000000000888 | 11.75 (8.8) | XYY syndrome | Table_S1 | Direct comorbidity |
Q99 | Other chromosome abnormalities. not elsewhere classified | 14 | 8 | 28.729 | 0.000000000000414 | 0.00000000000191 | 11.61 (10.64) | Turner syndrome | Table_S1 | Direct comorbidity |
Q99 | Other chromosome abnormalities. not elsewhere classified | 12 | 1 | 108.266 | 0.00000000000000329 | 0.0000000000000105 | 7.54 (11.09) | Cri-du-chat syndrome | Table_S1 | Direct comorbidity |
Q99 | Other chromosome abnormalities. not elsewhere classified | 12 | 13 | 16.521 | 0.00000000133 | 0.00000000472 | 5.97 (23.72) | Down syndrome | Table_S3 | Female DS direct comorbidity |
Q99 | Other chromosome abnormalities. not elsewhere classified | 24 | 14 | 28.420 | 2.69e-21 | 8.83e-21 | 18.12 (16.93) | Down syndrome | Table_S3 | Male DS direct comorbidity |
Q99 | Other chromosome abnormalities. not elsewhere classified | 14 | 22 | 11.375 | 0.00000000211 | 0.00000000587 | 19.57 (14.05) | Down syndrome | Table_S6 | Non-mosaic DS direct comorbidity |
Reference
If you use the information reported in this website please site:
Comorbidity landscape of the Danish patient population affected by chromosome abnormalities
Isabella Friis Jørgensen*, Francesco Russo*, Anders Boeck Jensen, David Westergaard, Mette Lademann, Jessica Xin Hu, Søren Brunak, Kirstine Belling#
*These authors contributed equally to this work.
#Corresponding author. E-mail: kirstine.belling[AT]cpr.ku.dk
If you have any question regarding this website, please write Francesco Russo (francesco.russo[AT]cpr.ku.dk). Webmaster: Troels Siggaard (troels.siggaard[AT]cpr.ku.dk)